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1. Schistosoma mansoni infection 
Schistosomiasis is a chronic, debilitating and poverty-related disease, common in many 
countries in the tropics and subtropics. Humans can become infected with several species of the 
parasitic schistosomes, of which Schistosoma mansoni, S. haematobium and S. japonicum are 
most prevalent. These schistosome species are endemic in different, sometimes overlapping 
areas in the world and show slightly different pathological and epidemiological characteristics 1. 
Like all schistosomes, the most intensely studied species S. mansoni has a complex life 
cycle that involves sexual reproduction in a definitive mammalian host as well as asexual 
reproduction in an intermediate host (Figure 1). During the early, acute stages of S. mansoni 
infection in humans, the dominant immune response against the parasite is T helper 1 (Th1)-
mediated, hallmarked by high levels of interleukin (IL)-1, IL-6 and interferon (IFN)-γ in 
peripheral-blood mononuclear cells (PBMCs), as well as upregulation of serum levels of tumor-
necrosis factor (TNF)-α 2. In some instances, the acute immune responses result in a disabling 
fever called “Katayama fever”, which is mostly observed in travelers infected by schistosomes for 
the first time 3. Upon deposition of eggs by adult female worms, the immune response drastically 
alters. Egg-derived molecules downregulate the initial Th1 response and initiate a marked Th2-
skewed response 4;5. In addition, eggs trapped in the liver and other organs induce periovular, 
Th2-mediated, granulomatous responses, characterized by the presence of alternatively activated 
macrophages, CD4+ T cells, eosinophils and collagen fibers. In the course of time, a regulatory 
response develops which downregulates the strong Th2 response, and granulomas around newly 
deposited eggs decrease in size 1. The egg-induced tissue granulomas and most notably the 
associated fibrosis are the main cause of morbidity in S. mansoni-infected individuals, as these 
reactions can lead to severe hepatic, splenic and intestinal damage.  
 Despite the strong immune responses elicited by schistosomal molecules, generally 
clearance of schistosomes cannot be achieved by the host, resulting in an ongoing chronic 
infestation that can last up to several decades. Therefore, treatment with anti-helminthics is 
required to resolve the infection. Today, the treatment of choice for schistosomiasis is 
praziquantel 6. This drug induces severe muscle spasms and paralysis in male adult worms, 
presumably by increasing the permeability of cell membranes for calcium ions leading to 
dislodgement and death of worms 7. The major disadvantage of this and other currently available 
drugs is that they do not protect individuals from re-infection. Moreover, the drug does not 
directly reverse damage caused by the host immune reaction against tissue-trapped eggs, and life 
stages other than mature worms remain unaffected by the drug 8. Further research on 
schistosome biology and immunology is vital to develop new drugs and find other more long-
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term solutions, such as an effective vaccine. Due to their specific immunological characteristics, 
schistosomes and schistosome molecules make excellent model systems for studying the 
development and function of Th2 and regulatory responses. Potentially, these molecules could 
provide a basis for the development of Th2- and/or Treg-polarizing therapies for the prevention 
of Th1-mediated autoimmune diseases.  
 
2. Schistosoma mansoni glycoconjugates  
Schistosomal glycoconjugates have been acknowledged to play a major role in the activation and 
modulation of the immune system during S. mansoni infection. Glycosylation is a common 
feature of proteins and lipids that pass through the rough endoplasmatic reticulum (RER) and 
the Golgi-complex, and follow the secretory pathway to the cell surface. Proteins can be 
decorated with N- and O-glycans linked to asparagine and serine/threonine, respectively, which 
 
Figure 1 Life cycle of schistosomes infecting humans. Cercariae, released from infested water snails, penetrate 
through the skin of human individuals and shed their tails. The developing schistosomula migrate through the tissue 
and enter blood vessels via which they are transported to the portal veins, where they mature into adults worms.
Upon maturation, female and male worms form pairs and migrate to their final location. The female worms start to
produce eggs, part of which enter the lumen wall of the intestine (S. mansoni and japonicum) or bladder (S. 
haematobium), after which they leave the body via the faeces or urine, respectively. Eggs hatch on contact with fresh
water and release miracidia. These motile larvae can infect snails, in which they asexually reproduce into sporocysts 




are formed via a highly regulated cell- and schistosome life stage-specific process involving the 
concerted actions of glycosyltransferases and other glycosylation-modifying enzyme activities 9. 
As is also the case in many other organisms including humans, a S. mansoni N-glycan consists of 
a Man3GlcNAc2 core that can be decorated with specific core-elements (Table 1) 10-14. The N-
glycans can be divided in three major classes, based on different diversifications of N-glycan 
core; the high-mannose-type, the complex-type and the hybrid-type (Table 1). S. mansoni O-
glycosylation can consist of short mono- or disaccharides, but also of more complex structures 
consisting of conventional mucin-type core 1 and 2 structures, as well as of a S. mansoni specific 
novel core (Table 1) decorated with complex antenna structures 10;14-16. Glycolipids can carry 
typical simple galactose or glucose-linked ceramides, but also larger, more extended glycolipids 
based on a so called “schisto-core” occur (Table 1) 17-19. The non-reducing termini of complex 
glycan structures on schistosomal glycoproteins and glycolipids are typically made up of 
(repetitive) Galβ1-4GlcNAc (LacNAc, LN) and GalNAcβ1-4GlcNAc (LacdiNAc, LDN) 
structures, which can be decorated with one or more fucoses 10-12. Notably, sialic acids, common 
terminal monosaccharides of mammalian antennae motifs, are not found on S. mansoni glycans. 
The precise structural features of schistosome glycans are highly dependent on the life 
stage and cell type in which they are expressed, as well as on the protein backbone by which they 
are carried. In the next paragraphs, the general characteristics of the glycoconjugates observed in 
cercariae and schistosomula (paragraph 2.1), adult worms (paragraph 2.2) and eggs and 
miracidia (paragraph 2.3), are described, as well as the current knowledge on the immune 
responses elicited by these structures. Finally, paragraph 2.4 will focus on the glycan-directed 
antibody responses observed during S. mansoni infection.  
 
2.1 Glycoconjugates of cercariae and schistosomula  
A clear feature of both protein- and lipid-linked glycans in cercariae is the abundance of LN- 
backbones, of which the immunogenic glycan motif Galβ1-4(Fucα1-3)GlcNAc (Lewis X, LeX) is 
most observed. LDN-based structures are present as part of the cercarial glycocalyx O-glycans, 
but in glycolipids and N-glycans they occur only in minor amounts 11;13-15;18. The majority of 
cercarial N-glycans are decorated with a core β2-xylose as well as an α6-fucose, while no core α3-
fucosylated glycans are detected in this life stage 11. Interestingly, the cercarial glycocalyx has 
been reported to carry complex O-glycans with repeating units of unique multi-fucosylated 
(Fucα1-2Fucα1-3, DF) LDN motifs 16. The cercarial glycolipids in addition to LeX express the 
Fucα1-3Galβ1-4(Fucα1-3)GlcNAc (pseudo-LeY) motif 18, which to date has not been observed 




The glycosylation of the schistosomula, which develop after transformation of the 
penetrating cercariae, is less thoroughly studied. While O-linked and lipid glycosylation have 
never been analyzed, one mass spectrometric analysis of N-glycosylation of in vitro transformed 
3-day old schistosomula has been published 13. In comparison to cercariae, the expression of LN 
and LeX-containing glycans is reduced, and truncated glycans are more prevalent. Xylosylation 
of complex glycans is nearly absent, but a major fraction of truncated glycans still carries this 
motif. Monoclonal antibody (mAb) studies have indicated the presence of LeX, LDN and 
GalNAcβ1-4(Fucα1-3)GlcNAc (LDN-F) on the surface of schistosomula 20;21. As LDN and LDN-
F motifs are not clearly detectable on N-glycans of schistosomula, these might be expressed by 
O-glycans and/or glycolipids. 
Many studies have indicated that in vitro killing of cercariae and schistosomula can be 
initiated by host complement complexes 20;22-25 and antibody-dependent cell mediated 
cytotoxicity (ADCC) 26-29. In some instances, the recognition of parasite glycans has been 
demonstrated to be involved in these immune processes 20;22;29. The glycocalyx of cercariae seems 
to activate the alternative pathway of complement binding, leading to efficient killing of a 
majority of cercariae 22. Schistosomula on the other hand are less susceptible to killing via this 
complement pathway 22, but instead can be targeted via the classical pathway, which requires 
Table 1. S. mansoni glycan structures (A) Core structures as present on S. mansoni N-glycans, O-glycans and 
glycolipids (B) N-glycans can be divided into three classes based on the antenna structures. The high-mannose 
type glycans carry multiple mannose residues. The complex type glycans carry up to four antenna structures 
consisting of a wide array of glycan motifs, including the ones displayed in table 2. The hybrid type carries one 




antigen-specific antibodies for its initiation 20;24;25. It was demonstrated that antibodies against 
LDN in the presence of complement could mediate in vitro lysis of schistosomula, indicating 
that glycan epitopes on the surface of schistosomula could be targets for antibody-mediated 
complement killing 20. Killing of schistosomula, at least in vitro, can also be mediated by ADCC 
mechanisms, which involve eosinophils, macrophages or platelets that bind to antigen-specific 
IgE bound on the surface of the schistosomula 26-28. In this respect, eosinophil-mediated killing 
was shown to be dependent on the interaction between LeX structures and selectins, both of 
which are expressed on eosinophils as well as schistosomula 29.  
Despite the clear evidence that the human immune system has the tools to kill the 
larval life stages of S. mansoni, infected individuals are generally unable to eradicate the parasite. 
Schistosomes appear to be masters of immune evasion but the exact mechanisms behind this, 
which involve shedding of the glycocalyx, membrane turnover, acquisition of host molecules 
and the induction of anti-inflammatory and regulatory immune responses by later life stages, are 
still elusive.  
 
2.2 Glycoconjugates of adult worms 
Upon maturation of the larvae into adult worms, xylosylation and α3-core fucosylation of N-
glycans totally disappears, and LeX structures become less abundant. Instead, N-glycosylation of 
adult worms is mainly characterized by α6-core fucosylated, mono- and di-antennary glycans 
terminating with LDN 12;13. Minor glycan subsets on adult worms include diantennary glycans 
with mixed LDN, LN and LeX termini as well as linear repeats of these structures 12. Although 
male and female glycans in general display a similar N-glycosylation profile, subtle differences in 
the minor glycan subsets are observed, with females expressing more LN/LeX-type glycans, 
whereas LDN/LDN-F-type glycans are more prevalent in males 30. MAb stainings revealed that 
these gender-specific glycans were at least in part found on the tegument, which might have 
consequences for the type of immune responses elicited by the two sexes. O-glycans could not be 
directly detected within the adult worm extract also used to characterize the N-glycans 12, 
however worms were shown to excrete the highly antigenic circulating anodic antigen (CCA) 
and circulating cathodic antigen (CAA) from the gut that carry long O-linked carbohydrate 
chains containing repeats of LeX units and a GlcA-substituted GalNAc polymer, respectively 31;32. 
Worm glycolipids have to date been poorly defined in terms of glycosylation. However, using 
defined anti-glycan antibodies, the presence of (multi-)fucosylated LDN structures including 
LDN-F and LDN-DF was demonstrated on worm glycolipids 33, as well as the presence of LeX 34.  
Interestingly, worm glycolipids were demonstrated to induce Th1 responses via 
modulation of dendritic cells (DCs) in vitro, a process which was shown to be dependent on 
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fucosylated glycan motifs on the glycolipids as well as DC-specific ICAM-3-grabbing 
nonintegrin (DC-SIGN) and TLR4 on DCs 34. It was hypothesized that DC-SIGN binds the 
fucosylated structures on glycolipids, thereby facilitating the binding of the lipid entity to TLR4 
and the induction of DC maturation via intracellular signaling cascades. This might provide a 
mechanism via which parasite glycans induce the initial Th1 responses as observed in infected 
humans and in animal models. 
CCA and CAA are excreted in such high levels by the worms that they are detectable in 
the serum and urine of infected individuals 35. They are widely used as diagnostic targets in 
epidemiological studies using specific mAbs that recognize glycan epitopes on these antigens 36.  
 
2.3 Glycoconjugates of eggs and miracidia 
The glycan profile of eggs evidently differs from that of adult worms. Within the N-glycan pool, 
β2-core xylosylation as observed in the cercarial stage re-appears, and a set of α3-core 
fucosylated glycans can be detected. As in most other life stages, antenna structures on N-, O- 
and lipid glycans for a large part consist of fucosylated LN and LDN motifs, including LeX and 
LDN-F structures 10;17. Another characteristic feature of egg glycans is the occurrence of multi-
fucosylated antenna structures containing the Fucα1-2Fucα1-3 motif 10;14;19. On glycolipids, these 
motifs are expressed in the form of repeating -4(Fucα1-2Fucα1-3)GlcNAcβ1-units terminating 
with (Fucα1-2)0/1Fucα1-3GalNAcβ1- at the non-reducing end.  
The N-glycans of miracidia seem to be very similar to the ones found on eggs 13, which 
is not surprising as the miracidium constitutes a major part of the mature egg (Figure 2). 
However, eggs contain certain additional, minor glycan structures which are most likely to be 
expressed on glycoproteins from the subshell area within the egg, and possibly the egg shell itself 
13. The glycan structures of miracidial O-glycans and glycolipids have not been analyzed yet, but, 
as observed for N-glycans, are expected to be largely similar to the respective egg glycans.  
Schistosome egg glycoconjugates and most notably the secreted egg (glyco)proteins 
(ES) contain potent immunomodulatory agents. In part 3 of the general introduction, we will 
focus on S. mansoni egg glycoproteins and their interactions with the host immune system.  
 
2.4 Anti-glycan antibody responses during S. mansoni infection 
It has long been acknowledged that schistosome glycans are important targets of the strong 
antibody responses observed during natural and experimental infections 20;37-39. Antibody 
responses against many schistosomal motifs including LeX, LDN, F-LDN, LDN-F and LDN-DF 
and F-GlcNAc 20;39;40 have been found. The most intense antibody responses in humans and 




against Fucα1-3GalNAc motifs 41-44, structures which are abundantly expressed on schistosome 
glycoconjugates but are uncommon in mammals. However, it should be noticed that the 
knowledge on antigenic glycans is far from complete due to the limited amount of glycan 
elements that have been studied. New technologies such as glycan arrays are expected to provide 
information on antibody responses in schistosomiasis cohorts to a much more complete set of 
antigenic glycans 45. 
Despite the differential antibody responses observed during S. mansoni infection 
against many parasite glycans, it remains to be established whether these antibodies could 
generate protective immune responses. In fact, it has been suggested that these high anti-glycan 
responses may even function as a “smokescreen”, preventing the generation of an effective 
humoral response 39. However, certain antibodies against parasite glycans have been reported to 
confer protection in animal models 46;47, as well as induce protective responses in vitro 20. 
 
3. Schistosoma mansoni eggs and the host immune system 
There is increasing evidence that the interplay between egg glycoproteins and C-type lectin 
receptors (CLRs) on host immune cells plays an important role in shaping immune responses 
during schistosomiasis. Paragraph 3.1 gives an overview of the molecular aspects of S. mansoni 
egg glycoproteins. Most experiments investigating the immunomodulatory properties of eggs so 
far have been performed using the complex (glyco)protein preparation SEA (Soluble Egg 
Antigens), as summarized in paragraph 3.2. The studies in addition indicated that a significant 
part of the immunological activity associated with these preparations seems to be mediated by 
the glycans present on SEA glycoproteins (paragraph 3.3). These glycans are thought to dictate 
interactions with CLRs and mediate antigen uptake by antigen presenting cells (APCs). 
Paragraph 3.4 gives an overview of the CLRs putatively involved in SEA glycan recognition, 
while paragraph 3.5 discusses SEA glycans which form possible ligands for these receptors. 
Importantly, it is still largely unclear which individual glycoproteins within SEA are 
immunologically active, as discussed in paragraph 3.6. 
 
3.1 Structural aspects of the Schistosoma mansoni egg and SEA 
S. mansoni eggs are released by female worms in an immature form consisting of an egg shell of 
cross-linked proteins containing an ovum and vitelline cells. While still in the host, the egg 
matures during 5-6 days by the development of the ovum to a miracidium, and the formation of 
the Von Lichtenberg’s envelope on the inside of the egg shell from which proteins are secreted 
into the environment through pores (Figure 2) 48;49. Many of the eggs traverse the gut tissue and 
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are excreted with the feces, but a significant number get lodged downstream in the liver where 
they eventually die. The host reacts to eggs and egg products by inducing a Th2-mediated 
immune response which may lead to granulomatous inflammation and pathological tissue 
remodeling and fibrosis 50. It is not clear if particular egg components are critical for the 
extravasation of the eggs from the blood vessels. Since freshly laid immature eggs are not yet 
believed to secrete proteins 48;49, one could hypothesize that the egg shell is involved in this 
process. More clearly however, the eggs’ secretory proteins which are formed in the sub-shell 
area upon maturation and secreted into the egg’s environment 49, induce a major immune 
response of the host that appears to be leading to Th2 polarization. To other components of the 
egg, such as the hatching fluid and most of the soluble SEA glycoproteins, the host will most 
likely be exposed only when eggs die and fall apart in host tissues.  
While a number of recent studies have identified single components of SEA and ES 
with immunomodulatory properties 51-55, the vast majority of all molecular studies into the 
immune mechanisms induced by schistosome eggs have been performed using SEA. SEA is a 
complex mixture of proteins of a potentially variable composition depending on the 
developmental stage of the eggs and the solubilisation procedure used. The properties of such 
preparations have been studied in vitro, e.g. in DC/T-cell skewing and signaling assays 54;56-59, and 
in vivo, e.g. by injections into an array of wild type, transgenic and knock-out mice 4;60;61. 
 




Proteomics studies using 2D-gel electrophoresis and mass spectrometry have shown that over a 
thousand proteins can be detected in SEA, with a broad range of functions on target cells. These 
can be exerted either inside (e.g. cytosolic and nuclear proteins) or outside (e.g. membrane 
proteins, secretory proteins) a cell 49;62. Although few studies have been conducted on individual 
SEA glycoproteins, it is clear that many SEA components are glycosylated 1;33. Structural studies 
on preparations of N- and O-glycans released from the peptide backbones have shown that SEA 
glycoproteins collectively display a very complex set of glycans, comprising specific schistosome 
glycans, as well as glycans expressed in the mammalian host (Table 2) 10;14. Each type of glycan or 
glycan element can be present on a larger subset of SEA glycoproteins 33. SEA includes the 
excretory/secretory (ES) (glyco)proteins, but it does not contain water insoluble glycoconjugates, 
including membrane glycoproteins and hydrophobic glycolipids, unless specific solubilisation 
procedures were followed.  
 
3.2 Immunomodulatory properties of SEA 
SEA consistently is an inducer of Th2 responses in different types of experiments either in vitro 
or in vivo and both in humans and in animal models. A central role in the initiation and 
modulation of these responses is played by APCs such as DCs and macrophages. APCs 
continuously sample their environment for “danger” signals derived from invading pathogens, 
upon which they migrate to lymph nodes to instruct T cells to polarize.  
Studies of DCs have been instrumental in understanding the polarization of immune 
responses towards Th2 by SEA 5;56-60. While DCs fail to show classic signs of maturation when 
stimulated with SEA 59;60, in vitro experiments show that SEA-primed monocyte-derived human 
and murine DCs are very potent in polarizing naive Th cells towards a Th2 type 5;56;60. In 
accordance with the in vitro data, eggs injected into the footpad 4 as well as SEA-primed bone 
marrow-derived DCs injected intraperitoneally 60 can induce Th2 responses in mice. Apart from 
inducing Th2 responses, SEA is also able to interfere with Toll-like receptor (TLR)-mediated DC 
activation 57;59. SEA can suppress maturation and cytokine production of human and murine 
DCs induced by the TLR4 ligand LPS and the TLR3 ligand poly-I:C 57;59. Recently, a single ES 
glycoprotein omega-1 has been shown to exert similar Th2-inducing and TLR-modulating 
effects on DCs as does SEA 54;55, as discussed in paragraph 3.6.  
Components of SEA are also suggested to play a role in the initiation and modulation 
of periovular granulomatous responses observed in host tissues. When eggs lodge into organs 
such as the liver, host APCs initiate a granulomatous response which is thought to protect the 
host from overt reactions to egg molecules. In hepatic as well as pulmonary mouse models using 










Table 2. Typical glycans and glycan elements on S. mansoni SEA and ES 
a granulomatous response 63;64, giving rise to granulomas with a comparable cellular composition 
to those around schistosome eggs 63;65. 
 
3.3 Glycan-mediated activities of SEA 
Several studies show that the observed immunomodulatory properties of SEA are at least in part 
dependent on the interaction of glycosylated egg proteins with glycan receptors on APCs. In a 
mouse model of intranasal sensitization, SEA but not SEA pretreated with metaperiodate could 
induce Th2-type responses including antigen-specific IgE production and induction of IL-4 66. 
Metaperiodate treatment destroys glycan integrity and functionality by disrupting the ring 
structure of monosaccharides such as mannose, galactose and fucose, abundant constituents of 
SEA glycans. Cells from lymph nodes of mice injected with DCs conditioned with SEA produced 
significantly more IL-4 and IL-5 upon in vitro restimulation than lymph node cells from mice 
that received metaperiodate-treated SEA-pulsed DCs 67. Production of IFN-γ was similar 




metaperiodate treatment could theoretically also have a destabilizing effect on the protein 
backbone and therefore disrupt the integrity of the glycoproteins, support for a role of glycans in 
Th2-skewing comes from studies using HSA-conjugated LNFPIII. It has been shown that this         
conjugate of LNFPIII, a pentasaccharide terminating with the LeX epitope, has Th2-skewing 
properties mimicking those of SEA in the murine model of intranasal sensitization 66;68. 
Furthermore, a Dextran-LNFPIII conjugate shows similar DC-modulating effects as SEA 69, and 
at least one glycoprotein carrying glycans terminating with LeX has been found in SEA 70.  
SEA glycans may also play a role in the initiation and modulation of periovular 
granulomatous responses observed in host tissues. In the hepatic mouse model, it was 
demonstrated that beads that carry SEA with glycans destroyed by metaperiodate treatment were 
no longer able to induce granulomas, but elicited only a monolayer of cells comparable to 
uncoated or albumin-coated beads 65. A set of model glycoconjugates carrying various synthetic 
oligosaccharides characteristic for schistosome eggs was tested in the same mouse model. From 
this set, only LDN- and LN-terminating glycoconjugates were able to induce granuloma 
formation. In contrast, glycoconjugates with terminal LeX, fucosylated LDN or GlcNAc, elicited 
only a monolayer of macrophages 71.  
 
3.4 C-type lectin receptors for SEA  
Distinctive glycan elements abundantly present on SEA and ES glycoconjugates are recognized 
by pattern recognition receptors (PRRs) 72;73. APC are equipped with an array of PRRs, including 
CLRs and TLRs, in order to recognize and differentiate between pathogens by binding pathogen-
associated molecular patterns (PAMPs) and instruct the immune system to mount a dedicated 
response. Although TLR4-mediated signaling by the LeX-containing glycoconjugate Dextran-
LNFPIII has been reported 74, and LDN, a terminal disaccharide element of SEA glycans, is a 
ligand for the S-type lectin galectin-3 on macrophages 75, the CLRs appear to be the most 
relevant PRRs for schistosome egg glycans. All CLRs carry one or more carbohydrate 
recognition domains (CRD), which determine the specificity of a CLR for specific pathogen-
derived molecules such as polysaccharides, glycolipids and glycoproteins. Binding of such 
molecules to CLRs typically leads to internalization, processing and antigen-presentation on 
MHC class I and II molecules. In addition, it was shown that binding of microbial ligands to 
CLRs can trigger induction of signaling cascades which lead to immune modulation, either by 
modulating TLR-induced signaling, or by direct induction of gene expression (as reviewed in 76).  
Many glycan structures found in SEA, including LeX, LDN and (multi-) fucosylated 
LDN, interact with CLRs (Table 3) 59;73;77;78. It has been shown in an in vitro model that DC-
SIGN, mannose receptor (MR) and macrophage galactose-type lectin (MGL) are the primary 
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recognition and uptake receptors on human monocyte-derived immature DCs for SEA 59. In the 
same system it was shown that exposure of DCs to SEA leads to Th2 skewing, but it was not 





By biochemical binding assays such as ELISA and glycan arrays is has been shown that 
DC-SIGN binds to many fucosylated motifs including (non-sialylated) Lewis antigens and LDN-
F 72;79. Guo et al. showed that recognition of LeX by DC-SIGN is conferred by binding of the α1-3 
fucose in a primary binding site of DC-SIGN, while the terminal galactose binds a secondary 
binding site 72. This implicates the necessity for a specific presentation and glycosidic linkage of 
the fucose residue as part of an oligosaccharide to be able to fit the binding sites of DC-SIGN. 
Indeed, α3- and α6-linked core fucoses 79 as well as LDN-DF 77 do not seem to be recognized by 
DC-SIGN. In addition to fucose-containing glycan motifs, DC-SIGN also binds N-linked high 
mannose-type glycans, as the binding pocket of DC-SIGN is able to bind multiple mannose 
residues 72;80. Interestingly, the type of ligand binding to DC-SIGN affects the immunological 
outcome, as recognition of respectively mannose- or fucose-containing glycans leads to distinct 
signaling pathways 81.  
L-SIGN, also named DC-SIGNR, is a DC-SIGN homologue that binds multi-
fucosylated motifs as well as mannosylated motifs 72;78. Interestingly, L-SIGN is expressed on 
liver sinusoidal endothelial cells (LSECs), but not on DCs and macrophages 82. In the liver, 
LSECs are part of the internal lining of blood vessels and they express high levels of adhesion 
receptors and lectins including MR and L-SIGN 83. LSECs are suggested to mediate the clearance 
of antigens from the circulation in a similar manner as DCs do 82;84.  
In mice, seven homologues of human DC-SIGN are found that closely resemble DC-
SIGN in terms of protein sequence and structure of the CRD domain 85;86. However, glycan array 
screening revealed that only SIGNR1 and SIGNR3 share with DC-SIGN the ability to bind both 
high mannose and fucose-containing glycans 86-88. SIGNR1 is expressed on murine macrophages 
and has been shown to bind SEA 89. Unlike DC-SIGN, SIGNR1 binds sialylated Lewis antigens in 
addition to unmodified Lewis antigens 87. Notably, SIGNR1 does not play a critical role during 
infection, as S. mansoni-infected SIGNR1-/- mice show an unaltered phenotype in terms of 
granulomatous responses and pathology 89. Moreover, in a pulmonary mouse model, the 
granuloma volume around in jected eggs as well as levels of IL-4, IL-10 and IFN-γ in lung tissue 
did not significantly differ between normal and SIGNR1-/- mice 89. SIGNR3 is reported to more 
closely resemble the glycan specificity of DC-SIGN 86 and it has been shown to mediate 
endocytosis and signaling 86;90. However, while DC-SIGN is abundantly expressed on human 
DCs 91, SIGNR3 in mice is expressed on small subsets of DCs, macrophages and monocytes in 
the skin, lungs and lymphoid organs only 92. Taken together, to date no murine receptor has 
been found which resembles human DC-SIGN in terms of binding and signaling properties as 
well as expression on APCs, which may have implications when studying the glycan-dependent 
immunomodulatory properties of SEA in mice. 
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Human MR has a slightly overlapping specificity with DC-SIGN and binds glycans 
terminating in mannose, fucose and GlcNAc residues 80;93. The binding motifs for MR have not 
been reported in detail; however it has been shown that MR is unable to effectively bind LeX 
residues, which may be caused by the steric hindrance of the galactose residue in the LeX 
structure 80. Furthermore, although MR can bind single mannose residues, it binds more 
complex mannose structures with higher affinity 80;93. In mice, one clear MR homologue exists 
which exhibits binding properties comparable to human MR 93. The expression of MR on 
macrophages and DCs, as well as the amino acid sequence of the eight CRD domains are well 
conserved among humans and mice 94;95.  
Finally, MGL is a CLR expressed by immature human DCs and macrophages. In 
contrast to DC-SIGN, MR and in fact most other CLR, MGL is unable to bind fucose and 
mannose residues. Instead, MGL has a narrow specificity for non-substituted, terminal α- and β-
linked GalNAc 73. In mice, two MGL homologues are found, named mMGL1 and mMGL2 96;97. 
Like human MGL, mMGL1 and mMGL2 are expressed by immature DCs and macrophages. 
However, only mMGL2 shares its narrow glycan specificity for GalNAc with human MGL, 
whereas mMGL1 primarily binds unsubstituted terminal galactose 97;98.  
 
3.5 Molecularly defined CLR ligands in SEA 
It is yet unknown which egg glycans and CLRs are responsible for the modulatory effects of SEA 
via APCs. The reported importance of DC-SIGN, MR and MGL in the recognition and uptake of 
SEA 59 would suggest a role for these receptors and specific subsets of SEA as ligands. Many of 
the glycan motifs recognized by these CLRs have indeed been found to be abundantly present in 
SEA by chemical structural studies (Table 2). LeX and LDN-F have been shown to be involved in 
DC-SIGN-SEA binding 77. Moreover, LDN and LDN-F have been shown to be binding ligands 
for MGL in SEA 73, while MR could potentially bind fucosylated LDN motifs. In addition, SEA 
glycosylation also contains high-mannose N-glycans, which are potential ligands for DC-SIGN, 
L-SIGN and MR.  
The glycosylation of an important immunomodulatory subfraction of SEA, the ES 
glycoproteins, has also been extensively studied 14. The major complex N-glycan structures and 
the O-glycans are rather similar for ES and SEA-released glycans, although high-mannose and 
truncated N-glycan structures were found to be less abundant in ES glycoproteins than in SEA. 
While many other helminths also carry potential CLR ligands such as the LDN-F motifs and 
other fucosylated HexNAc motifs, only Dictyocaulus viviparus and schistosomes have been 





3.6 Which individual glycoproteins in SEA are immunomodulatory via CLR?  
Although it would be fair to hypothesize that SEA glycoproteins that carry LeX and other CLR 
ligands are the natural molecules responsible for glycan-induced Th2 induction that has been 
observed with other LeX-containing glycoconjugates, this has not been proven so far. Most 
structural information about SEA glycans has been obtained by releasing the glycans from the 
protein mixtures, SEA or ES, thereby losing all information about which individual proteins and 
glycans actually combine. To date, only one glycoprotein from S. mansoni eggs has been studied 
in detail in terms of glycosylation. IPSE/α1 102 (also named SmEP25 103 / SmCKBP 104) is a major 
constituent of ES 62;105 and for the most part carries diantennary N-glycans of the complex-type 
70. The antennae are mainly composed of LeX and LN structures, with a minority composed of 
(fucosylated) LDN structures. In addition, the innermost core GlcNAc is typically decorated 
with α3/α6 difucosylation. IPSE/α1 has been shown to exhibit Th2-regulatory properties, as it is 
capable of inducing IgE-dependent IL-4 in human basophils 52;102 and an innate IL-4 production 
by murine basophils 106. However, non-glycosylated recombinant IPSE/α1 induced similar effects 
on basophils as native IPSE/α1 106, indicating that the LeX glycans of IPSE/α1 are in this case not 
playing a critical role. IPSE/α1 also seems to play an anti-inflammatory role during 
granulomogenesis by reducing cellular infiltration into granulomas 104. This effect is likely to be 
explained by the chemokine binding properties of IPSE/α1, as Smith et al. showed that IPSE/α1 
can block interaction of chemokines with their host chemokine receptors and inhibit their 
biological activity in vivo 104, indicating that glycans are probably also not involved in the effects 
of IPSE/α1 on downregulation of granuloma formation. 
Another ES glycoprotein, omega-1 107, harbors potent Th2 skewing activities via 
modulation of DCs 54;55. Omega-1-treated DCs are capable of generating Th2 responses in in 
vitro studies 54;55 as well as when transferred into naive mice 55. Furthermore, omega-1 is a major 
factor in SEA and ES that conditions DCs for Th2 priming 54;55, although SEA depleted from 
omega-1 still harbors Th2-inducing capacities, both in vitro and in vivo 54. RNAse inhibition 
experiments indicate that the RNase activity of omega-1 might be involved in Th2 skewing 55.  
A third major S. mansoni egg glycoprotein is kappa-5 54. The function of kappa-5 is 
unknown, but it is present in high amounts in SEA, and although not produced in the sub shell 
envelope but by the miracidium, it appears to be a constituent of the hatching fluid. 
Interestingly, S. mansoni infected individuals often mount pronounced IgE responses against 
this glycoprotein 108. As opposed to natural kappa-5, recombinant kappa-5 expressed in human 
embryonic kidney (HEK) cells does not reveal any IgE reactivity. Since mammalian-derived 
HEK cells have a different glycosylation repertoire from schistosomes, this may point to a role of 
specific glycans as the IgE target 108. It has been demonstrated that kappa-5 is the primary S. 
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mansoni SEA constituent that binds to soybean agglutinin (SBA), a lectin specific for terminal 
α/β-D-GalNAc 108. This indicates that kappa-5 carries LDN, which is a common S. mansoni 
glycan epitope to which several immunogenic properties have been attributed 20;38;71;75. 
In addition to glycoproteins, S. mansoni eggs also excrete a series of multi-fucosylated 
free glycans 109, which structurally resemble egg glycolipid glycans 19. Although this has not been 
tested so far, it would not be surprising if these oligosaccharides could bind to the same CLRs as 
the multi-fucosylated glycolipids or glycoproteins. Meyer et al. showed that glycosphingolipids 
from schistosome eggs were bound by L-SIGN as present on LSECs, presumably via Fucα1-
3GalNAcβ1-4(Fucα1-3)GlcNAc (F-LDN-F) motifs, and these may have a function in the initial 
immune recognition of schistosome eggs when they enter the liver 78. In in vitro experiments 
using PBMCs of donors unexposed to schistosomes, egg glycolipids carrying difucosylated (DF) 
HexNAc motifs could trigger cytokine responses, whereas worm glycolipids, in which those 
motifs are absent, could not 110. The functional consequences of the interaction with CLRs of 
these glycans and glycolipids may differ from that of (multivalent) protein-conjugated variants. 
Finally, it might be relevant that the insoluble egg shell also appears to be glycosylated 111, but it 
is not yet clear if egg shell-associated glycans could exhibit immunoregulatory properties and 
what the exact structure of these glycans is. 
 
4. Multivalency and molecular presentation of CLR ligands 
Conclusions about the immunomodulatory potential of the SEA glycoprotein ligands for CLRs 
cannot easily be drawn from primary structural data and binding assays. The involvement of 
DC-SIGN, MR and MGL on DCs in SEA binding and uptake was discovered initially using a 
system where SEA was covalently coupled to fluorescent beads 59. Such a system may not be 
entirely representative for secreted/excreted glycoproteins, such as those that are present in ES, 
which are not bound to a solid surface, particle or pathogen. Multivalency is an important aspect 
of CLR binding and subsequent signaling since the spatial presentation of glycans as well as the 
degree of multimerisation of receptors is of importance to generate stable interactions. The MR 
for instance is able to recognize oligomannose structures more efficiently than single mannose 
monosaccharides. This specificity has been shown to be dependent on the presence of multiple 
CLR domains within a single MR molecule 93;112. In contrast to MR, most other CLRs contain 
only one CRD domain, however receptors have been reported to oligomerize, often resulting in 
enhanced affinity for multivalent ligands 80;113-116.  In vitro, soluble DC-SIGN molecules can form 
tetramers stabilized via an α-helical stalk, which has been demonstrated to amplify the specificity 




SIGN specificity in a glycan array using a bivalent DC-SIGN-Fc molecule 79. In this assay they 
found a 4-fold increase in binding affinity of bivalent DC-SIGN-Fc towards N-glycans carrying 
diantennary LeX or diantennary LDN-F, compared to the respective monovalent trisaccharide 
determinants. Indeed, for DC-SIGN the manner of presentation of a ligand might influence its 
affinity due to clustering of this receptor on the cell surface. Immature DCs have been reported 
to express DC-SIGN in nanometric microdomains, whereas on intermediate DCs, which 
represents an earlier stage of DC development, DC-SIGN is randomly distributed along the cell 
surface 115;116. This clustering of receptors on the cell membrane of immature DCs significantly 
enhanced binding and internalization of virus particles, while recognition of larger particles 
remained similar 115. Due to this DC-SIGN clustering on immature DCs, soluble molecules 
would be recognized differentially as molecules presented on a solid surface of particles or beads, 
or at the surface of a cell or on a pathogenic organism. Similarly, multivalency or clustering 
density will be an important parameter when using synthetic model glycoconjugates to study the 
immunological aspects of S. mansoni glycans, as small carrier-coupled glycans will not 
necessarily mimic their natural counterparts from schistosome eggs. 
 
5. Glycosylation analysis of S. mansoni egg glycoproteins 
In depth structural information on the glycans of S. mansoni egg glycoproteins is commonly 
generated using mass spectrometry (MS)-based methods. A thorough sample preparation, as 
described in paragraph 5.1, is an essential part of these methods. A mass spectrometer generally 
consists of an ionization source, a mass analyzer and an ion detector. The ionization source 
converts the sample molecules into positively or negatively charged ions. These ions are then 
directed into a mass analyzer where they are separated according to their mass over charge (m/z) 
ratio and detected to generate a mass spectrum. First choice MS set-ups for the structural 
analysis of glycan and glycopeptides mixtures are matrix-assisted laser desorption ionization-
time of flight (MALDI-TOF)-MS (paragraph 5.2) and electrospray-ionisation (ESI)-ion-trap MS, 
(paragraph 5.3), the latter of which is typically on-line coupled to a liquid chromatography (LC) 
system in order to separate the sample prior to analysis. Tandem mass analysis (MS/MS) is 
generally used to further determine the composition and sequence of glycan structures 
(paragraph 5.4).  
Although these MS-based techniques can provide a wealth of structural information, 
the identity (e.g. galactose vs mannose) and linkage position of the constituting 
monosaccharides in a glycan can usually not be directly deduced. Additional techniques can be 
exploited to complement and extend the MS data, which might include the use of specific exo-
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glycosidases, permethylation and anti-glycan antibodies. To generate an overview of the 
techniques used for the in depth analysis of S. mansoni egg glycans, current studies on the glycan 
analysis of complex egg glycoprotein preparations are summarized in paragraph 5.5, whereas 
paragraph 5.6 describes a study on the glycosylation of a single egg glycoprotein. 
 
5.1 Sample preparation 
The majority of S. mansoni glycan data is obtained from glycans released from complex total life 
stage preparations by enzymatic or chemical treatments 10-14;16. N-glycans are commonly released 
using PNGase F and/or PNGase A, as these enzymes provide fast and reliable results 117. PNGase 
F releases all N-glycans except those containing a fucose α3-linked to the innermost GlcNAc of 
the N-glycan core, while PNGase N cleaves off all N-glycans irrespective of their nature, in each 
case provided that the glycosylation sites have been made accessible by denaturation or 
proteolytic digestion of the protein. As the α3-core fucose is a common modification in 
schistosome glycoproteins, sequential treatment with the two enzymes can already provide 
useful information on the type of glycans present. To facilitate detection and analysis of released 
glycans, the reducing end of the glycans can be labeled with a fluorescent tag, such as 2-
aminobenzoic acid (2-AA) and 2-aminobenzamide (2-AB). For the release of O-glycans, no 
enzyme is presently available due to the diversity of O-glycan core structures (Table 1). A 
common and reliable chemical method to release O-glycans from their protein backbone is 
reductive β-elimination 118;119.  
The analysis of released glycans is an easy and fast way to assess a diversity of glycan 
structures in complex mixtures. However, crucial information is lost about how individual 
proteins are glycosylated. Therefore, the direct analysis of glycans still attached to peptides of 
isolated, native glycoproteins is a recently-emerging technique. Glycoproteins are treated with 
an appropriate protease (e.g. trypsine) to generate peptides containing a single glycosylation site, 
and the resulting glycopeptides are analyzed directly by MS. Up till now, such an in-depth 
glycosylation analysis been carried out for only one schistosome glycoprotein, the ES egg 
glycoprotein IPSE/α1 70, as discussed in paragraph 5.6. 
 
5.2 MALDI-TOF-MS 
In MALDI-TOF-MS, a sample is generally co-crystallized with an ultraviolet-absorbing matrix 
on a target plate, and ionised by a laser pulse. The resulting molecular ions, which are normally 
singly charged due to the soft ionization method, are then accelerated in an electric field and 
detected by a TOF mass analyzer. This analyzer detects the time that each ion needs to travel 




directly correlated to their m/z ratio. Although the exact ionization mechanisms are unclear, it is 
thought that the matrix absorbs the laser energy and transfers part of the energy to the sample, 
resulting in the ionization and transfer of the sample to the gas phase 120;121.  
MALDI-TOF-MS is very suitable for the analysis of small amounts of glycans or 
glycopeptides, as it can detect ions in the femtomole to picomole range. A decent sample clean-
up is essential though, as salts or other impurities in the sample can hamper analysis. Low 
abundant molecules in complex mixtures can however easily be missed due to limitations in the 
dynamic range of detection. Separation of the mixture (e.g. by using chromatography) prior to 
measuring can overcome this problem.  
 
5.3 ESI-MS 
In a standard ESI-MS setting, a solution containing the sample is dispersed via a metal-tipped 
glass capillary into a fine spray of highly charged droplets. The droplets are accelerated by high 
voltage and evaporate under a drying gas at atmospheric pressure, creating (multiply) charged 
molecular ions that can be analyzed by a mass analyzer. Nano-ESI-MS is a variation on ESI-MS 
for which only very small amounts of sample are required. This technique is more sensitive 
compared to standard ESI-MS and is more tolerant of salts and impurities 122;123.  
As ESI-MS involves the continuous flow of liquids, it is very suitable for the online 
coupling to a LC system. This allows easy purification and/or separation of the sample prior to 
mass analysis. Separation of glycans and glycopeptides is dependent on their retention time on 
the stationary phase of a LC column. LC methods commonly used for the separation of glycans 
and glycopeptides are Hydrophilic Interaction LIquid Chromatography (HILIC) and Reverse 
Phase (RP) chromatography. In HILIC, glycans are retained by hydrogen bonding, ionic 
interactions and dipole-dipole interactions. These HILIC features enable separation of glycans 
and glycopeptides on the basis of size, presence of glycan modifications and sometimes even 
allow separation of isomeric structures. For RP chromatography, retention is primarily based on 
the hydrophobic properties of the peptide moiety (glycopeptides) or an added fluorescent tag 
(released glycans). Therefore, glycan variation on a certain glycosylation site, the so-called 
microheterogeneity, can be easily picked up as glycopeptides with the same peptide moiety but 
different masses elute at similar time points. Notably, certain monosaccharide moieties slightly 
influence the retention time, causing small shifts for some glycan variants. By coupling an LC 
system with (nano-)ESI-MS, low quantity molecules in a complex mixture are more effectively 





5.4 Tandem mass spectrometry 
Many MS instruments have the capacity to determine the composition of glycans by the 
fragmentation of selected precursor ions, a process which is called tandem MS or MS/MS. The 
order in which monosaccharides are lost from the parent structure is indicative of the sequence 
of monosaccharides and the branching pattern within a selected glycan or glycopeptide. Often, 
amino acid sequence information of the peptide part of glycopeptides can be additionally 
obtained.  
In this thesis, laser-induced dissociation (LID) (for MALDI-TOF) as well as collision-
induced dissociation (CID) (for ESI-ion-trap MS) have been employed. In the MALDI-TOF 
used, the laser-induced tandem MS is based on post-source decay induced by the laser and is 
usually indicated as MALDI-TOF/TOF 121. CID-induced fragmentation is performed by 
colliding a selected ion with inert gas molecules 126. Various other tandem MS techniques have 
also been developed to elucidate the composition of glycans and glycoproteins, as reviewed in 
120;127. 
 
5.5 Glycosylation analysis of complex S. mansoni egg preparations 
The first MS-based glycosylation analysis of S. mansoni egg glycoproteins was performed by 
Khoo et al. on the complex SEA mixture using fast atom bombardment (FAB)-MS 10. N-glycans 
were released from tryptic glycopeptides via sequential digestion with PNGase F and PNGase A, 
and subsequent reductive elimination released the O-glycans. The released glycan preparations 
were permethylated to facilitate the determination of branching and glycosidic linkages, and 
were analyzed with FAB-MS. Using this technique, a sample is mixed with a matrix and 
bombarded under vacuum with a high energy beam of atoms, generating glycans as well as 
glycan fragments at the same time. The generated data, combined with accepted models of 
eukaryotic N-glycan structures, revealed important structural features of SEA glycans, as 
described in paragraphs 2.3 and 3.5. However, FAB-MS lacks the high sensitivity observed for 
MALDI-TOF-MS and ESI-MS techniques and is not compatible with tandem MS analysis. Due 
to these drawbacks, minor glycan structures in complex mixtures can remain undetected, and 
the complete structural characterization of glycans is not possible. More recently, a pilot study 
on egg N-glycans, using a MALDI-TOF-MS-based method, validated many of the glycan 
structures found earlier by Khoo et al. 10, but in addition found previously unidentified, PNGase 
A sensitive glycans containing unusual triantennary LDN motifs 13.  
The glycosylation of the secretory ES glycoproteins, a major immunogenic subset of 
SEA, was extensively analyzed by Jang-Lee et al. 14. Initial analysis of released, permethylated N- 




the released glycan pools. To generate more in-depth, structural information on the observed 
glycans, the majority of molecular ions were fragmented by MALDI-TOF/TOF as well as ESI-
MS/MS. In addition, monosaccharide compositions and glycosidic bond positions were defined 
using gas chromatography (GC)-MS. Together, this study provides an in-depth overview of 
major and minor, N- and O-linked glycans present on ES glycoproteins. 
 
5.6 Glycosylation analysis of the S. mansoni egg glycoprotein IPSE/α1 
The reported role of individual glycoproteins and their glycans in the immunoregulatory effects 
of S. mansoni eggs, as outlined in part 3 of the introduction, stresses the need for detailed 
protein-specific glycosylation analysis. Up to now, only the egg glycoprotein IPSE/α1 has been 
subjected to such an analysis 70. For this, IPSE/α1 was trypsinized and resulting glycopeptides 
were initially analyzed by MALDI-TOF-MS in the positive-ion reflectron mode. Two 
glycopeptides clusters were found, representing the “microheterogeneity” (glycan variation) of 
the two N-glycosylation sites of IPSE/α1. Additional analysis demonstrated that within each 
cluster, mass differences of 146, 162 and 203 Da were present, indicating that the IPSE/α1 
glycans differed in the presence of fucose (F), hexose (H) and HexNAc (N) residues, respectively. 
Based on the deduced masses from MALDI-TOF-MS, the mass of the peptide parts, as well as 
already existing knowledge on the general structures of S. mansoni N-glycans, tentative glycan 
compositions were generated.  
An extensive analysis of the exact glycopeptide structures was generated using tandem 
MS fragmentation as well as exo-glycosidase treatments. To confirm the characteristics of the 
peptide part of the glycopeptides, glycopeptides were deglycosylated with PNGase A, after which 
the amino acid sequence and glycan attachment site was revealed using nano-LC-MS/MS. 
Tandem mass spectrometry was also used to deduce the antenna composition and core 
substitutions of the glycan part. However, during fragmentation, fucose rearrangements within 
the antenna fucoses have been reported for protonated glycoconjugates, potentially leading to 
misleading fragmentation ions. To validate the fucose localization at the antennae, glycopeptides 
were treated with β-galactosidase. This enzyme can differentiate between fucosylated and non-
fucosylated LN antennae, as it cleaves terminal galactose from LN but not from fucosylated 
variants such as LeX. 
For example, on the basis of the MALDI-TOF data and previous knowledge on S. 
mansoni N-glycans, the major glycan structure H4N5F4 on site N80 of IPSE/α1 was suggested to 
consist of a difucosylated N-glycan core carrying two LeX antennae. The presence of peptide 
fragments containing a HexNAc with two fucoses (pep-N1F2) indicated that the core structure 
indeed was di-fucosylated. β-galactosidase treatment clearly demonstrated that each of the LN 
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antennae carry one fucose, as the enzyme was not able to cleave off any galactoses, in line with 
the presence of two LeX units.  
Conclusively, the MS and tandem MS studies on tryptic glycopeptides of IPSE/α1 
combined with the enzymatic treatment provided a detailed, site-specific glycosylation analysis 
that is also applicable to other S. mansoni glycoproteins. 
 
6. Scope of this thesis 
Three major, immunogenic egg glycoproteins have been identified; omega-1, IPSE/α1 and 
kappa-5. The studies in this thesis aim to unravel structural and molecular details of the 
interaction between these three glycoproteins and innate immune cells of the host, with an 
emphasisis on the role of the glycoprotein glycans in the induction of Th2 responses and 
granulomogenesis.  
To generate a better understanding of the interactions between the host and the 
parasite, it is essential to unravel the structural details of native glycosylation of omega-1, 
IPSE/α1 and kappa-5. The glycans of IPSE/α1 have been already described in detail, as outlined 
in paragraphs 3.6 and 5.6 of this introduction In chapter 2 and 3, we describe the glycosylation 
of omega-1 and kappa-5 respectively, using an approach combining mass spectrometric 
techniques and enzymatic treatments.  
To induce or modulate immune responses, egg glycoproteins interact with CLRs on 
APCs such as DCs and macrophages. It was previously shown that SEA glycoproteins interact 
with the CLRs DC-SIGN, MGL and MR on immature DCs, leading to internalization of 
glycoproteins. The involvement of these receptors in the recognition of single, native 
glycoproteins are described in chapter 4 (kappa-5 and IPSE/α1) and chapter 5 (omega-1). It is 
shown that specific glycan motifs on the egg glycoproteins determine differential binding to the 
CLRs.  
The importance of glycans in the induction of S. mansoni egg-induced Th2 responses 
and periovular granuloma formation has been acknowledged for years; however the exact native 
glycoproteins involved in this process remained unknown. Recently, omega-1 has been 
identified as the major component of the secretory egg glycoproteins that induces Th2 responses 
via the conditioning of DCs. In chapter 5, the underlying characteristics of omega-1 that drive 
this immunomodulatory effect are identified. Omega-1 glycosylation as well as its RNase activity 
are both demonstrated to play critical roles. Chapter 6 describes the identification of kappa-5 as 




part this immunogenic effect. Chapter 3 in addition shows that the glycans of kappa-5 are 
targets of the IgE response observed in S. mansoni-infected individuals. 
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Soluble egg antigens (SEA) of the human parasite Schistosoma mansoni are among the strongest 
natural stimuli of Th2 responses. Omega-1, a major glycoprotein in SEA, initiates these characteristic 
Th2 responses through conditioning of dendritic cells (DCs). In view of the reported 
immunomodulatory potential of SEA glycans, we have investigated omega-1 glycosylation, using an 
approach combining mass spectrometric (MS) techniques and enzyme treatments at the glycopeptide 
level. We demonstrate that omega-1 has two fully occupied N-glycosylation sites, each mainly 
carrying core-difucosylated diantennary glycans with one or more LeX motifs in the antennae. Using 
a specific approach of nanoscale LC-MS(/MS) and MALDI-TOF(/TOF)-MS in combination with exo-
glycosidase treatments of tryptic glycopeptides, we were able to provide a detailed, site-specific 
glycosylation analysis of a single, native S. mansoni glycoprotein. The obtained knowledge of the 
glycans present on omega-1 contributes to a full understanding of the mode of action of this 
immunomodulatory glycoprotein. 
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Introduction 
Schistosomiasis, a disease caused by infection with parasitic flatworms, is a major public health 
burden in many developing countries in the tropics and sub-tropics. Schistosome larvae released 
from infested water snails penetrate through the skin of the host, and the developing 
schistosomes migrate towards the mesenteric venules of the bowel (Schistosoma mansoni and S. 
japonicum) or the venous plexus of the bladder (S. haematobium), where adult female and male 
worms pair and produce hundreds of eggs per day. Instead of being excreted with the feces or 
urine to continue the schistosome life cycle, many of the eggs get trapped inside organs where 
they induce granulomatous immune reactions, the main cause of morbidity associated with 
schistosomiasis 1.  
During S. mansoni infection, an initial T helper 1 (Th1)-mediated response to the 
parasite shifts to a highly Th2-polarized immune response. This shift coincides with the start of 
egg production by the mature worms, suggesting that egg-derived molecules are capable of 
inducing the Th2-polarization 2. Indeed, schistosome eggs 3, soluble egg antigens (SEA) 4;5, and 
more specifically a subfraction of SEA formed by the excretory/secretory (ES) egg proteins 6 are 
highly potent inducers of a Th2 immune response. Recently, the major single factor from ES that 
is responsible for Th2-priming in vitro and in vivo has been identified as omega-1, a 
glycoprotein with RNase activity and a major constituent of ES 7;8. In vitro, omega-1 conditions 
human monocyte-derived dendritic cells (DCs) to drive Th2-polarization, while SEA depleted 
from omega-1 shows a significantly reduced activity 6;9. Furthermore, when injected in IL-4 dual 
reporter mice, omega-1 is sufficient for Th2-induction in vivo. Although is has been suggested 
that the RNase activity of omega-1 may be involved in its capacity to drive Th2-polarization 9, 
total SEA requires intact glycosylation to be able to induce Th2-type responses including 
antigen-specific IgE production and induction of IL-4 and IL-10 5. Moreover, synthetic 
conjugates of the Galβ1-4(Fucα1-3)GlcNAc (Lewis X, LeX) element occurring in SEA have been 
shown to harbor Th2-promoting properties 10;11. These observations suggest that glycans or 
glycan motifs carried by SEA glycoproteins such as omega-1 play a role in the mechanisms by 
which they exert their Th2-inducing activity. 
Schistosome egg glycosylation has been studied extensively, mainly by mass 
spectrometric analysis of released N- and O-glycans. A wide spectrum of complex and partly 
stage-specific structures has been found 12-15. Glycoprotein glycans from SEA comprise high 
mannose, complex-type and truncated N-glycans which are predominantly α3/α6-difucosylated 
at the Asn-linked GlcNAc, potentially accompanied by a core-xylose 12. The non-reducing N-
glycan termini are for a large part composed of Galβ1-4GlcNAc (LacNAc, LN), LeX and (mono- 
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or di-fucosylated) GalNAcβ1-4GlcNAc (LacdiNAc, LDN) motifs 12;13. Egg glycoprotein O-
glycans are mainly based on the mucin-type core 1 (Galβ1-3GalNAc) and core 2 (Galβ1-
3(GlcNAcβ1-6)GalNAc) structures, but also a S. mansoni-specific Galβ1-3(Galβ1-6)-GalNAc 
core was found 12,14, while O-glycan termini were mainly composed of LeX, LN and (multi-
fucosylated) LDN motifs. Recently, the glycans released from the ES fraction of S. mansoni eggs 
were analyzed, showing that these display N-glycan α3/α6-core fucosylation and terminal LN, 
LeX and (fucosylated) LDN motifs as main features 15. 
Although it is currently debated exactly which proteins make up the ES fraction 16-18 of 
S. mansoni eggs, it is clear that multiple N- and O-glycosylated proteins are present 16. The 
presence or absence of specific glycans may confer antigenic properties to individual proteins in 
ES and influence binding to C-type lectin receptors (CLRs) on immune cells, such as dendritic 
cell-specific intercellular adhesion molecule-2-grabbing non-integrin (DC-SIGN), mannose 
receptor (MR) or macrophage galactose-type lectin (MGL) 19-22. Therefore, it would be 
appropriate to analyze the glycosylation of ES in a protein-specific fashion, instead of by 
releasing glycans from the protein mixture and thus losing crucial information about how 
individual proteins are glycosylated. To date, only in the case of IPSE/α1 23, another major 
component of ES, has a protein-specific in-depth glycosylation analysis been carried out 24.  
In view of the immunomodulatory properties of omega-1 and the lack of structural 
information about omega-1 glycans, we performed a detailed analysis of omega-1 glycosylation 
using nanoscale LC-MS(/MS), and MALDI-TOF(/TOF) MS measurements of tryptic 
glycopeptides in combination with exo-glycosidase treatments. We show that omega-1 has two 
fully occupied N-glycosylation sites, which carry mainly core-difucosylated diantennary glycans 
with one or two terminal LeX motifs. These data provide a molecular basis for investigations on 
functional properties of omega-1 glycosylation and shed light on the structural details of 
schistosome egg glycan antigens. 
 
Results 
Initial analysis of omega-1 glycosylation 
Omega-1 is produced in the subshell area of S. mansoni eggs where also IPSE/α1 is produced 8,24. 
To investigate whether omega-1, like IPSE/α1, carries LeX motifs 24, purified omega-1 (Figure 
1A) was subjected to Western blot analysis. The anti-LeX mAb 128-4F9-A binds to omega-1 
(Figure 1B), demonstrating the presence of LeX. Treatment of omega-1 with α-fucosidase to 
remove terminal α1-3,4-linked fucoses (omega-1 fuco, Figure 1B) strongly reduces binding of 
the antibody, confirming the presence of the fucosylated LeX motif on omega-1. For subsequent 
2 
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in depth glycosylation analysis of omega-1, the purified glycoprotein was subjected to SDS-
PAGE and the gel piece containing omega-1 was cut, reduced, alkylated and treated with trypsin 
to generate (glyco)peptides. Extracted (glyco)peptides were subjected to nano-RP-LC-MS 
analysis. Omega-1 has two concensus glycosylation sites at residues N71 (tryptic peptide Q69-
R77) and N176 (tryptic peptide E172-R183) 8. In the LC chromatogram, based on the 
observation of the glycosylation marker ions at m/z 366 (LN antenna) and m/z 512 (LeX 
antenna), three glycopeptide regions were registered at time windows 7.4-9.3, 14.3-16.9 and 
19.3-20.9 minutes (data not shown). The first and second glycopeptide clusters are 
indistinguishable in terms of glycan heterogeneity and both arise from peptide Q69-R77. 
Evidently, the glutamine at the amino terminus of the second cluster had undergone cyclization, 
forming a pyroglutamate, leading to a mass shift of m/z - 5.3 [M+3H]3+ compared to the 
glycopeptide cluster with native N-terminal glutamine, and a shift in elution time due to an 
increase in hydrophobicity upon cyclization. The nano-LC-mass spectrum belonging to the first 
cluster (site N71) is shown in Figure 2A. The nano-LC-mass spectrum of tryptic glycopeptides 
containing site N176 which eluted at 19.3-20.9 minutes is shown in Figure 2B. 
The glycans of both glycosylation sites are composed of variable numbers of hexoses 
(H), N-acetylhexosamines (N) and fucoses (F), as reflected by corresponding mass differences 
 
Figure 1. Visualization and characterization of omega-1. Omega-1 was separated under reducing 
conditions by SDS-PAGE and stained with Colloidal blue (A). For testing the presence of terminal 
LeX, omega-1 and omega-1 treated with α1-3,4 fucosidase (Omega-1 fuco) were subjected to 
Western blot using a monoclonal antibody against LeX (128-4F9-A) (B). 
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(162, 203, and 146 Da, respectively) between the registered glycopeptides. For glycopeptides 
containing site N71 (Figure 2A), the assumption of a Q69-R77 peptide moiety decorated with an 
N-glycan leads for the major glycopeptide species ([M+3H]3+ at m/z 1080.5) to the deduced 
glycan composition H5N4F4. This composition may represent an N-glycan with two LeX 
antennae and core-difucosylation, which has also been found on IPSE/α1 15;24. Other major 
signals include N-glycans composed of H5N4 and H4N5 substituted with two to six fucoses, 
suggesting a high abundance of multi-fucosylated LN and, to a lesser extent, LDN antennae. 
Tryptic glycopeptides covering site N176 (Figure 2B) were found to contain glycans which were 
similar in composition to those of site N71. However, ratios of glycan variants were significantly 
different for the two sites (Figure 2). In general, glycopeptides of site N176 showed a lower 
degree of fucosylation than those of site N71. Non-glycosylated forms of the peptides Q69-R77 
and E172-R183 were not detected by LC-MS, indicating that in both peptides the N-





 Figure 2. nano-LC-MS of glycopeptides from a tryptic digest of omega-1, covering glycosylation sites N71 
(A) and N176 (B). Signals are triple positively charged and labeled with monoisotopic masses. Compositions 
of the glycan moieties are given in terms of hexose (H), N-actetylhexosamine (N) and fucose (F). Differences 
in fucose content are indicated by double-headed arrows. 
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N-glycosylation analysis of glycopeptide E172-R183  
To confirm the tentative assignment of the glycopeptide clusters presented in Figure 2, the 
tryptic glycopeptides were subjected to enzymatic treatment with -galactosidase and/or α-
fucosidase and analyzed by MALDI-TOF-MS (Figures 3 and 4). Selected untreated and α-
fucosidase treated glycopeptides were in addition subjected to fragmentation using MALDI-
TOF/TOF-MS to further substantiate the structural assignments. A set of illustrative 
glycopeptide fragmentation spectra is shown in Figures 5-7 and Supplementary figures 1 and 2. 
For the other glycopeptides, the fragmentation data are summarized in Table 1 (untreated) and 
Supplementary table 1 (α-fucosidase treated). First, we confirmed that the glycopeptides 
assigned to site N176 (Figure 2B, 3A, and 4A) comprised the peptide moiety E172-R183: for the 
glycopeptide at m/z 3594.7 (Figure 3A), a characteristic MALDI-TOF/TOF-MS pattern of 
fragment ions was observed (Figure 5), including m/z 1370.2 (protonated peptide-NH3), m/z 
1470.2 (0,2X-ring fragmentation of the innermost N-acetylglucosamine), m/z 1736.3 (protonated 
peptide with N-acetylglucosamine and one fucose) and m/z 1882.2 (protonated peptide with N-
acetylglucosamine and two fucoses). This indicates a peptide mass of 1387.3 Da [M + H]+ and a 
glycan moiety of H5N4F4. The deduced peptide mass of 1387.3 Da fits the theoretical mass of the 
tryptic peptide E172-R183 of 1388.6 Da [M + H]+. In addition, peptide fragments in the low 
mass region provided a GSANCIR sequence tag that further confirms the assignment. For the 
other fragmented glycopeptides belonging to the peptide moiety E172-R183 containing 
glycosylation site N176, similar signal patterns were observed (Figures 6 and 7, Supplementary 
figures 1 and 2 and Table 1).  The combined data from enzymatic treatments and MALDI-
TOF/TOF-MS analysis showed that H5N4F4 on N176 is an N-glycan constructed of a 
trimannosyl core with two fucoses on the innermost N-acetylglucosamine and two fucosylated 
LN antennae. Based on the reactivity of omega-1 with an anti-LeX antibody (Figure 1B) and 
previously published data on the glycosylation of ES proteins including IPSE/α1 15;24, the 
fucosylated LN antennae were interpreted as LeX motifs. Both enzyme treatments (Figures 3 and 
4) and fragmentation data (Figure 5) are consistent with this interpretation. The galactose 1-4 
linkage in a LeX trisaccharide is not cleavable by -galactosidase because of the 3-substitution of 
GlcNAc by fucose. In line with the assumption that the H5N4F4 species contains two LeX 
antennae, -galactosidase treatment did not lead to the disappearance of the signal at m/z 3594.7 
and at the same time no increased signal at m/z 3432.6 was observed (Figures 3A and B). On the 
other hand, when the glycopeptides were treated with α-fucosidase from Xanthomonas 
manihotis, the fucoses in the LeX motif were removed (loss of signals at m/z 3594.7 (H5N4F4) and 
m/z 3448.6 (H5N4F3); Figure 4A and B), yielding a set of signals at m/z 3302.7, 3156.1 and 3010.1 




Figure 4. α-fucosidase and -galactosidase treatment of omega-1 glycopeptides. Omega-1 was subjected to 
reduction and alkylation, digested with trypsin and the resulting (glyco)peptides of glycosylation site N176 
were analyzed  by MALDI-TOF-MS before treatment (A), after treatment with -fucosidase only (B) or in 
combination with -galactosidase (C). Signals are singly positively charged and labeled with monoisotopic 
masses. Composition of the glycan moieties are given in terms of hexose (H), N-actetylhexosamine (N) and 
fucose (F). Differences in fucose content are indicated by double-headed arrows. Non-glycopeptide signals are 
marked with asterisks (*). 
 
Figure 3. -galactosidase treatment of omega-1 glycopeptides. Omega-1 was subjected to reduction and 
alkylation, digested with trypsin and the resulting (glyco)peptides of glycosylation site N176 were analyzed  by 
MALDI-TOF-MS before (A) and after (B) treatment with -galactosidase. Signals are singly positively charged 
and labeled with monoisotopic masses. Composition of the glycan moieties are given in terms of hexose (H), 
N-actetylhexosamine (N) and fucose (F). Differences in fucose content are indicated by double-headed arrows. 
Non-glycopeptide signals are marked with asterisks (*). 
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galactosidase subsequent to this fucosidase treatment leads to a complete removal of the antenna 
galactoses from each of the H5N4F2, H5N4F1 and H5N4 species (shift of two times 162 Da; e.g. the 
signal at m/z 3302.2 in Figure 4B shifts to m/z 2978.6 in Figure 4C). The resistance of the H5N4F4 
glycopeptide to -galactosidase treatment and the gained susceptibility after α-fucosidase 
treatment further supports our proposal that the terminal fucosylated structures are LeX motifs. 
To corroborate this, a MALDI-TOF/TOF-MS fragmentation spectrum of the E172-R183-H5N4F4 
glycopeptide was recorded (Figure 5) in which the losses of 511 Da and 673 Da (signals at m/z 
3083.3 and 2920.7) from the parent ion are observed, corresponding to the loss of a LeX 
(H1N1F1) and a LeX-Man fragment (H2N1F1), respectively. In addition, a core cleavage pattern 
with an intense signal at m/z 1882.2 (peptide-N1F2) (Figure 5) is observed, indicating that two 
fucose residues in the H5N4F4 species are linked to the core GlcNAc residue. The lower intensity 
signal at m/z 1736.3 (peptide-N1F1), is interpreted as the result of a chitobiose cleavage in 
combination with loss of a core fucose. This interpretation was further confirmed by MALDI-
TOF/TOF-MS of the E172-R183-H5N4F2 glycopeptide species which is formed after the α-
fucosidase treatment (Supplementary figure 1). In this spectrum, signals derived from antenna 
fragmentations are observed at m/z 2937.1 and 2774.9 (loss of H1N1 and H2N1, respectively), but 
no loss of H1N1F1 is observed, indicating that all antenna fucoses had been removed. In addition, 
the core fragmentation pattern including an intense signal at m/z 1882.4 (peptide-N1F2) 
accompanied by a minor signal at m/z 1736.4 (loss of one fucose from peptide-N1F2), a pattern 
highly similar to that present in Figure 5, indicates that two core fucoses remain. 
A second abundant signal in the MALDI-TOF MS spectrum in Figures 3A and 4A is 
that of glycopeptide E172-R183-H5N4F3. Our data indicate that the H5N4F3 species carry two LN 
antennae and comprise two differentially fucosylated isomers. A fraction of the E172-R183-
H5N4F3 glycopeptides is resistant to -galactosidase treatment (part of the signal at m/z 3448.6 in 
Fig. 3A remains in Fig. 3B), which, as previously explained for H5N4F4, indicates the presence of 
two LeX antennae. The other fraction of the glycopeptides exhibited the loss of one hexose after 
-galactosidase treatment (loss of 162 Da, resulting in a signal at m/z 3286.6 in Figure 3B), which 
suggests the presence of one non-fucosylated and one fucosylated LN. Based on these results, we 
suggest that H5N4F3 on site N176 consists of two isomeric glycans, one containing two LeX 
antennae and a mono-fucosylated core, while the other carries one LeX and one LN antenna and 
two core fucoses. The assumed presence of LeX and LN motifs on the isomers was verified using 
MALDI-TOF/TOF-MS (Figure 6). The fragmentation spectrum reveals the loss of 511 Da and 
673 Da (signals at m/z 2937.9 and 2775.5) from the parent ion, corresponding to the loss of a 
LeX (H1N1F1) and a LeX-Man (H2N1F1) moiety, respectively. Furthermore, the observed losses of 




Figure 5. MS/MS of peptide E172–R183 carrying H5N4F4 N-glycans. The MS/MS spectrum was acquired by 
MALDI-TOF/TOF-MS of a tryptic digest of omega-1. The single-headed arrow indicates the precursor ion. 
Differences in fucose content are indicated by double-headed arrows. Triangle, fucose; light circle, galactose; 
dark square, N-acetylglucosamine; dark circle, mannose. 
Figure 6. MS/MS of peptide E172–R183 carrying H5N4F3 N-glycans. The MS/MS spectrum was acquired by 
MALDI-TOF/TOF-MS of a tryptic digest of omega-1. The single-headed arrow indicates the parent ion. 
Differences in fucose content are indicated by double-headed arrows. Triangle, fucose; light circle, galactose; 
dark square, N-acetylglucosamine; dark circle, mannose.
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LN-Man (H2N1) antennae, respectively, in one of the isomers. In addition, a core cleavage 
pattern is observed (Figure 6) which clearly differs from the pattern characteristic of core-
difucosylation (Figure 5 and Supplementary figure 1). In Figure 6, the signal at m/z 1736.8 
(pep+N1F1) is more intense than the signal at m/z 1882.9 (pep+N1F2). By comparison with the 
core cleavage patterns in Figure 5 and Supplementary figure 1, the pattern in Figure 6 can only 
partially be explained as resulting from an isomer with difucosylated core (left structure in 
Figure 6). The fragment ion at m/z 1736.8 (pep+N1F1) is in addition formed by chitobiose 
cleavage of the second isomer having a monofucosylated core (right structure in Figure 6). 
The composition of the H4N5F4 variant on glycosylation site N176 indicates the 
presence of an N-glycan with two fucoses at the Asn-linked GlcNAc, combined with one LeX 
and one fucosylated LDN antenna, LDN being a common structural element in helminth 
glycans 28. The H4N5F4 fragmentation data (Supplementary figure 2) are in line with this 
interpretation. Signals derived from the loss of N2F1 (m/z 3081.8) and H1N1F1 (m/z 3124.7) from 
the precursor ion are observed, as well as the characteristic core fragmentation pattern indicative 
of a difucosylated core GlcNAc. The mass spectrometric data do not allow differentiation 
between Fucα1-3GalNAcβ1-4GlcNAc (F-LDN) and GalNAcβ1-4(Fucα1–3)GlcNAc (LDN-F) 
structures. However, using synthetic F-LDN and LDN-F glycoconjugates 29, the α-fucosidase 
from Xanthomonas manihotis was shown to cleave only the fucose α1-3 linked to the GlcNAc in 
LDN-F, but not the α1-3 linkage between the fucose and GalNAc in F-LDN (data not shown). α-
Fucosidase treatment of omega-1 glycopeptides (Figure 4B) results in removal of antenna 
fucoses from H4N5F4, as the signal at m/z 3635.7 in Figure 4A almost completely shifts to signals 
at m/z 3051.4, 3197.1 and 3343.1, representing glycans with one LN and one LDN motif and 
zero, one or two core fucoses, respectively (Supplementary table 1). Similar shifts were observed 
for other glycans that carry fucosylated LDN based on their monosaccharide composition 
(Figure 4B). Therefore, we propose that some glycoforms of omega-1 carry LDN-F motifs, but F-
LDN motifs do not occur. 
Another representative example of a fragmentation is given by the MALDI-TOF/TOF 
mass spectrum of E172-R183-H6N5F5 which carries one LeX and one dimeric LeX antenna 
accompanied by two fucoses at the core (Figure 7). The presence of the dimeric LeX motif was 
demonstrated by a high signal at m/z 3082.4 after fragmentation, indicative of the loss of two 
interlinked LeX elements. The results of the successive treatment of α-fucosidase and -
galactosidase support this interpretation. α-Fucosidase treatment of H6N5F5 glycopeptides results 
in the loss of up to three antenna fucoses (signal at m/z 4106.0 in Figure 4A shifts to m/z 3813.6 
and 3668.1 in Figure 4B). After subsequent treatment with -galactosidase, the signals at m/z 
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of the loss of two galactoses. This observation is in line with the occurrence of one non-
susceptible internal galactose in the proposed structure of H6N5F5. In addition to the 
aforementioned signals, a signal at m/z 3181.7 appears, which might be interpreted as the loss of 
three galactoses from the signal at m/z 3668.1. However, we believe that the latter signal is not 
derived from fucosidase/galactosidase treatment of H6N5F5, but arises from H4N5F2 (m/z 3343.1 
in Figure 4B), which represents a core difucosylated glycopeptide with one LN and one LDN 
antenna. Upon -galactosidase treatment, the H4N5F2 glycoform loses one galactose residue from 
the LN antenna, thereby giving rise to a signal at m/z 3181.7 in Figure 4C, derived from the 
similar intense signal at m/z 3343.1 in Figure 4B. 
In a similar manner, combination of fragmentation analysis by MALDI-TOF/TOF-MS 
and α-fucosidase/-galactosidase treatment led to structure proposals for most other glycoforms 
observed for the E172-R183 peptide. The data are summarized in Table 1 and Supplementary 
table 1. 
 
a Glycan compositions are given in terms of hexose (H), N-acetylhexosamine (N) and fucose (F).  
b Monoisotopic masses of glycopeptide precursors are given throughout. Glycopeptides are singly positively 
charged, unless specified otherwise. Singly-charged glycopeptide species were registered by MALDI-TOF-MS, and 
multiply charged species were detected by LC-ESI-MS. For many glycopeptides, masses after β-galactosidase (β-gal) 
and/or α-fucosidase (α-fuc) treatment are listed and the loss of n hexose or n fucose is concluded (respectively - n 
Hex and - n Fuc). 
c Relative peak height is expressed as a percentage of cumulative peak height per site.   
d Fragment ions were determined by MALDI-TOF/TOF-MS unless specified otherwise (ESI-MS/MS indicates 
analysis by nano-HPLC ESI-ion trap-MS/MS); pep1 corresponds to peptide E172FGYNGSANCIR183 containing 
glycosylation site N176; pep2 corresponds to peptide Q69PNCTGSLR77 containing glycosylation site N71.  
e Proposed glycan structures are deduced from glycopeptide MS after enzyme treatments and fragmentation data. 
Triangle, fucose; light circle, galactose; light square, N-acetylgalactosamine; dark square, N-acetylglucosamine; dark 
circle, mannose. Glycan isomer percentages are calculated using the relative peak heights of glycopeptides after β-
galactosidase treatment and/or relative peak heights of peptides after fragmentation. 
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N-glycosylation analysis of glycopeptide Q69-R77 
Unlike from the E172-R183 glycopeptides, signals from peptide Q69-R77 containing the 
glycosylation site N71 could not be detected by MALDI-TOF-MS. The most abundant Q69-R77 
glycopeptide, carrying a H5N4F4 glycan (Figure 2A), would correspond to a [M+H]+ ion of a 
theoretical mass of 3095.4 Da, but this was not observed in the spectrum in Figure 3A, nor were  
any other signals detected that would correspond to glycopeptides from Q69-R77. Therefore, 
with the specific aim of further characterizing the glycosylation of the Q69-R77 glycopeptides, 
untreated and -galactosidase-treated glycopeptides from omega-1 were also measured by nano-
LC-MS (Figure 8) and LC-MS/MS (Figure 9 and Table 1). Registered masses, fragmentation data 
as well as deduced glycan compositions for all the detected glycopeptide species are given in 
Table 1. 
For the most abundant glycopeptide of Q69-R77 carrying the N-glycan H5N4F4, the 
main structure is composed of a trimannosyl core with two fucoses attached to the innermost N-
acetylglucosamine and two LeX antennae (left structure in Figure 9), using similar reasoning as 
for the H5N4F4 glycan on site N176. However, ~15% of the H5N4F4 glycans on site N71 contain a 
non-fucosylated LN antenna, as demonstrated by the removal of one hexose after -
 
 
Figure 7. MS/MS of peptide E172–R183 carrying H6N5F5 N-glycans. The MS/MS spectrum was acquired by 
MALDI-TOF/TOF-MS of a tryptic digest of omega-1. The single-headed arrow indicates the parent ion. 
Differences in fucose content are indicated by double-headed arrows. Triangle, fucose; light circle, galactose; 
dark square, N-acetylglucosamine; dark circle, mannose. 
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galactosidase treatment (m/z 1080.5 [M+H]3+ in Figure 8A shifts to m/z 1026.4 in Figure 8B). 
This indicates that two fucoses are located at the other LN branch. To verify this, the H5N4F4 
glycopeptide was fragmented using nano-LC-MS/MS (Figure 9). Losses of 365 Da and 657 Da 
(signals at m/z 1437.6 and 1291.6) were observed from the parent ion, which corresponds to the 
loss of LN (H1N1) and difucosylated LN (H1N1F2), respectively. Notably, fragmentation data of 
protonated glycans and glycopeptides may be compromised due to the occurrence of fucose 
rearrangements, possibly contributing to the generation of the above described fragments. This 
phenomenon is commonly seen in the analysis of N-glycans by MALDI as LC-MS fragmentation 
30. However, based on the results from the -galactosidase treatment, it was clearly demonstrated 
that a small part of H5N4F4 glycans on site N71 contain one LN and one difucosylated LN 
antenna, a glycan structure which was not observed for H5N4F4 on site N176. In analogy with 
this, we propose for glycopeptide Q69-R77 containing an N-glycan with composition H4N5F5 a 
similar structural assignment as for H4N5F4, being one isomer with a difucosylated core in 
combination with one mono-fucosylated LDN and one difucosylated LN antenna, and another 
with a difucosylated core and one LeX and one difucosylated LDN antenna (Table 1). 
For most of the other N-glycans at site N71, similar information was obtained, as 
summarized in Table 1. Most of the glycan structures at site N71 were identical to the structures 
of glycosylation site N176, however in some cases with differences in fucosylation as described 
above. The main differences between the sites are in the relative abundance of glycan structures, 
with site N71 containing a higher amount of multi-fucosylated structures compared to site 
N176.  
 
General overview of omega-1 glycosylation 
An overview of the most abundant glycosylation forms of omega-1, combining the data from 
glycosylation sites N71 and N176, is given in Table 2. Notably, the abundance of individual 
glycan structures was calculated using signal intensities derived from LC-MS data for site N71 
(Figure 10A) and MALDI-TOF-MS data for site N176 (Figure 3A), which might have 
implications for the comparability of the two sites. On the other hand, when comparing the LC-
MS derived data (Figure 2A) and MALDI derived data (Figure 3A) from site N176, the ratio of 
the high intensity signals are very comparable, although the low abundant species show some 
deviations.  
The majority of the glycan structures on the two sites exhibit two fucoses on the 
innermost N-acetylglucosamine and one or two LeX antennae. In view of the documented 
immunogenic properties of LeX and core fucosylation 10;31, we estimated the abundance of these 
structures on omega-1 using the most abundant glycans as markers (Table 2). 
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Figure 8. -galactosidase treatment of omega-1 glycopeptides. Omega-1 was subjected to reduction and 
alkylation, digested with trypsin and the resulting (glyco)peptides of glycosylation site N71 were analyzed by 
nano-LC-MS before (A) and after (B) treatment with -galactosidase. Signals are triple positively charged and 
labeled with monoisotopic masses. Composition of the glycan moieties are given in terms of hexose (H), N-
actetylhexosamine (N) and fucose (F).  
Figure 9. MS/MS of peptide Q69–R77 carrying H5N4F4 N-glycans. The MS/MS spectrum was acquired by 
nano-LC-MS/MS of a tryptic digest of omega-1. Differences in fucose content are indicated by double-headed 
arrows. Triangle, fucose; light circle, galactose; dark square, N-acetylglucosamine; dark circle, mannose. 
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One omega-1 glycan carries an average of 1.3 LeX motifs, meaning that on average 2.6 LeX units 
are present on the omega-1 glycoprotein. To estimate the occurrence of core fucosylation, the 
data from the α-fucosidase treatment of site N176 were used. As evident from the mass spectra 
in Figure 4B and 4C, recorded after the removal of antenna fucoses, the vast majority of N176 
glycans carry one or two core fucoses. This conclusion was verified by MALDI-TOF/TOF-MS 
for the high abundant glycans (Table 2). We calculated that 60 % of the glycans at N176 carry 
two fucoses at the core, 30 % carry one core fucose and 10 % have no core fucosylation. For site 
N71, when focusing on the twelve most abundant glycan structures of site N71 (Table 2), we 
calculated that 74 % of these glycans carry two core fucoses, 10 % carry one core fucose and 16 % 
have no core fucosylation. As already reported for the egg and ES glycoprotein mixture 12;15, the 
observed difucosylated core structures are expected to be comprised of α1-3,α1-6-linked fucoses. 
It remains unclear whether the fucose at the mono-fucosylated core is α1-3 or α1-6 linked.  
  To conclude, the analysis of tryptic glycopeptides by MALDI-TOF/TOF-MS and nano-
LC-MS/MS, in combination with -galactosidase and/or α-fucosidase treatment reveal that the 
majority of N-glycans of omega-1 express two fucoses on the innermost N-acetylglucosamine 
and contain one or two terminal LeX motifs. Less abundant antenna structures include LN and 
difucosylated LN, non, mono- and difucosylated LDN and (fucosylated) LN and LDN repeats. 
 
Discussion 
Omega-1 is a single glycoprotein in S. mansoni SEA that harbors the potent Th2-inducing 
properties characteristic for this complex antigen mixture 6;9. Glycans from schistosome egg 
glycoproteins are ligands for multiple CLRs present on immune cells 20;32, and these glycans 
appear to be involved in immunomodulatory activities attributed to SEA 5;10. Prompted by these 
observations and the lack of structural information about omega-1 glycans, we performed a site-
specific analysis of the glycosylation pattern of omega-1. 
This study reveals that omega-1 has two fully occupied N-glycosylation sites. Both sites 
display similar glycan heterogeneity, but with different relative abundances of the individual 
glycans present (Figure 2 and Table 2). All glycans on omega-1 are of a diantennary complex 
type, and most display an α3 and/or α6 fucosylation of the innermost N-acetylglucosamine 
(Tables 1 and 2). LeX was found to be the major antenna motif, but also other terminal glycan 
elements were found to be expressed on omega-1, including LDN-F, tandem repeats of LeX, and 
difucosylated LN and LDN. In addition, we searched the LC-MS-derived data for O-glycosylated 
peptides, focusing on O-glycosylation marker oxonium ions at m/z 204 (HexNAc antenna), m/z 
350 (fucosylated HexNAc antenna), m/z 407 (LDN antenna), m/z 496 (difucosylated HexNAc 
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antenna), m/z 512 (LeX antenna) and m/z 699 (difucosylated LDN antenna). Using these marker 
ions, we could not find any indications for O-linked glycosylation on omega-1. 
The occurrence of these types of N-glycan elements in a schistosome egg glycoprotein 
is in line with data generated by non-protein-specific analysis of the N-glycans of S. mansoni egg 
glycoproteins in SEA 12 as well as in ES 15, the latter being a mixture of excretory/secretory 
glycoproteins of which omega-1 is a major component 16;17. Simultaneous expression of LDN- 
and LN-based antenna elements has been reported in the egg glycoprotein mixtures as well as in 
the protein-specific glycosylation analysis of IPSE/α1 24. Based on the LN and LDN backbones, 
 
Table 2. Schematic representation of the most abundant N-glycans detected on omega-1 
 
a Triangle, fucose; light circle, galactose; light square, N-acetylgalactosamine; dark square, N-
acetylglucosamine; dark circle, mannose.  
b Numbers are based on glycopeptide signal intensities in MALDI-TOF-MS (site N176) or LC-MS (site 
N71), in combination with signal intensities from fragmentation and enzyme data for isomeric structures.  
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both LeX and LDN-F antigens are present on omega-1, most likely due to action of a LeX-type 
fucosyltransferase (FucT) in S. mansoni eggs that is also capable of transferring fucose to the 
GlcNAc residue in LDN in addition to that in LN 33. We also detected difucosylated LN and 
LDN variants on omega-1. The F-LDN-F element has been previously described in schistosome 
glycoproteins and glycolipids 12;15;26. In contrast, the difucosylated LN element has not been 
detected before in schistosome eggs or ES. This element likely represents the pseudo-LeY motif 
(Fucα1-3Galβ1-4(Fucα1-3)GlcNAc) as has previously been described in a major fraction of S. 
mansoni cercarial glycolipids 34. Hypothetically, a difucosylated LN motif also may contain the 
Fucα1-2Fucα1-3 sequence. This disaccharide sequence is abundantly present on schistosome egg 
O-glycans 15, glycolipids 26 and free excretory oligosaccharides 35, but only in the context of chito-
oligomeric or LDN backbones. We did not find indications for the occurrence of the Fucα1-
2Fuc element on omega-1. With respect to the biosynthesis of the different fucosylated elements 
present in omega-1, some may be formed by the action of the same FucT (e.g. LeX and LDN-F 
33), as has also been suggested for the formation of the Fucα1-3GalNAc linkage in F-LDN-F and 
the Fucα1-3Gal in pseudo-LeY 34;36. Still, at least 4 different FucTs appear to be active at the site 
of production of omega-1, and taking into account the occurrence of the other fucosylated 
motifs in S. mansoni eggs and other life stages, it is not surprising that at least 20 FucT genes are 
present in the S. mansoni genome 37, some of which display highly regulated expression levels by 
transcriptome analysis 38. It is unclear at present what the precise acceptor and linkage 
specificities of these FucTs are, as current annotation based on sequence homology is not 
sufficient to classify these FucTs. 
With respect to the overall set of N-glycans found on ES glycoproteins 15, truncated and 
high-mannose type glycans as well as core xylosylation observed in a minor set of ES 
glycoproteins were not found for omega-1. On the other hand, the glycosylation of IPSE/α1, the 
only other S. mansoni egg glycoprotein of which specific glycosylation data is available to date, 
appears to be highly homologous to omega-1 24. IPSE/α1 is produced in the sub-shell area of the 
schistosome egg, at the same location as omega-1, which suggests that these two proteins, both 
major constituents of S. mansoni ES, are subjected to the same glycosylation machinery. 
According to Mathieson et al., at least four other major glycoproteins are present in S. mansoni 
egg ES, including thioredoxin and three micro-exon-gene (MEG) proteins 18, and it would be 
interesting to see if these proteins carry the O-glycans as well as the subset of N-glycans found in 
ES, but not present on omega-1 and IPSE/α1. In this respect, it must be noted that proteomic 
analysis of ES by another group led to the identification of 188 proteins 16 instead of only a few 18. 
This discrepancy may be explained by the different methods used for the preparation of ES. 
Furthermore, while Cass et al. analyzed the whole ES mixture 16, Mathieson and Wilson 
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separated ES proteins on a 2-DE gel and merely investigated the spots visible after Sypro Ruby 
staining, possibly missing low-abundant proteins 18. However, in spite of the large differences 
between the protein contents of ES fractions, in both cases omega-1 and IPSE/α1 were identified 
as the most abundant ES proteins, underlining also the relative abundance of the glycans they 
carry in the overall ES glycome.  
The finding that omega-1 contains the LeX motif is of importance. In the context of a 
LNFPIII conjugate, LeX has previously been shown to induce Th2 responses in a mouse model 
following intranasal immunization 10. Furthermore, it can stimulate murine DCs in vitro towards 
a type 2 DC capable of inducing the development of Th2 cells from naive mouse-derived CD4+ 
T cells 11. Based on these data, it would be tempting to attribute the recently reported Th2-
polarizing properties of omega-1 to its LeX structures 6;9. However, IPSE/α1, which carries 
virtually identical LeX-containing glycans to omega-1, is not able to induce the strong DC-
mediated type 2 responses observed for omega-1 in the same assay 6;24, indicating that in this case 
also properties provided by the underlying protein backbone play a role. Interestingly, 
Steinfelder et al. recently demonstrated in an in vitro bystander polarization assay that upon 
treatment with diethyl pyrocarbonate, a chemical which irreversibly modifies histidine residues, 
omega-1 is no longer able to condition DCs for Th2-induction 9. Clearly, the possible 
contributions of the glycan and protein parts to the immunological properties of omega-1 need 
to be further investigated. In this respect, it is interesting to note that fucosylated glycan 
structures abundantly present on omega-1, are recognized by CLRs such as DC-SIGN and MR 
19;39, which have been reported to mediate internalization of SEA constituents by DCs 20. 
The detailed examination of the site-specific glycosylation of omega-1 was made 
possible by an approach based on MALDI-TOF(/TOF)-MS and nano-LC-MS/(MS) analysis. 
Importantly, by combining the MS analyses with specific exo-glycosidase treatments, we could 
validate structural assignments of important glycan elements, exclude potential false 
interpretations of the MS/MS spectra due to frequently occurring fucose rearrangements 30, and 
thus provide a solid basis for the identification and characterization of the glycan structures. 
This methodology, based on gel-derived tryptic glycopeptides, is also easily applicable to many 
other glycoproteins as it does not require extensive or complicated sample workup.  
 
Materials and Methods 
Purification of omega-1 
Omega-1 was purified from SEA as previously described 7,23,25. In short, SEA was prepared from 
Schistosoma mansoni eggs and fractionated by cation exchange chromatography. Omega-1, 
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together with IPSE/α1 a constituent of the highly cationic egg fraction CEF6, was separated from 
IPSE/α1 by affinity chromatography using specific anti-IPSE/α1 monoclonal antibodies coupled 
to an NHS-HiTrap Sepharose column according to the manufacturer’s instructions (GE 
Healthcare, Little Chalfont, UK).  
 
α -Fucosidase treatment for Western blot analysis 
Antigens were dissolved in 10 l 100 mM sodium phosphate buffer, pH 5.0 and treated with α-1-
(3,4)-fucosidase from Xanthomonas manihotis (0.5 mU; Sigma, Zwijndrecht, The Netherlands) 
overnight at 37 oC.  
To confirm removal of fucoses, omega-1 was reduced by incubation with 0.025 
volumes of 200 mM dithiothreitol for 30 minutes at 60oC, after which the antigen solution was 
mixed with 0.075 volumes of 200 mM iodoacetamide and incubated for 30 minutes in the dark 
at room temperature. Trypsin (Promega, Leiden, The Netherlands) was added to the sample at a 
1:100 trypsin/antigen ratio and incubated overnight at 37oC. After incubation, the digestion was 
quenched with 1 μl of 5% trifluoroacetic acid. Tryptic digests were measured using MALDI-
TOF-mass analysis in the positive ion reflectron mode (results not shown). 
 
Western blot analysis 
1 μg of untreated and fucosidase-treated omega-1 was subjected to SDS-PAGE under reducing 
conditions on a 12% gel using the Mini-Protean Cell system (Bio-rad, Veenendaal, The 
Netherlands). The proteins were transferred onto a nitrocellulose membrane in a Bio-rad 
Criterion Blotter system according to manufacturer’s instructions. The protein blots were 
stained as described previously 26. In short, blots were blocked with BSA and incubated with the 
primary anti-carbohydrate mAb 128-4F9-A, which binds to LeX antennae. Blots were 
subsequently incubated with AP-labeled goat-anti-mouse IgG (Caltag; Invitrogen, Breda, The 
Netherlands) and stained with NBT/BCIP. 
 
Sample preparation for mass spectrometric analysis 
10 μg of omega-1 were separated on a 12% polyacrylamide gel by SDS-PAGE electrophoresis 
under reducing conditions using the Mini-Protean Cell system (Bio-rad) and stained with 
Colloidal blue (Invitrogen, Groningen, The Netherlands) according to manufacturer’s 
recommendations. The stained omega-1 band (31 kD) was excised and stored in 1% acetic acid 
at 4oC. The gel piece containing omega-1 was reduced, alkylated and digested with 0.015 μg 
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trypsin (Promega), as previously described 27. After digestion, peptides were extracted twice with 
20 μl of 0.1% TFA. Extracts were pooled and stored at -20 °C. 
 
Exo-glycosidase treatment for mass spectrometric analysis 
Tryptic glycopeptides were treated with -galactosidase from bovine testis (1 mU; Sigma, 
Zwijndrecht, the Netherlands) in 10 l 100 mM sodium phosphate  buffer, pH 5.0, for 24 hours 
at 37oC. α-Fucosidase treatment was performed on tryptic glycopeptides with α1-(3,4)-
Fucosidase from Xanthomonas manihotis (0.5 mU; Sigma) in 100 mM sodium phosphate buffer, 
pH 5.0, for 24 hours at 37oC. Part of the α-fucosidase-treated glycopeptides was subsequently 
treated with -galactosidase for 24 hours at 37oC.  
 
MALDI-TOF(/TOF) MS  
Total tryptic digest of omega-1, as well as glycopeptides after -galactosidase and/or α-
fucosidase treatment, were purified by Zip-Tip μ-C18 following the manufacturer’s instructions 
(Millipore, Billerica, MA, USA), eluted with 10 mg·ml-1 DHB in 50% acetonitrile, 0.1% 
trifluoroacetic acid onto a MALDI target plate and air dried. MALDI-TOF(/TOF)-MS data were 
obtained using an Ultraflex II time-of-flight mass spectrometer (Bruker-Daltonics, Bremen, 
Germany) equipped with a LIFT-MS/MS facility. Spectra were acquired in the positive ion 
reflectron mode. For fragment ion analysis in the tandem time-of-flight (TOF/ TOF) mode, 
precursors were accelerated to 8 kV and selected in a timed ion gate. Fragment ions generated by 
metastable decomposition of the precursor in the field-free drift region were further accelerated 
by 19 kV in the LIFT cell, and their masses were analyzed after the ion reflector passage. MS/MS 
spectra with fragment ions showing a high mass deviation were subjected to internal calibration 
using chitobiose cleavage products as calibrant signals. 
 
Nano-HPLC ESI-ion trap-MS(/MS)  
Total tryptic digest of omega-1, as well as glycopeptides after -galactosidase treatment, were 
applied to a reverse-phase column (PepMap, 3 μm, 75 μm·100 mm; Dionex /LC Packings, 
Amsterdam, the Netherlands) using an Ultimate 3000 nano-LC system (Dionex /LC Packings). 
The column was equilibrated at room temperature with eluent A (0.1% formic acid in water) at a 
flow rate of 200 nL·min-1. After injection of the sample, elution conditions were switched to 10% 
solvent B (95% acetonitrile, 0.1% formic acid), followed by a gradient to 60% B in 45 min and a 
subsequent isocratic elution of 10 min. The eluate was monitored by absorption at 215 nm. 
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The LC column was coupled to an Esquire HCT-Ultra ESI-ion trap-MS (Bruker-
Daltonics, Bremen, Germany) equipped with an online nanospray source operating in the 
positive-ion mode. For electrospray (1100–1250 V), electropolished, stainless steel LC/MS 
emitters (150 μm OD, 30 μm ID) from Proxeon A/S (Odense, Denmark) were used. The solvent 
was evaporated at 175oC employing a nitrogen stream of 7 L·min-1. Ions from m/z 500 to m/z 
1800 were registered in the MS mode. When operated in the auto MS/MS mode, registering ions 
from m/z 140 to 2200, each MS scan was followed by the acquisition of MS/MS spectra of up to 
three of the most abundant ions in the MS spectrum. 
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Supplementary figures  
 
Supplementary figure 1. MS/MS of peptide E172–R183 carrying H5N4F2 N-glycans. The MS/MS spectrum 
was acquired by MALDI-TOF/TOF-MS of a tryptic digest of omega-1 treated with -fucosidase. The single-
headed arrow indicates the parent ion. Differences in fucose content are indicated by double-headed arrows. 
Triangle, fucose; light circle, galactose; dark square, N-acetylglucosamine; dark circle, mannose. 
 
 
Supplementary figure 2. MS/MS of peptide E172–R183 carrying H4N5F4 N-glycans. The MS/MS spectrum 
was acquired by MALDI-TOF/TOF-MS of a tryptic digest of omega-1. The single-headed arrow indicates the 
parent ion. Differences in fucose content are indicated by double-headed arrows. Triangle, fucose; light circle, 





a  Glycan compositions are given in terms of hexose (H), N-acetylhexosamine (N) and fucose (F).  
b Monoisotopic masses of glycopeptide precursors are given throughout. Glycopeptides are singly positively 
charged, as registered by MALDI-TOF-MS. For many glycopeptides, masses after β-galactosidase (β-gal) 
treatment are listed and the loss of n hexose is concluded (- n hex).  
c Relative peak height is expressed as a percentage of cumulative peak height.  
d Fragment ions were determined by MALDI-TOF/TOF-MS. Pep1 corresponds to peptide 
E172FGYNGSANCIR183 containing glycosylation site N176.  
e Proposed glycan structures are deduced from glycopeptide MS after enzyme treatments and fragmentation 
data. Triangle, fucose; light circle, galactose; light square, N-acetylgalactosamine; dark square, N-
acetylglucosamine; dark circle, mannose. 
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Glycans present on glycoproteins from the eggs of the parasite Schistosoma mansoni are 
mediators of various immune responses of the human host, including T-cell modulation and 
granuloma formation, and they are the target of glycan-specific antibodies. Here we have 
analyzed the glycosylation of kappa-5, a major glycoprotein antigen from S. mansoni eggs using 
a targeted approach of lectin purification followed by mass spectrometry of glycopeptides as well 
as released glycans. We demonstrate that kappa-5 has four fully occupied N-glycosylation sites 
carrying unique triantennary glycans composed of a difucosylated and xylosylated core region, 
and immunogenic GalNAcβ1-4GlcNAc (LDN) termini. Furthermore, we show that the kappa-5 
specific IgE antibodies in sera of S. mansoni-infected individuals are directed against the core 
region of the kappa-5 glycans. Whereas two previously analyzed immunomodulatory egg 
glycoproteins, IPSE/α1 and omega-1, both express diantennary N-glycans with a difucosylated 
core and one or two Galβ1-4(Fucα1-3)GlcNAc (LeX) antennae, the kappa-5 glycosylation 
appears unique among the major soluble egg antigens of S. mansoni. The distinct structural and 
antigenic properties of kappa-5 glycans suggest a specific role for kappa-5 in schistosome egg 
immunogenicity. 
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Schistosomiasis, a debilitating disease caused by infection with Schistosoma parasites, forms a 
major public health burden in many areas in the tropics and sub-tropics. The main pathological 
symptoms of Schistosoma mansoni infection are caused by the deposition of parasite eggs into 
the organs of the host and the subsequent immunological consequences, which include the 
formation of perioval granulomas associated with a pronounced T helper 2 (Th2) response 1.  
Many aspects of these egg-induced immune processes are thought to be at least partly 
mediated by protein glycosylation 2-5. The role of glycans during granuloma formation has been 
explored in vivo by hepatic implantation of antigen-coated Sepharose beads as artificial eggs into 
mice 3. In this model, beads that carry soluble egg antigens (SEA) of S. mansoni give rise to 
granulomas very similar to granulomas around actual schistosome eggs. In contrast, granulomas 
were not formed around beads coated with SEA of which the glycans had been destroyed by 
periodate treatment. Intact glycosylation has also been reported to be crucial for Th2-polarizing 
properties of SEA in a murine model of intranasal sensitization giving rise to antigen-specific 
IgE production and induction of IL-4 and IL-10 2.  
The structure of SEA glycans has been studied extensively, mainly by mass 
spectrometric (MS) analysis of released N- and O-glycans 6-8. However, to obtain knowledge 
about the contribution of glycosylation to the functional properties of individual glycoproteins, 
protein-specific glycosylation analyses, rather than studies on glycans released from glycoprotein 
mixtures, are essential. Up to now, only for two schistosome egg glycoproteins, omega-1 9 and 
IPSE/α1 10, a protein-specific in-depth glycosylation analysis has been carried out 11;12, and both 
these glycoproteins were found to carry the immunogenic Galβ1-4(Fucα1-3)GlcNAc (Lewis X. 
LeX) motif 13-17. The similar glycosylation patterns of these proteins do not account for the 
variety of antigenic glycan elements found in schistosome eggs, emphasizing the need for 
detailed studies on the glycosylation of other subsets of the egg glycoproteome. Recently, kappa-
5, an immunogenic egg glycoprotein from S. mansoni putatively involved in host-parasite 
interactions, has been identified 18. Schramm et al. showed that kappa-5 is the target of a 
pronounced IgE response in the human host 18. Recombinant kappa-5 expressed in human 
embryonic kidney (HEK) cells did not reveal any IgE reactivity. Since mammalian-derived HEK 
cells have a different glycosylation repertoire from schistosomes, this may point to a role of 
specific glycans as the IgE target. In addition, kappa-5 was shown to be the primary S. mansoni 
SEA constituent that binds to soybean agglutinin (SBA), a lectin that is specific for terminal αβ-
D-N-acetylgalactosamine (GalNAc) 19. Terminal GalNAc is a common monosaccharide in 
several S. mansoni life stages 6, 20, 21 including eggs 6 as part of GalNAcβ1-4GlcNAc (LacdiNAc, 
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LDN), a structure to which several immunogenic properties have been attributed 4, 22-24. The 
selective binding of SBA to kappa-5 suggests that kappa-5 carries such GalNAc-containing 
glycans. 
The significance of schistosome glycans with respect to host-schistosome interactions 
and the peculiar properties of kappa-5 glycosylation prompted us to perform a detailed analysis 
of kappa-5 using nanoscale LC-MS(/MS) and MALDI-TOF(/TOF)-MS measurements of 
released glycans as well as tryptic glycopeptides, in combination with exoglycosidase treatments. 
We here show that each glycosylation site of kappa-5 to a large degree carries a unique type of 
core-difucosylated, core-xylosylated triantennary glycan with three terminal LDN motifs, setting 
it apart from the other members of the egg glycoproteome. Furthermore, we show that IgE 
reactivity of kappa-5 is attributable to its glycans. These observations underscore the antigenic 
properties of kappa-5 glycans and emphasize the need for further unraveling the role of 





Figure 1. Visualization and characterization of kappa-5. SEA, kappa-5 (κ5) and β-N-acetylhexosaminidase- 
treated kappa-5 (κ5 HexNAc) were separated under reducing conditions by SDS-PAGE and silver stained (A). 
For testing the presence of terminal LDN, the antigens were subjected to Western blot using a monoclonal 
antibody against LDN (273-3F2) (B). Kappa-5 is indicated by arrowheads. 
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Kappa-5 is the major LDN-containing glycoprotein in S. mansoni soluble egg antigens (SEA)   
Kappa-5 was purified from SEA by SBA-affinity chromatography and subjected to SDS-PAGE 
under reducing conditions, giving rise to a prominent kappa-5 band at ~ 50 kDa (Figure 1A), as 
previously shown 18. The peptide mass fingerprint analysis of the tryptic digest matched to the 
secretory glycoprotein k5 precursor of Schistosoma mansoni (kappa-5), accession AAX83117 
(NCBInr) with a Mowse score of 198, a sequence coverage of 58%, and 27 of 59 mass values 
searched matched. Mass spectrometric analysis demonstrated that the 50 kDa kappa-5 isomer 
contains four glycosylation sites N116, N143, N174 and N251 (Figure 2). In a previous study, an 
additional protein band at a lower apparent molecular weight was found, containing an isomer 
of kappa-5 with only three glycosylation sites due to a single nucleotide mutation 18. Mass 
spectrometric analysis of glycopeptides isolated from this protein band (data not shown) 
indicated that the glycans carried by the kappa-5 isomer with three glycosylation sites were 
identical to those of the kappa-5 carrying four glycans. 
 
 
Figure 2. Heterogeneity of the glycan moieties on the four glycosylation sites of kappa-5. Kappa-5 was 
subjected to reduction and alkylation, digested with trypsin and the resulting glycopeptides were analyzed by 
LC-ion trap-MS. Mass spectra cover the four glycosylation sites N116 (A), N143 (B), N174 (C), and N251 (D). 
Differences in fucose, N-acetylglucosamine and N-acetylgalactosamine content of the glycan moiety are
indicated. Non-glycopeptide signals are marked with asterisks (*). Triangle, fucose; light square, N-
acetylgalactosamine; dark square, N-acetylglucosamine; dark circle, mannose; open star, xylose. 
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SBA binds terminal GalNAc 19, a monosaccharide which abundantly occurs in S. 
mansoni glycoconjugates in the context of the disaccharide element LDN 6;20;21. To investigate 
whether kappa-5 carries LDN motifs, SBA-purified kappa-5 was subjected to Western blot 
analysis. The LDN-reactive mAb 273-3F2 was found to bind to kappa-5 (Figure 1B), 
demonstrating the presence of LDN. Treatment of kappa-5 with β-N-acetylhexosaminidase (κ5 
HexNAc) to remove terminal -linked HexNAc residues and thereby LDN completely abrogated 
binding of the antibody, verifying the presence of a terminal LDN motif on kappa-5. Moreover, 
on SDS-PAGE the molecular weight of κ5 HexNAc decreased by > 5kD upon -N-
acetylhexosaminidase treatment (Figure 1A), which implies the presence of multiple LDN 
termini on kappa-5. Western blot analysis of SEA with mAb 273-3F2 showed one reactive 
protein band at the same molecular weight as isolated kappa-5 (Figure 1B). Together, these data 
demonstrate that kappa-5 is the major glycoprotein in SEA that carries terminal, unsubstituted 
LDN. 
 
Kappa-5-reactive IgE antibodies in human infection sera are directed against glycans 
To investigate the hypothesis that glycans are the target of kappa-5-reactive IgE in S. mansoni 
infection sera 18, SBA-purified kappa-5 was subjected to SDS-PAGE under reducing conditions, 
blotted onto a nitrocellulose membrane and treated with periodate to destroy its glycan  
structures. After treatment, SBA-reactivity of kappa-5 was lost, while protein staining using 
silver stain and reactivity to a mAb against the kappa-5 protein were unaffected (Figure 3A), 
indicating that by periodate treatment of kappa-5 on a blotting membrane the integrity of the 
glycans is destroyed, while the protein remains intact. Untreated kappa-5 is bound by IgE 
antibodies in human S. mansoni infection sera (Figure 3B), as previously shown by Schramm et 
al. 18. Upon treatment with periodate, IgE reactivity was lost or strongly diminished (Figure 3B), 
confirming that kappa-5 glycans are responsible for the binding of IgE antibodies in human 
infection sera to kappa-5.  
Next, to investigate whether the reactivity of IgE antibodies from S. mansoni infection 
sera is targeted against the LDN antennae of kappa-5 or not, we performed an ELISA to measure 
IgE binding to kappa-5 variants generated by β-N-acetylhexosaminidase and fucosidase 
treatments. To ensure success of removal of HexNAc and fucose residues, glycopeptides 
generated after tryptic digestion of an aliquot of the exoglycosidase-treated kappa-5 variants 
were analyzed by LC-MS (data not shown), similarly as demonstrated for the exoglycosidase-
treated glycopeptides (see Figure 4 and 5). Figure 3C shows that β-N-acetylhexosaminidase-
treated kappa-5 exhibits similar IgE reactivity as untreated kappa-5, indicating that LDN on 
kappa-5 is not the primary target for serum IgE. Similarly, kappa-5 of which antenna fucoses  
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Figure 3. Reaction of IgE in human 
infection sera with kappa-5. (A,B) Blots 
containing SBA-purified kappa-5 were 
treated (p) with metaperiodate to destroy 
glycan structures, or without (-). Kappa-5 is 
indicated by the arrowhead. (A) Treatment 
efficiency was analyzed with a protein stain 
(Silver), a monoclonal antibody against 
kappa-5 (1G2) and SBA reactivity (SBA). (B) 
Sera from six human subjects known to be 
infected with S. mansoni were used to probe 
the kappa-5 blots. IgE antibody reactivity was 
visualized by a secondary antibody specific 
for IgE. (C) Kappa-5 was treated with β-N-
acetylhexosaminidase (κ5 HexNAc), α-
fucosidase from X. manihotis (κ5 Fuc) or a 
combination of the enzymes (κ5 
FucHexNAc), and the kappa-5 variants were 
tested in an ELISA for their reactivity with 
IgE from two human infection sera. One out 
of two representative experiments is shown. 
were removed by treatment with α1-(3,4)-fucosidase from X. manihotis, and a variant treated 
sequentially with the fucosidase and β-N-acetylhexosaminidase, respectively, also display IgE 
reactivity comparable to untreated kappa-5 (κ5 Fuc and κ5 FucHexNAc, respectively, in Figure 
3C). Together, these observations indicate that the core structure rather than the antenna of 
kappa-5 glycans are associated with the IgE-reactivity of kappa-5. 
The structural details of the antigenic kappa-5 glycans were further analyzed using 
various MS-based techniques and glycosidase treatments. 
 
Analysis of PNGase A-released N-glycans from kappa-5 
To obtain a general overview of N-glycans on kappa-5, tryptic kappa-5 glycopeptides were 
treated with PNGase A, which releases all N-glycans including those with the core α3-linked 
fucose modification frequently occurring in schistosome glycoproteins. The glycan pool was 
analyzed by MALDI-TOF-MS in the positive reflectron mode (Figure 6). Single charged sodiated 
ions were detected (indicated by single-headed arrows in Figure 6), accompanied by a signal 
with lower intensity corresponding to a potassium adduct. The major glycan species in the 
MALDI-TOF-MS spectrum (~ 46% of total glycan pool) is observed at m/z 2575.9 [M+Na]+ and 
m/z 2591.9 [M+K]+ (Figure 6), which corresponds to a reducing glycan with a mass of 2552.9 Da 






Figure 4. -N-Acetylhexosaminidase treatment of kappa-5 glycopeptides. Kappa-5 was subjected to 
reduction and alkylation, digested with trypsin and the resulting glycopeptides W172-K188 and T108-K117 
were analyzed by LC-MS before (A) and after (B) treatment with -N-acetylhexosaminidase. Signals are 
labeled with monoisotopic masses. Differences in fucose, N-acetylglucosamine and N-acetylgalactosamine 
content of the glycan moiety are indicated. Triangle, fucose; light square, N-acetylgalactosamine; dark square, 
N-acetylglucosamine; dark circle, mannose; open star, xylose. 
 
Figure 5. α-Fucosidase treatment of kappa-5 glycopeptides. Kappa-5 was subjected to reduction and 
alkylation, digested with trypsin and the resulting glycopeptide T108-K117 was analyzed by LC-MS before (A) 
and after (B) treatment with α-fucosidase from X. manihotis. Signals are labeled with monoisotopic masses. 
Differences in fucose, N-acetylglucosamine and N-acetylgalactosamine content of the glycan moiety are 
indicated. Triangle, fucose; light square, N-acetylgalactosamine; dark square, N-acetylglucosamine; dark 
circle, mannose; open star, xylose. 
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pentose, xylose). To further assess the glycan structure, the sodiated species at m/z 2575.9 was 
subjected to MALDI-TOF/TOF-MS fragmentation analysis (Figure 7). Aided by the 
fragmentation pattern, we propose that H3N8F2P consists of a trimannosyl N-glycan core 
containing two fucoses at the reducing N-acetylglucosamine, a xylose residue linked to the β-
linked mannose and three terminal LDN branches. The occurrence of LDN termini was 
indicated by the signal at m/z 429.5 (Figure 7), which corresponds to sodiated HexNAc2 
fragments. Based on the strong reactivity of kappa-5 with an LDN antibody (Figure 3B), we 
interpret these fragments as terminal LDN motifs. This interpretation was supported by the 
presence of signals at m/z 2170.9 and 2374.1 [M+Na]+, corresponding to the loss of respectively 
one and two terminal HexNAc residues from the parent ion. The positioning of the fucose 
residues was revealed by a H3N7P fragment at m/z 2064.7 [M+Na-H2O]+ in Figure 7, indicative of 
a chitobiose cleavage product which has lost the reducing end GlcNAc with one α3- and one α6-
linked fucose. Furthermore, the signal at m/z 1048.3, corresponding to a sodiated H3N2P 
fragment indicates that the xylose residue is associated with the trimannosyl core, as previously 
described for S. mansoni egg 6 and cercarial 33 N-glycans. 
The remaining PNGase A-released glycans visualised in Figure 6 were assigned on the 
basis of mass differences compared to the above described major glycan signal at m/z 2575.9 
[M+Na]+. Evidently, heterogeneity of the glycan moieties on kappa-5 is caused by variation in 
the number of HexNAc and fucose residues, as reflected by corresponding mass differences (203 
and 146 Da, respectively) between the registered glycans. The second major glycan (at m/z 
2722.0 [M+Na]+ and 2738.0 [M+K]+, Figure 3) accounts for ~17 % of glycans on kappa-5 and 
contains an additional fucose residue compared to the major signal, which may imply the 
presence of a fucose residue linked to one of the LDN antennae. Other glycan variations include 
structures containing two or four LDN motifs and a mono-fucosylated core (Figure 6). 
 
Identification and characterization of N-glycosylation sites of kappa-5 
To obtain in-depth, site-specific glycosylation information, kappa-5 was subjected to reduction, 
alkylation and trypsinization, after which resulting glycopeptides were analyzed by reversed 
phase LC-ion trap-MS. The most abundant glycopeptide species for all four glycosylation sites 
was found to be pep-H3N8F2P (m/z 1207.9 [M+3H]3+ for site N116, 1244.7 [M+3H]3+ and 1252.1  
[M+Na+2H]3+ for site N143, 1113.8 [M+4H]4+ for site N174 and 1138.9 [M+3H]3+ and 1146.1 
[M+Na+2H]3+ for site N251 in Figs. 2A, 2B, 2C and 2D, respectively), which is in accordance 
with the major glycan species found among the PNGase A-released glycans (Figure 3). 
Moreover, the same heterogeneity of the number of HexNAc and fucose moieties observed in 




To further substantiate the tentative assignments based on the analysis of the released 
glycans and to verify the linkage position of HexNAc and fucose residues, kappa-5 glycopeptides 
were rerun on the RP-LC-MS system, including glycopeptides treated with exoglycosidases. In 
addition, glycopeptides were subjected to fragmentation using LC-MS/MS. Nano-LC-MS/MS of 
glycan H3N8F2P on peptide W172-K188 (m/z 1113 [M+4H]4+; Figure 8A) verifies the presence of 
LDN antennae by intense signals at m/z 407.2 [HexNAc2+H]+, m/z 1349.0 [M-2HexNAc+3H]3+ 
and 2022.9 [M-2HexNAc+2H]2+ (loss of one LDN from the parent ion), and m/z 1819.9 [M-
4HexNAc+2H]2+ (loss of two LDN). Furthermore, the absence of signals at m/z 610.3 
[HexNAc3+H]+, 553.2 [HexNAc2Fuc1+H]+ and 813.4 [HexNAc4+H]+ confirms the absence of 
HexNAc3, fucosylated LDN or dimeric LDN antennae, which is a further indication that W172-
K188-H3N8F2P contains three, non-fucosylated terminal LDN branches. Additionally, data from 
β-N-acetylhexosaminidase treatment underline this assumption (Figure 4). The signal of 
untreated W172-K188-H3N8F2P (m/z 1113.7 [M+4H]4+ in Figure 4A) completely disappears 
upon treatment, while a similarly intense signal at m/z 1078.4 [M+3H]3+ (Figure 4B) appears, 
corresponding to the loss of six HexNAc residues (three LDN antennae). To obtain detailed 
information on the core structure, a MALDI-TOF/TOF-MS of W172-K188-H3N8F2P was 
 
Figure 6. MALDI-TOF-MS of PNGase A-released glycans from kappa-5. SBA- purified kappa-5 was 
digested with trypsin followed by PNGase A treatment. Released carbohydrates were subsequently purified 
using carbon adsorption chromatography and measured by MALDI-TOF-MS in the positive-ion reflectron 
mode. Signals are labeled with monoisotopic masses. m/z Values indicated with an arrow correspond to 
sodiated species. Triangle, fucose; light square, N-acetylgalactosamine; dark square, N-acetylglucosamine; dark 
circle, mannose; open star, xylose. 
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recorded (Figure 8B). A core cleavage pattern with an intense signal at m/z 2411.7 
[peptide+HexNAc1Fuc2+H]+ was observed, which verifies that the two fucoses in H3N8F2P are 
linked to the core GlcNAc residue. In this respect, it must be noted that the lower intensity 
signals at m/z 2265.3 [peptide+HexNAc1Fuc1+H]+ and 2119.6 [peptide+HexNAc1+H]+ are 
interpreted as the result of a chitobiose cleavage in combination with loss of core fucoses. For 
glycan H3N8F2P on the other three glycosylation sites, similar results were obtained using 
fragmentation and exoglycosidase derived data (Figure 4 and Supplementary Figures 1-4), 
leading to the conclusion that the N-glycan H3N8F2P is structurally identical for all sites and 
contains three terminal LDN branches, two fucoses linked to the innermost GlcNAc and a xylose 
linked to the β-linked mannose. 
The composition of a substitution present on a minor portion of each glycosylation 
site, H3N8F3P (Figure 2), points to an N-glycan with two core fucoses, one core xylose and three 
LDN antennae of which one is fucosylated, as verified by LC-MS/MS (Supplementary Figure 5). 
The position of the antenna fucose was determined by enzymatic degradation using a set of three 
exoglycosidases. First, the specificities of α1-(3,4)-fucosidase from X. manihotis, α-L-fucosidase 
from bovine kidney and β-N-acetylhexosaminidase from C. ensiformis were tested using two 
synthetic glycoconjugates containing the terminal GalNAcβ1-4(Fucα1-3)GlcNAc (LDN-F-tag) 
and Fucα1-3GalNAcβ1-4GlcNAc (F-LDN-tag) sequences 25, 26. Treatment with α-fucosidase 
Figure 7. MS/MS of the major PNGase A-released glycan from kappa-5. The major PNGase A-released 
carbohydrate (m/z 2577 [M+Na]+) in Figure 3 was analyzed by MALDI-TOF/TOF-MS. The parent ion is 
indicated by an arrow. Differences in fucose content are indicated by double-headed arrows. The given glycan 
structures are examples. Triangle, fucose; light square, N-acetylgalactosamine; dark square, N-
acetylglucosamine; dark circle, mannose; open star, xylose; #, loss of water; , presumably potassium adduct 
co-isolated during precursor selection. 
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from X. manihotis resulted in the partial loss of one fucose from LDN-F-tag (m/z 936.5 [M+H]+ 
in Figure 8A shifts to m/z 790.5 [M+H]+ in Figure 9B), while F-LDN-tag was not affected by the 
enzyme (m/z 936.5 [M+H]+ in Figure 8E does not shift in Fig 9F). Interestingly, α-fucosidase 
from bovine kidney has the opposite specificity. Under the conditions applied, it was able to 
partially cleave the fucose of F-LDN-tag (Figure 9G) but not of LDN-F-tag (Figure 9C). Upon 
treatment with β-N-acetylhexosaminidase, LDN-F-tag loses one HexNAc (m/z 936.5 [M+Na]+ in 
Figure 9A shifts to m/z 733.4 [M+Na]+ in Figure 9D), while the enzyme has no effect on F-LDN-
tag (Figure 9H). The tryptic glycopeptides of kappa-5 were treated with the same glycosidases. 
We used glycopeptide T108-K117 containing glycosylation site N116 to monitor the effect of 
exoglycosidase treatment on glycan H3N8F3P by LC-MS. Treatment of kappa-5 glycopeptides 
with α-fucosidase from X. manihotis results in removal of one fucose from T108-K117-H3N8F3P 
 
 
Figure 8. MS/MS of peptide W172-K188 carrying H3N8F2P N-glycans. The MS/MS spectra were acquired by 
LC-ion trap-MS/MS (A) and MALDI-TOF/TOF-MS/MS (B) from a tryptic digest of kappa-5. Glycopeptides 
are singly positively charged, unless specified otherwise. The given glycan structures are examples. Triangle, 
fucose; light square, N-acetylgalactosamine; dark square, N-acetylglucosamine; dark circle, mannose; open 
star, xylose; pep, peptide. 0,2X, ring fragmentation of the N-linked N-acetylglucosamine. 
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as the signal at m/z 1256.5 [M+3H]3+ in Figure 5A completely shifts to the signal at m/z 1207.5 
[M+3H]3+ in Figure 5B, while the α-fucosidase derived from bovine kidney has no effect on the 
glycopeptide (data not shown). In addition, treatment with β-N-acetylhexosaminidase results in 
the disappearance of the signal at m/z 1257.4 [M+3H]3+ in Figure 4A and the appearance of a 
signal at m/z 1376.5 [M+2H]2+ in Figure 4B, representing the loss of the two (non-fucosylated) 
LDN structures and one HexNAc from the fucosylated LDN antenna, as confirmed by 
fragmentation analysis (Supplementary Figure 6). Together, these data demonstrate the presence 
of the LDN-F but not the F-LDN motif on glycopeptide T108-K117-H3N8F3P. 
Fragmentation spectra and exoglycosidase treatment data were also obtained for the 
other glycans on kappa-5, as summarized in Table 1. Interestingly, the glycosylation patterns 
were found to be remarkably similar for the four glycosylation sites, although some differences 
in relative abundances as well as presence or absence of low abundant glycans existed. 
 
Discussion 
Our data show that the S. mansoni egg antigen kappa-5 carries a unique set of glycans with three 
LDN antennae on an α3/α6-difucosylated, xylosylated N-glycan core. These glycans appear to be 
exclusively expressed on kappa-5. No other SEA components were detected that are bound by an 
LDN-reactive mAb or SBA, the GalNAc-binding lectin used to purify kappa-5 from S. mansoni 
egg protein extracts. So far, two other abundant S. mansoni egg glycoproteins have been 
characterized in terms of glycosylation, IPSE/α1 34 and omega-1 9. The glycan profiles of IPSE/α1 
and omega-1 are highly similar to each other and are characterized by the presence of 
diantennary glycans with core difucosylation and LeX antennae 11;12, whereas in contrast to 
kappa-5 core xylosylation is absent and LDN-motifs were observed only in minor amounts in 
these two proteins.  
The striking differences between the glycosylation of kappa-5 on the one hand and 
IPSE/α1 and omega-1 on the other, emphasize the value of protein-specific MS-based 
glycosylation analyses. Although glycomics studies of glycans released from protein mixtures 
derived from cercariae, worms or eggs provide useful information on the glycan repertoire of a 
cell or organism, such studies usually lack the structural information required to address glycan-
related properties of individual glycoproteins. 
Schistosome-derived glycoproteins play an important role in immunomodulatory 
mechanisms associated with schistosomiasis via their action on a range of immune cells 
including dendritic cells (DCs) and T-cells 35. Glycosylated SEA components from S. mansoni 
are internalized by immature monocyte-derived DCs primarily via the C-type lectin receptors 
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 (CLRs) Mannose receptor (MR), macrophage galactose-type lectin (MGL) and DC-SIGN, 
leading to suppression of Toll like receptor-induced DC activation 36. It is currently unknown 
which individual glycoproteins in SEA bind to these different CLRs. Binding of pathogen-
derived glycans to DC-SIGN and MR can trigger intracellular pathways associated with 
immunomodulation 37;38, but MGL-mediated signaling pathways involving pathogen glycans 
have to our knowledge not yet been described. The structural elucidation of kappa-5 glycans, 
and the previously reported studies on the glycosylation of IPSE/α1 12, a basophil modulator 39 
and of omega-1 11, an SEA component recently described to condition DC to drive Th2 
responses 40, provide a starting point to further detail the contribution of these abundant SEA 
glycoproteins to CLR-mediated immunomodulatory processes. Guided by the reported binding 
characteristics of MR, MGL and DC-SIGN, the LeX elements present on both IPSE/α1 and 
omega-1 are potential ligands for DC-SIGN 41, and they may also confer MR binding 42;43. In 
contrast, kappa-5 is a candidate ligand for MGL that binds to α and β-linked GalNAc residues 44.  
 
 
Figure 9. MALDI-TOF-MS of exoglycosidase treated glycoconjugates. To test the specificity of 
exoglycosidases, GalNAcβ1-4(Fucα1-3)GlcNAcβ1-3Galα1-(CH2)5-squarate (A-D) and Fucα1-3GalNAcβ1-
4GlcNAcβ1-3Galα1-(CH2)5-squarate (E–H) were either not treated (A and E) or treated with α1-(3,4)-
fucosidase from Xanthomonas manihotis (B and F), α-L-fucosidase from bovine kidney (C and G) or -N-
acetyl-hexosaminidase from Canavalia ensiformis (D and H) and analyzed by MALDI-TOF-MS. Non-
glycoconjugate signals are marked with asterisks (*).Triangle, fucose; light square, N-acetylgalactosamine; dark 
square, N-acetylglucosamine. 
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Table 1. Kappa-5 glycopeptide species detected after trypsin digestion 
Glycan composition Glycopeptide signal (m/z) Structural characteristics 
Peptide T106-K117  with glycosylation site N116 
H3N6F2P 1072.6 [M+3H]
3+ 3,6F, Xyl, two LDN 
H3N7F2P 1140.3 [M+3H]








3,6F, Xyl, two LDN, one LDN-F 
Peptide N143-K152  with glycosylation site N143 
H3N6F2P 1109.4 [M+3H]
3+ 3,6F, Xyl, two LDN 
H3N7F2P 1177.0 [M+3H]









3,6F, Xyl, two LDN, one LDN-F 
H3N8F4P 1342.4 [M+3H]
3+ 3,6F, Xyl, one LDN, two LDN-F 
Peptide W172-K188 with glycosylation site N174 
H3N6F2P 1012.3 [M+4H]
4+ 3,6F, Xyl, two LDN 
H3N8F2P 1113.8 [M+4H]
4+ 3,6F, Xyl, three LDN 
H3N8F3P 1150.3 [M+4H]
4+ 3,6F, Xyl, two LDN, one LDN-F 
H3N8F4P 1186.8 [M+4H]
4+ 3,6F, Xyl, one LDN, two LDN-F 
Peptide I246-K252 with glycosylation site N251 
H3N6F2P 1003.7 [M+3H]
3+ 3,6F, Xyl, two LDN 
H3N7F2P 1071.3 [M+3H]




















3,6F, Xyl, four LDN 
H3N10F3P 1322.7 [M+Na+2H]
3+ 3,6F, Xyl, three LDN, one LDN-F 
3,6F, α3⁄α6-di-fucosylation of the innermost GlcNAc. 
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Kappa-5 was subjected to reduction, alkylation and subsequent trypsinization. 
Resulting glycopeptides were analyzed by LC-ESI-MS. Glycan compositions are given in terms 
of hexose (H), N-acetylhexosamine (N), fucose (F) and pentose/xylose (P). Monoisotopic masses 
of glycopeptide precursors are given throughout. Proposed glycan structures are deduced from 
glycopeptide MS after enzyme treatments and fragmentation data. Another special property of 
kappa-5 is that it is recognized by IgE as well as IgG antibodies in sera from S. mansoni infected 
individuals but not from uninfected individuals, whereas no other SEA components are as 
strongly reactive with IgE 18. In serum from S. mansoni-infected mice IgE has been detected that 
is specific for the N-glycan core modifications α3-fucose and possibly β2-xylose 45, which can 
both be present on S. mansoni egg glycans 6;8. Interestingly, recombinant kappa-5 from HEK-
cells, a mammalian cell type not capable of producing core α3-fucosylated and/or β2-xylosylated 
glycans, did not reveal IgE reactivity but had ample IgG reactivity in human sera, suggesting that 
glycans are the IgE targets 18. Our data confirm that kappa-5 glycans constitute the IgE epitopes 
(Figure 3) and moreover demonstrate that the antenna structures on kappa-5 glycans, including 
the LDN epitopes, are not involved in IgE binding of kappa-5 to human infection sera (Figure 
3C). As the N-glycan core of kappa-5 glycans contains two fucoses linked to the innermost 
GlcNAc and a xylose (Table 1), our data together with the previously published data on the 
antigenic properties of the α3-core fucose and β2-xylose 45, strongly suggest that the IgE 
antibodies in S. mansoni infection sera are targeted against the core decorations of kappa-5. 
Notably, asparagine-linked glycans belong to the most abundant environmental immune 
determinants and form the basis of the so-called cross-reactive carbohydrate determinants 
(CCDs) 46. About 20% or more of allergic patients generate specific anti-glycan IgE, often 
accompanied by IgG. Despite some structural variation, the two main motifs in these CCDs are 
the xylose and the core α3-linked fucose, which form the essential part of two independent 
epitopes. With respect to kappa-5, we believe that in particular the xylose residue forms part of 
the minimal glycan IgE epitope, since omega-1 and IPSE/α1, which also contain core di-
fucosylated glycans but lack the xylose residue, are not bound by IgE in schistosomiasis infection 
sera 18. 
In a global glycomic comparison of glycans from S. mansoni and S. japonicum eggs, N-
glycans with a α3-, β6-difucosylated, xylosylated core were found exclusively in the S. japonicum 
egg-derived glycan fraction 6. We here show that also S. mansoni is capable of expressing this 
highly unusual combination of core decorations. The specific three LDN antennae-containing 
glycan of kappa-5 was not observed by Khoo et al. 6. It is possible that within the total PNGase 
A-released glycan pool of S mansoni eggs, the major kappa-5-derived glycan H3N8F2P forms a 
minor fraction that could not be detected because it was obscured by other more abundant 
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glycans. However, in a recent MALDI-TOF MS based profiling study of released glycans from 
several life stages of S. mansoni, the PNGase A-sensitive H3N8F2P glycan species was observed in 
eggs as well as miracidia 7. Also, kappa-5 was detected in eggs as well as miracidia, both at the 
protein and mRNA level 18, which is in line with the current data indicating that the H3N8F2P 
glycan is associated with kappa-5. Interestingly, the core-difucosylated LeX-containing glycans 
observed on IPSE/α1 and omega-1 11;12 were detected in the PNGase A-released fraction of eggs, 
but not of miracidia 7, which is in line with the observation that IPSE/α1 and omega-1 are 
expressed in the sub shell area of the egg 9;10. Kappa-5 has been located to the same area, but as 
yet it is not clear whether kappa-5 is glycosylated differently from IPSE/α1 and omega-1 because 
it is produced in the context of a different cellular glycosylation machinery, or because protein-
specific effects play a role.   
The observation that kappa-5 is the major LDN-expressing glycoprotein from 
schistosome eggs is additionally relevant in view of a previous report that a synthetic LDN-
glycoconjugate can induce granulomas in a mouse model based on the implantation of coated 
Sepharose beads as artificial eggs 4. Liver granulomas with high similarity in terms of cellular 
constituency and temporal regulation compared to granulomas induced by schistosome eggs in 
a natural infection were induced by SEA- and LDN-coated beads, but not by a range of 
fucosylated conjugates including LeX 4. The potential role of kappa-5 as an authentic granuloma-
inducing component of schistosome eggs should be investigated. 
MS techniques are at the basis of structural analysis of glycans, and MS is an 
indispensible tool to obtain sensitive and detailed structural information on scarce and complex 
material such as pathogen-derived glycoproteins. It remains particularly difficult, however, to 
determine the specific positions and linkages of antenna elements in branched glycans. 
Therefore, validation of the structural assignments by glycosidase treatments and/or anti-glycan 
antibodies is critical for a detailed and solid interpretation of MS data and the determination of 
glycan structures. To generate a tool to discriminate between the immunogenic LDN-F and F-
LDN elements, we investigated the specificity of two α-fucosidases and one β-N-
acetylhexosaminidase using synthetic LDN-F- and F-LDN-containing glycoconjugates. 
Interestingly, under the conditions applied, α1(-3,4)-fucosidase derived from X. manihotis was 
found to specifically cleave the fucose from LDN-F, whereas α-L-fucosidase from bovine kidney 
could cleave off the fucose of F-LDN but not LDN-F. In addition, β-N-acetylhexosaminidase 
from C. ensiformis provided structural information by the cleavage of unsubstituted HexNAc 
from LDN-F. Using this knowledge, we were able to demonstrate that a minor subset of kappa-5 
glycans carries terminal LDN-F motifs, whilst no F-LDN motifs were observed on kappa-5. 
These specific glycosidases will be useful tools to distinguish F-LDN and LDN-F in a variety of 
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settings, as these isomers form antigenically different motifs. For instance, in schistosome 
infections, high IgG antibody responses are found against F-LDN, but not against LDN-F 25;47. 
With the completion of the glycosylation analysis of kappa-5, three major S. mansoni 
egg antigens 48;49 have now been identified in terms of protein and glycan sequence. This 
information will contribute to our understanding of the immunological mechanisms induced by 
these proteins and/or the glycans that they carry. The collective glycans detected on these three 
major egg antigens seem to make up the majority of N-glycans detected in S. mansoni ES 
glycoproteins 8 and in the specific PNGase A-sensitive fraction of egg N-glycans 7.  
 
Materials and Methods 
Antigens, glycoconjugates and sera 
S. mansoni SEA was prepared as described previously 10. Kappa-5 was isolated by soybean 
agglutinin (SBA; Sigma, Zwijndrecht, the Netherlands) affinity chromatography as described 
previously 18 or via a slightly adapted method. For the adapted method, two mg of SBA was 
coupled to one ml N-hydroxysuccinimide-activated Sepharose beads (GE Healthcare, Uppsala, 
Sweden) according to the manufacturer’s instructions. SEA in PBS, pH 7.4, was applied to a 
column containing the SBA beads and the bound material was eluted with 0.1 M galactose in 
PBS, pH 7.4. To maximize extraction efficiency, the effluent was reapplied once to the column. 
Effluent and eluate fractions were analyzed by SDS-PAGE with silver staining and Western 
blotting for the presence and purity of kappa-5. Eluate fractions containing purified kappa-5 
were pooled, concentrated by ICON concentrators (9K MWCO, Thermo scientific, Rockford, 
IL, USA), dialyzed against PBS using Slide-a-lyzer dialysis cassettes (3.5 MWCO, Thermo 
scientific) and stored at -20°C.  
For testing the specificity of exoglycosidases used in this study, the synthetic 
glycoconjugates Fucα1-3GalNAcβ1-4GlcNAcβ1-3Galα1-(CH2)5-squarate (F-LDN-tag) and 
GalNAcβ1-4(Fucα1-3)GlcNAcβ1-3Galα1-(CH2)5-squarate (LDN-F-tag), recovered after 
derivatization with diethylsquarate during a protein coupling procedure 25;26 were used. 
Approval for this study has been granted by the Medical Ethics Committee of the 
Leiden University Medical Center. The serum samples used to determine the IgE-reactive 
properties of kappa-5 were provided from an immunoepidemiological study that was previously 
carried out in the village of Ndombo, Senegal. The study design, epidemiology, sample collection 
and ethical procedures have been described in detail 27;28. In short, consent forms were developed 
in the local language. The purpose and contents of the study were explained in detail to the 
community in the local language. Informed consent was obtained from individual adult 
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participants but for children, the parents or guardians consented on their behalf. Each individual 
signed a consent form before commencement of any activity. All information obtained from 
participants was kept confidential.  
Venous blood samples were collected, allowed to stand at room temperature for 1 
hour, and centrifuged at 1500 rpm. The serum was carefully removed and stored frozen at -15°C. 
The serum samples were transported on dry ice to the Netherlands, aliquoted in 1.5 ml tubes 
(Eppendorf, Hamburg, Germany) and stored at -80°C until use.  
 
SDS-PAGE and Western blotting 
Kappa-5 was separated on a 12% polyacrylamide gel by SDS-PAGE under reducing conditions 
using the Mini-Protean Cell system (Bio-rad, Veenendaal, the Netherlands). Proteins were 
detected with silver stain, as previously described 29. For Western blotting, the proteins were 
transferred onto a nitrocellulose membrane in a Bio-rad Criterion Blotter system according to 
manufacturer’s instructions. For detection of LDN glycosylation, protein blots were stained as 
described previously 30. In short, blots were blocked with BSA and incubated with monoclonal 
antibody (mAb) 273-3F2, which binds to LDN 21. Blots were subsequently incubated with 
alkaline phosphatase-labeled goat-anti-mouse IgG,A,M (Caltag; Invitrogen, Breda, the 
Netherlands) and stained with nitro blue tetrazolium (NBT) / 5-bromo-4-chloro-3-indolyl 
phosphate (BCIP). 
To test the glycan-dependent binding of IgE antibodies to kappa-5, nitrocellulose 
membranes carrying kappa-5 were blocked with PBS/0.1% Tween and treated with meta-
periodate in acetate buffer or only acetate buffer as a control. Then, membranes were incubated 
with human infection sera diluted 1:100 and subsequently with alkaline phosphatase-labeled 
mouse anti-human IgE (Sigma). Antibody binding was visualized by NBT/BCIP. To determine 
the efficacy of meta-periodate treatment, meta-periodate- and mock-treated membranes were 
stained with SBA-HRP and 3,3'-Diaminobenzidine (DAB). As a control, membranes were 
stained with silver stain as described before 31 and the anti-kappa-5 antibody 1G2 (18 and 
unpublished results).  
 
IgE binding ELISA 
Maxisorp immuno plates (NUNC, Roskilde, Denmark) were coated with 5μg/ml of the indicated 
kappa-5 variants and blocked with PBS/0.05% Tween. Then, plates were incubated with human 
infection sera diluted 1:100 and subsequently with alkaline phosphatase-labeled mouse anti-




Sample preparation for mass spectrometry 
Tryptic digestions were either performed in solution or in gel after SDS-PAGE. For the in-
solution approach, to ~ 5 μg of kappa-5 in 50 μl 50 mM ammonium bicarbonate, 0.1 μg of 
trypsin was added (Promega, Leiden, the Netherlands) followed by overnight incubation at 37°C 
with or without prior reduction and alkylation. For reduction and alkylation, the sample was 
mixed with 0.05 volumes of 200 mM dithiothreitol, incubated for 30 min at 56°C, after which 0.2 
volumes of 200 mM iodoacetamide were added and the sample was incubated for 30 min in the 
dark at room temperature. After digestion, the sample was stored at −20°C and used for nano-
LC-MS and PNGase A treatment. 
In-gel digestion was performed as described previously 32. Individual protein bands of 
interest were excised from the gel. After tryptic digestion, (glyco)peptides were collected using 
two rounds of extraction with 20 μl of 0.1% trifluoroacetic acid (TFA) and stored at -20°C. 
 
Exo-glycosidase treatments 
Glycoproteins, tryptic glycopeptides or glycoconjugates were treated with β-N-
acetylhexosaminidase from Canavalia ensiformis (62.5 mU; Sigma) in 100 mM sodium 
phosphate buffer, pH 5.0, for 24 h at 37°C. α-Fucosidase treatment on these samples was 
performed with α1-(3,4)-fucosidase from Xanthomonas manihotis (0.5 mU; Sigma) or α-L-
fucosidase from bovine kidney (15 mU; Sigma) in 100 mM sodium phosphate buffer, pH 5.0, for 
24 h at 37°C. Untreated and treated samples were subjected to nano-LC-MS(/MS), in case of 
glycoproteins after trypsin digestion. 
 
PNGase A release  
A tryptic digest of kappa-5 was adjusted to pH 5.0 by addition of TFA and incubated with 
PNGase A (10 mU; Roche Diagnostics) overnight at 37°C. The sample was applied to a Zip-
TipC18 (Millipore, Billerica, MA, USA), washed 5 times with 20 μl 0.1% TFA and eluted with 50% 
acetonitrile (ACN), 0.1% TFA. The flow-through containing released glycans was applied to a 
self-packed (20 μl) porous graphitized carbon column (Carbograph; Alltech, Deerfield, IL, 
U.S.A.). The column was first equilibrated with a standard of 10 pmol maltopentaose to prevent 
irreversible binding of kappa-5-released carbohydrates. The maltopentaose was eluted from the 
column with 70% aqueous ACN and after washing the carbon column with water, the kappa-5-









PNGase A-released and purified glycans of kappa-5 were spotted directly on the MALDI target 
plate and mixed with one μl of matrix solution, 2,5-dihydroxybenzoic acid (DHB; Bruker 
Daltonics, Bremen, Germany), 10 mg/ml 50% ACN/0.1% TFA. Sample spots were dried under a 
stream of warm air. MALDI-TOF(/TOF)-MS data were obtained using an Ultraflex II time-of-
flight mass spectrometer (Bruker Daltonics) equipped with a LIFT-MS/MS facility. Spectra were 
acquired in the positive-ion reflectron mode. For fragment ion analysis in the tandem time-of-
flight (TOF/TOF) mode, precursors were accelerated with 8 kV and selected in a timed ion gate. 
Fragment ions generated by laser-induced decomposition of the precursor were further 
accelerated by 19 kV in the LIFT cell, and their masses were analyzed after the ion reflector 
passage. For confirmation of the identity of the isolated kappa-5, peptides extracted after in-gel 
digestion were purified by Zip-TipC18, eluted with 1 μl 50% ACN, 0.1% TFA onto the sample 
target plate, and mixed with 1 μl of matrix solution (10 mg/ml DHB in 50% ACN, 0.1% TFA). 
The peptide mass fingerprint (PMF) spectrum acquired was processed with FlexAnalysis version 
3.3. The baseline subtraction algorithm Median was used, and peaks were detected using the 
Snap algorithm with following settings: S/N threshold >7, relative intensity threshold 10%, 
minimum intensity threshold 50, maximal number of peaks 100, quality factor threshold 90, 
Snap average composition averagine. The PMF data were searched with Mascot version 2.2.06 
(Matrix Science, London, UK) against all entries (12,852,469) in the NCBInr database (release 31 
Jan 2011), using Biotools version 3.2 as interface. Mascot parameter settings were trypsin 
digestion, up to 2 missed cleavages allowed, fixed carbamidomethyl modification of cysteine and 
variable methionine modification. The maximum mass tolerance was set at 0.1 Da. A protein 
score greater than 85 was significant (p >0.05), with the scores for hits to the kappa-5 variants in 
the NCBInr protein database ranging from 162 to 198. 
 
Nano-HPLC-ESI-ion trap-MS(/MS) 
(Glyco)peptide samples were applied to a reverse-phase column (PepMap, 3 μm, 
75 μm × 100 mm; Dionex, Amsterdam, the Netherlands) using a Ultimate 3000 nano-LC system 
(Dionex). The column was equilibrated with eluent A (0.1% formic acid in water) at a flow rate 
of 300 nL·min-1. After injection of the sample, a linear gradient was applied to 25% B (95% ACN, 
0.1% formic acid) in 15 min, followed by a gradient to 70% B in 10 min and subsequent isocratic 
elution of 5 min. The eluate was monitored by absorption at 215 nm. 
The LC column was coupled to an Esquire HCT Ultra ESI-IT-MS (Bruker Daltonics) 
equipped with an online nanospray source operating in the positive-ion mode. Electropolished, 
stainless steel LC-MS emitters (150 μm OD, 30 μm ID) from Proxeon A/S (Odense, Denmark) 
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were used for electrospray (1100-1250 V). The solvent was evaporated at 170°C employing a 
nitrogen stream of 6 L min-1 and ions from m/z 400 to m/z 1800 were registered in the MS mode. 
When operated in the auto MS/MS mode, registering ions from m/z 140 to 2200, each MS scan 
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Supplementary figure 2. -N-acetylhexosaminidase treatment of glycopeptide I246-K252. Kappa-5 was 
subjected to reduction and alkylation, digested with trypsin and the resulting glycopeptides were analyzed by 
LC-MS before (A) and after (B) treatment with -N-acetylhexosaminidase. Signals are labeled with 
monoisotopic masses. Differences in fucose, N-acetylglucosamine and N-acetylgalactosamine content of the 
glycan moiety are indicated. Triangle, fucose; light square, N-acetylgalactosamine; dark square, N-
acetylglucosamine; dark circle, mannose; open star, xylose.
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Supplementary figure 1. -N-acetylhexosaminidase treatment of glycopeptide N143-K152. Kappa-5 was 
subjected to reduction and alkylation, digested with trypsin and the resulting glycopeptides were analyzed by 
LC-MS before (A) and after (B) treatment with -N-acetylhexosaminidase. Signals are labeled with 
monoisotopic masses. Differences in fucose, N-acetylglucosamine and N-acetylgalactosamine content of the 
glycan moiety are indicated. Triangle, fucose; light square, N-acetylgalactosamine; dark square, N-
acetylglucosamine; dark circle, mannose; open star, xylose.
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Supplementary figure 3. α-Fucosidase treatment of glycopeptide N143-K152. Kappa-5 was subjected to 
reduction and alkylation, digested with trypsin and the resulting glycopeptides were analyzed by LC-MS 
before (A) and after (B) treatment with α-fucosidase from X. manihotis. Signals are labeled with 
monoisotopic masses. Differences in fucose, N-acetylglucosamine and N-acetylgalactosamine content of the 
glycan moiety are indicated. Triangle, fucose; light square, N-acetylgalactosamine; dark square, N-
acetylglucosamine; dark circle, mannose; open star, xylose. 
 
Supplementary figure 4. α-Fucosidase treatment of glycopeptide I246-K252. Kappa-5 was subjected to 
reduction and alkylation, digested with trypsin and the resulting glycopeptides were analyzed by LC-MS 
before (A) and after (B) treatment with α-fucosidase from X. manihotis. Signals are labeled with monoisotopic 
masses. Differences in fucose, N-acetylglucosamine and N-acetylgalactosamine content of the glycan moiety 
are indicated. Triangle, fucose; light square, N-acetylgalactosamine; dark square, N-acetylglucosamine; dark 





Supplementary figure 5. MS/MS of peptide I246-K262 carrying H3N8F3P N-glycans. The MS/MS spectrum 
was acquired by LC-ion trap-MS/MS of a tryptic digest of kappa-5. Glycopeptides are singly positively 
charged, unless specified otherwise. The given glycan structures are examples. Differences in fucose content 
are indicated by double-headed arrows. Triangle, fucose; light square, N-acetylgalactosamine; dark square, N-
acetylglucosamine; dark circle, mannose; open star, xylose; pep, peptide.  
 
Supplementary figure 6. MS/MS of peptide T108-K117 carrying H3N3F3P N-glycans. The MS/MS spectrum 
was acquired by LC-ion trap-MS/MS of a tryptic digest of kappa-5 after treatment with β-N-
acetylhexosaminidase. Glycopeptides are singly positively charged, unless specified otherwise. The given 
glycan structures are examples. Differences in fucose content are indicated by double-headed arrows. Triangle, 
fucose; light square, N-acetylgalactosamine; dark square, N-acetylglucosamine; dark circle, mannose; open 
star, xylose; pep, peptide. 
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During infection with the blood fluke Schistosoma mansoni, glycan motifs present on 
glycoproteins of the parasite’s eggs mediate immunomodulatory effects on the host. The 
recognition of these glycan motifs is primarily mediated by C-type lectin receptors (CLR) on 
dendritic cells (DC) and other cells of the immune system. So far, it is unknown however which 
individual glycoproteins interact with the different CLR, and which structural components are 
involved. Here we investigated the structural basis of the binding of two abundant egg antigens, 
kappa-5 and IPSE/α1, by the CLR DC-specific ICAM3-grabbing non-integrin (DC-SIGN), 
macrophage galactose-type lectin (MGL) and mannose receptor (MR). In the natural soluble 
form, the secretory egg glycoprotein IPSE/α1 interacts with DC mainly via MR. Surprisingly, in 
plate-based assays MR preferentially bound to mannose conjugates, while in cell-based assays, 
IPSE/α1 is bound via the fucosylated Gal1-4(Fucα1-3)GlcNAc (LeX) motif on diantennary N-
glycans. Kappa-5, in contrast, is bound by DC via all three CLR studied and for a minor part also 
via other, non-CLR receptors. Kappa-5 interacts with MGL via the GalNAc1-4GlcNAc (LDN) 
antenna present on its triantennary N-glycans, as well as the GalNAc1-4(Fucα1-3)GlcNAc 
(LDN-F) antennae present on a minor N-glycan subset. DC-SIGN binding of kappa-5 was 
mediated via the LDN-F antennae, whereas binding of MR may involve either LDN-F antennae 
or the fucosylated and xylosylated chitobiose core. This study provides a molecular and 
structural basis for future studies of the interaction between CLR and other soluble egg antigen 
(SEA) glycoproteins and their effects on the host immune response. 
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Schistosomes are parasitic helminths that infect over 200 million people world-wide. The main 
pathological symptoms of schistosomiasis are caused by the deposition of parasite eggs by adult 
worms into the organs of its human host and the subsequent immunological consequences, 
which include the formation of perioval granulomas associated with a pronounced Th2-type 
immune response 1. Many aspects of these egg-induced immune processes are thought to be at 
least partly mediated by protein glycosylation of the soluble egg antigens (SEA) 2. This requires 
binding of the glycans to host receptors on antigen presenting cells (APCs) such as macrophages 
and dendritic cells (DC), leading to internalisation of the glycoprotein and/or activation of 
signaling pathways. 
  Previously, Van Liempt et al. demonstrated that the complex Schistosoma mansoni SEA 
mixture when coated on beads, is recognised by monocyte-derived human immature DC (iDCs) 
primarily through three C-type lectin receptors (CLR): dendritic cell-specific ICAM3-grabbing 
non-integrin (DC-SIGN), macrophage galactose-type lectin (MGL) and mannose receptor (MR) 
3. The binding of DC-SIGN to the SEA-coated beads could be partly inhibited using monoclonal 
antibodies (mAbs) directed against the glycans Galβ1-4(Fucα1-3)GlcNAc (Lewis X, LeX) and 
GalNAcβ1-4(Fucα1-3)GlcNAc (LDN-F), suggesting that these two glycan structures on SEA 
glycoproteins contribute to the interaction between DC-SIGN and SEA 4. In contrast, MGL 
appears to recognise terminal GalNAc moieties in (fucosylated) GalNAcβ1-4GlcNAc (LDN) 
ligands on solid phase coupled SEA glycoproteins, as concluded from studies using anti-LDN 
and anti-LDN-F blocking antibodies 5. MR ligands in SEA have not been investigated yet, but it 
is known that MR can bind fucose- and mannose-containing glycans 6.  
While these studies provide valuable indications for the involvement of specific glycan 
elements in SEA-CLR interactions, the role of individual glycoprotein components of the 
complex SEA mixture in these interactions has not yet been assessed. Moreover, binding and 
uptake of SEA by the CLRs has only been studied using SEA coupled to a solid phase as in coated 
to beads or to ELISA-plates 3;4. In the natural S. mansoni egg context, however, protein and 
glycoprotein constituents of SEA are presented to the host as soluble molecules rather than 
bound to a particle, cell or whole organism. Some SEA components are excreted by the 
schistosome egg through pores in the egg shell, forming the so-called excretory/secretory 
fraction (ES) while others come into contact with the host after eggs die and release their soluble 
contents into the tissue surrounding the egg. Therefore, the biological context may be better 




Previously, three major soluble S. mansoni egg glycoproteins displaying immunogenic 
activities have been identified: omega-1 7, which is able to drive DC-mediated Th2 responses 
both in vitro and in vivo 8; IPSE/α1 9, an inducer of IgE-dependent IL-4-release in human and 
murine basophils 10;11; and kappa-5 12, which has been shown to be a target of IgE in human S. 
mansoni infection sera. Detailed glycosylation analysis showed that the glycans expressed by 
these glycoproteins make up a major subset of glycans found in total SEA 13;14. Omega-1 and 
IPSE/α1 are glycosylated almost identically, both carrying diantennary N-glycans with a 
difucosylated core and LeX antennae (Figure 1 and 15;16). Kappa-5, on the other hand, expresses a 
completely different set of SEA glycans, characterised by the presence of triantennary N-glycans 
with terminal LDN and, to a lesser extent, LDN-F motifs (Figure 1 and 17). 
In this study, we have examined the interaction of IPSE/α1 and kappa-5 with DC-SIGN, MGL 
and MR as expressed by DC and single CLR-cell lines. Using exo-glycosidases, we were able to 
create specific glycoprotein variants and could precisely define the structural elements involved 
in the binding of the egg glycoproteins by individual cellular CLR. To our knowledge, this is the 
first report that assesses the binding of individual, native S. mansoni egg glycoproteins to CLR in 
a cellular context. These data provide a molecular basis for the CLR-mediated interaction of DC 
with soluble glycoproteins secreted/excreted by schistosome eggs and thereby contribute to the 






Figure 1. Major glycan structures of IPSE/α1 and kappa-5. Triangle, fucose; open square, N-
acetylgalactosamine; dark square, N-acetylglucosamine; open circle, galactose; dark circle, mannose; open 
star, xylose; LeX, Gal1-4(Fucα1-3)GlcNAc; LDN, GalNAc1-4GlcNAc; LDN-F, GalNAc1-4(Fucα1-
3)GlcNAc. *Structure is present on a small subset of kappa-5 glycoproteins. 
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Binding of CLR-Fc constructs to SEA-associated glycoconjugates 
SEA is a largely uncharacterised mixture of proteins and glycoproteins that interacts with DC-
SIGN, MR and MGL on cells of the innate immune system 3. We have previously studied the 
glycosylation of two proteins abundantly present in SEA; IPSE/α1 carries diantennary glycans 
with one or two LeX antennae (15 and Figure 1), while kappa-5 glycosylation is characterised by 
the presence of triantennary N-glycans with terminal LDN motifs with a minor subset of kappa-
5 glycans carrying terminal LDN-F motifs (17 and Figure 1). To test and confirm that DC-SIGN, 
MR and MGL can bind to glycan elements present on kappa-5 and IPSE/α1, binding of Fc 
constructs of these CLR to a glycoconjugate microarray containing several schistosome-related 
synthetic glycoconjugates was analysed (Figure 2).  
The majority of fucose-containing conjugates on the array, including LeX and LDN-F, 
were bound by DC-SIGN-Fc in a concentration-dependent manner (Figure 2A). This is in line 
with previous data showing that DC-SIGN has a broad specificity for α1-3 and α1-4 fucosylated 
motifs 18;19. Relatively weak binding of DC-SIGN was observed to conjugates terminating with 
 
Figure 2. Binding of Fc-constructs of DC-SIGN, MGL and MR to an extensive set of schistosome-related, 
synthetic glycoconjugates. Glycan-binding specificities of human DC-SIGN (A), murine MR (B) and human 
MGL (C) were tested by glycan array screening. The glycan array was probed with 2 μg ml-1 DC-SIGN-Fc or 5 
μg ml-1 MGL-Fc and MR-Fc. Results of one out of two independent experiments are shown. Triangle, fucose; 
light square, N-acetylgalactosamine; dark square, N-acetylglucosamine; light circle, galactose. 
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Fucα1-2Fucα1- (see F2-GlcNAc and F3-GlcNAc in Figure 1A), a sequence that has so far only 
been found in schistosomes 13;20. F-LDN-F is not bound by DC-SIGN-Fc (Figure 2A), even 
though it contains α1-3-linked fucoses, which may be explained by spatial interference due to 
close proximity of the two fucoses. MR, like DC-SIGN, is considered to be a mannose- and 
fucose-recognising receptor 6;18. On the glycoconjugate array, MR-Fc showed a relatively high 
affinity only for mannose-BSA (Figure 2B), while binding of DC-SIGN-Fc to mannose-BSA was 
similar to the binding to fucosylated ligands such as LeX (Figure 2A). MGL-Fc selectively bound 
to LDN and LDN-F on our array (Figure 2C), which is in accordance with the reported affinity 
of MGL to terminal, unsubstituted GalNAc residues 5.  
 Conventional ELISA confirms that DC-SIGN-Fc binds to LeX-expressing IPSE/α1 
(Figure 3A). Surprisingly, DC-SIGN-Fc bound kappa-5 to a similar extent as IPSE/α1 (Figure 
3A), which is remarkable as the only known DC-SIGN-ligand present on kappa-5, LDN-F 
(Figure 2A and 18), is present on only a very minor subset of kappa-5 glycoproteins (17 and Figure 
 
Figure 3. Interaction of IPSE/α1 and kappa-5 with DC-SIGN-Fc and MGL-Fc constructs. Binding of DC-
SIGN-Fc (A, C) and MGL-Fc (B, D) to IPSE/α1 and kappa-5 (A,B) and SEA depleted of kappa-5 (SEAΔkappa-
5) (C,D) was determined by ELISA in the presence (black bars) or absence (grey and white bars) of EGTA. 
Various concentrations for each Fc construct were used. Results are representative for three independent 
experiments. 
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1). In ELISA, MGL-Fc binds relatively intensely to kappa-5 as compared to IPSE/α1 (Figure 3B), 
likely because LDN-motifs are abundantly expressed on kappa-5 (17 and Figure 1). Kappa-5 has 
been demonstrated to be the major LDN-containing glycoprotein in SEA 17. In line with this 
observation, MGL-Fc binding to SEA depleted of kappa-5 (SEAΔkappa-5) is decreased 
compared to that of total SEA (Figure 3D), but significant other MGL ligands are still present. 
The affinity of DC-SIGN-Fc for SEA upon kappa-5 depletion remained high (Figure 3C).  
 
Human iDCs bind the differentially glycosylated kappa-5 and IPSE/a1 through different CLR 
The array and ELISA data using Fc-constructs of CLRs indicate that MGL and DC-SIGN are 
candidate receptors for kappa-5 and IPSE/α1. As a more accurate reflection of the natural 
situation in which soluble egg glycoproteins are bound by cell surface expressed CLRs, we next 
incubated fluorescently labeled kappa-5 and IPSE/α1 in vitro with human iDCs. The iDCs 
expressed each of the CLR DC-SIGN, MGL and MR (Supplementary Figure 1). The contribution 
of each single CLR in binding of kappa-5 and IPSE by DCs was assessed by addition of specific 
CLR blocking agents (Figure 4). 
The observation that binding of IPSE/α1 to iDCs was strongly inhibited by addition of 
the calcium chelator EGTA indicates that this binding is CLR mediated (Figure 4A). Moreover, 
mannan, a natural ligand that competes for binding to DC-SIGN and MR, significantly reduced 
IPSE/α1-binding by DCs. More specifically, preincubation with blocking antibodies against DC-
SIGN, MGL and MR showed that MR is the major receptor for IPSE/α1 on iDCs, while MGL 
and DC-SIGN both appeared to play only a minor role (Figure 4A).  
In contrast, for kappa-5, preincubation with the specific CLR antibodies as well as with 
EGTA and mannan suggested the involvement of all three CLRs in kappa-5 binding by iDCs 
without one or the other in a dominant role (Figure 4B). Inhibition induced by mannan 
evidently exceeded the inhibition by the specific antibodies against DC-SIGN or MR, strongly 
supporting a role for both MR and DC-SIGN in the binding of kappa-5 by iDCs. Mannan 
inhibited the binding of kappa-5 by iDCs to a lesser extent as compared to IPSE/α1-iDC binding, 
in line with the larger role of MR for the binding of IPSE/α1. In addition, after preincubation of 
the iDCs with EGTA, still 24% of the initial kappa-5 binding could be detected (Figure 4B), 
indicating a role for other, Ca2+-independent receptors in the interaction of kappa-5 with DCs.  
In summary, iDCs bound IPSE/α1 preferentially via MR, while kappa-5 was recognised 
through multiple CLRs including DC-SIGN, MGL and MR, as well as via other, Ca2+-




Figure 4. Interaction of IPSE/α1 and kappa-5 with CLR on immature DCs. Binding of fluorescently-labeled 
IPSE/α1 (A) and kappa-5 (B) to monocyte-derived human iDCs was assessed in the absence or presence of 
EGTA (blocking all CLR), mannan (blocking DC-SIGN and MR) or blocking mAbs directed against DC-SIGN, 
MGL, MR or a control antibody (IgG1). Unblocked conditions ( - ) were set to 100 %. The presented results 
represent three combined, independent experiments. Error bars represent standard error of the mean. * p < 
0.05, ** p<0.01, for significant differences compared to the unblocked conditions ( - ), based on a two-sided 
paired t-test. # n=2, no statistical analysis was performed. MFI; mean fluorescence intensity. 
Antenna fucoses on kappa-5 and IPSE/a1 are involved in binding to DC-SIGN and MR, while 
terminal GalNAc residues confer binding of kappa-5 to MGL 
Next, we set out to identify the precise glycan elements which mediate kappa-5 and IPSE/α1 
recognition by the individual CLRs in a cellular context. Kappa-5 and IPSE/α1 were treated with 
β-N-acetylhexosaminidase (hexnac) and/or α-fucosidase (fuc) to remove specific 
monosaccharides that form potential CLR ligands. Of note, α-fucosidase from X. manihotis was 
used which specifically removes α1-3-linked antenna fucoses of N-glycopeptides while being 
unable to cleave off the core-linked fucoses 17. α-Fucosidase treatment of IPSE/α1 generated a 
glycoprotein variant mainly carrying diantennary glycans with unsubstituted Galβ1-4GlcNAc 
(LN) antennae (major set), as well as some LDN antennae (minor fraction) on an N-glycan core 
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which is substituted with α3- and α6-linked fucoses (IPSE/α1fuc, Supplementary Figure 2 for site 
N80). The effect of this enzyme was previously established in a mass spectrometric structural 
study on the egg glycoprotein omega-1, which carries nearly identical glycosylation 16. Treatment 
of kappa-5 with β-N-acetylhexosaminidase resulted in the complete removal of unsubstituted 
GlcNAc and GalNAc residues in LDN and LDN-F, as verified by nano-LC-MS analysis of site 
N251 (κ5hexnac, Supplementary Figure 3).  In addition, a kappa-5 variant was generated of which 
fucoses were removed from LDN-F by treatment with α-fucosidase (κ5fuc, Supplementary 
Figure 3), as well as a variant treated sequentially with α-fucosidase and β-N-
acetylhexosaminidase (κ5fuc/hexnac, data not shown) leaving intact only the trimannosyl core 
structure with α3/α6-fucose and β2-xylose core-modifications.   
Subsequently, binding of the native and modified glycoprotein variants by cell lines 
expressing only one of the three human CLR, DC-SIGN, MR or MGL, was tested (Figure 5). 
Incubation of IPSE/α1 with the cell lines showed that all three CLRs had affinity for IPSE/α1 in a 
Ca2+-dependent manner (Figures 5A, B and C). Interestingly, while MR proved to be the 
dominant receptor for IPSE/α1 on iDC which express all three CLRs (Figure 4A), IPSE/α1 was 
bound by the DC-SIGN cell line similarly well as the MR cell line (Figures 5A and B, 
respectively). Binding of soluble IPSE/α1 by the MGL-expressing cell line appeared minor as 
compared to binding by the MR- and DC-SIGN cell lines (Figure 5C). In contrast, in the 
corresponding ELISA (Figure 3B), soluble MGL-Fc showed clear Ca2+-dependent binding to 
plate-bound IPSE/α1, which indicates that significantly different affinities or specificities are 
observed in these two binding assay types. Furthermore, α-fucosidase treatment of IPSE/α1 
revealed the involvement of the antenna fucose, as present in the major antenna motif LeX, in 
the interaction with both DC-SIGN and MR (Figures 5A and B). As expected, the fucoses did 
not have any role in the interaction between MGL and IPSE/α1 (Figure 5C).  
Incubation of kappa-5 with the cell lines showed strong interactions between kappa-5 
and cellular DC-SIGN (Figure 5D) as well as MGL (Figure 5F). Exo-glycosidase treatment of 
kappa-5 revealed that the terminal GalNAc in LDN(-F) is required for MGL-binding (Figure 
5F), while the fucoses of LDN-F appeared essential for the binding of DC-SIGN for kappa-5 
(Figure 5D). The latter finding is striking, as an estimated less than 5% of kappa-5 LDN 
antennae are fucosylated 17, which may indicate a relatively high affinity of DC-SIGN for LDN-F. 
Binding of kappa-5 by the MR cell line seemed only minor as compared to binding observed for 
the DC-SIGN and MGL cell lines, and α-fucosidase treatment did reduce kappa-5-MR binding 
only slightly (Figure 5E). Indeed, the glycoconjugate array data indicated that MR has little to no 
affinity for LDN-F (Figure 2B). Possibly MR displays affinity for the core-fucoses which remain 




Figure 5. Structural characteristics of the glycan epitopes on IPSE/α1 and kappa-5 involved in CLR 
binding. Binding of untreated and exo-glycosidase-treated fluorescently labeled IPSE/α1 (A,B,C) and kappa-5 
(D,E,F) to a DC-SIGN-expressing cell line (A,D), a MR-expressing cell line (B,E) and a MGL-expressing cell 
line (C,F), was assessed in the absence (grey bars) or presence (black bars) of EGTA. Untransfected or mock-
transfected cell lines were used as control (white bars). The given glycan structures represent the major glycans 
present on the (treated) glycoproteins, while the structures marked with an asterisk (*) are present on a small 
subset of kappa-5 glycoproteins. The experiments were performed in duplicate and one representative 
experiment out of two is shown. Error bars represent standard deviation. Triangle, fucose; light square, N-
acetylgalactosamine; dark square, N-acetylglucosamine; light circle, galactose; dark circle, mannose; open star, 
xylose; κ5, kappa-5; κ5hexnac, kappa-5 treated with β-N-acetylhexosaminidase; κ5fuc, kappa-5 treated with α-
fucosidase; κ5fuc/hexnac, kappa-5 treated sequentially treated with α-fucosidase and β-N-
acetylhexosaminidase; IPSE/α1fuc, IPSE/α1 treated with α-fucosidase. MFI; mean fluorescence intensity. 
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β-N-acetylhexosaminidase treatment of kappa-5 increased binding of kappa-5 by MR (Figure 
5B), which is probably due to exposure of the xylosylated trimannoside, a structure also 
frequently observed on native glycoproteins of various S. mansoni life stages including eggs 14. 
This effect induced by β-N-acetylhexosaminidase treatment was not observed in relation to 
kappa-5-binding by DC-SIGN (Figure 5D). On the contrary, β-N-acetylhexosaminidase 
treatment of kappa-5 reduced the interaction with DC-SIGN, indicating a higher affinity of DC-
SIGN for intact LDN-F as compared to the Fucα1-3GlcNAc elements left after treatment. 
Furthermore, in contrast to MR, DC-SIGN seems not able to bind the xylosylated and 
fucosylated trimannosyl core (Figure 5D; κ5fuc/hexnac). Finally, ELISA format experiments 
revealed a recognition pattern of the exo-glycosidase treated glycoproteins by DC-SIGN and 
MGL (Supplementary Figure 4) analogous to the cell based binding assays. In conclusion, the 
three CLRs DC-SIGN, MGL, and MR, display differential affinity for the individual 
glycoproteins which is determined by specific glycan elements. 
 
Discussion 
During S. mansoni infection, immunogenic SEA glycoproteins are released by eggs and bound 
and internalised by DCs and other APCs patrolling the host tissues. We investigated the 
differential interaction of DC-SIGN, MR and MGL with two abundant soluble S. mansoni egg 
glycoproteins IPSE/α1 and kappa-5 each representing a differently glycosylated group of SEA 
glycoproteins. A first surprising observation was that on iDCs, MR is the main receptor for 
IPSE/α1 (Figure 4A) via its LeX glycans, while in the glycan array format LeX-glycoconjugates 
form relatively weak ligands for MR-Fc (Figure 2 and 21). Secondly, although we hypothesised 
that MGL would play a dominant role in kappa-5-iDC interaction due to its capacity to bind to 
the LDN motifs on kappa-5 5, all three CLR studied appeared to be involved in the interaction 
between iDCs and kappa-5 (Figure 4B). In particular the presence of LDN-F motifs on a minor 
subset of kappa-5 glycans contributed significantly to cellular binding via DC-SIGN. 
van Liempt et al. previously indicated the importance of the DC-SIGN, MR and MGL, 
in the interaction of iDCs with SEA 3. A mixture of blocking antibodies against these CLRs could 
abrogate binding of iDCs to SEA-coated 1 μm-beads by 90%, which is to the same level as 
reached with EGTA, a Ca2+-chelator which blocks the binding of all CLRs. Also studies using 
synthetic glycoconjugates have suggested that DC-SIGN and MGL can bind glycan motifs that 
have been detected in schistosomes 4;5. However, SEA is a complex mixture of (glyco)proteins 22, 
and it is yet unknown how many and which SEA glycoproteins actually carry glycan motifs that 
can be bound by CLRs, possibly leading to modulation of DC function. We believe that the 
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cellular binding studies using single well-characterised glycoproteins and enzymatically 
modified glycoforms thereof presented here are required to more precisely define the molecular 
basis of SEA-DC interactions.  
Both the DC-SIGN- and the MR-expressing cell line bound IPSE/α1 in a Ca2+-
dependent way (Figures 5A and B). While LeX-glycoconjugates form relatively weak ligands for 
MR but strong ligands for DC-SIGN in the glycan array format (Figure 2 and 18;21), on iDCs,  the 
LeX-expressing IPSE/α1 is predominately bound by MR (Figure 4A). To be able to bind 
IPSE/α1, both DC-SIGN and MR require the presence of the antenna fucoses present mainly in 
the form of LeX (Figures 5A and B). Studies using bead-coupled glycans 4 or glycan arrays 
(Figure 1A and 4;18;19) suggest that DC-SIGN has a strong preference for LeX motifs presented on 
pathogens, particles or a solid surface in a multivalent fashion. It can be hypothesised from our 
observations that MR plays a dominant role over DC-SIGN in the binding of LeX-containing 
glycoproteins if presented as soluble ligands. This is in line with a previous report showing a role 
for MR in the uptake of soluble antigens, but not in that of cell-associated antigens 23. For DC-
SIGN molecules, which bear only one CRD domain, it has been shown that the extracellular 
domains can aggregate in vitro to form DC-SIGN tetramers, which have been suggested to 
possess enhanced DC-SIGN capacity to bind multivalent ligands 24. In addition, clustering of 
DC-SIGN in lipid rafts on the surface of iDCs has been shown to enhance binding and 
internalisation of viral particles 25.  
Although the main glycans present on kappa-5 carry multiple termini of the MGL-
ligand LDN 17, MGL did not display a dominant function in kappa-5-iDC interaction (Figure 
4B). Clearly, multiple glycan elements present on kappa-5 contribute to the binding to different 
CLRs. Removal of the terminal GalNAc and GlcNAc units of LDN in kappa-5 by β-N-
acetylhexosaminidase treatment abolishes MGL binding (Figure 5F), whereas removal of LDN-F 
associated fucose leads to the loss of DC-SIGN binding (Figure 5D) and the partial loss of MR 
binding (Figure 5E). These observations suggest that exposure of CLRs or CLR-expressing cells 
to single glycoproteins can still include multiple putative ligands due to glycan 
microheterogeneity, the natural variation in protein glycosylation leading to different so-called 
glycoforms of a single glycoprotein. This underlines that a thorough investigation of all major 
and minor glycan structures on a specific glycoprotein is imperative for the identification of 
glycan motifs putatively involved in CLR binding. Moreover, the observation that the LDN-F 
unit, which is present in only a very minor subset of kappa-5 glycoforms 17, dictates its binding 
by DC-SIGN (Figure 5D) indicates that small variations in glycosylation may have important 
biological effects. Consistent with this observation, LDN-F has been shown to be a strong ligand 
for DC-SIGN by glycan array studies (18 and Fig. 2). 
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The current study, together with the structural data of the glycans of kappa-5 17 and 
IPSE/α1 15, as well as a third SEA glycoprotein omega-1 16, provides structural background 
knowledge to several recent functional studies. First, kappa-5 is the major glycoprotein in SEA 
that carries the granulomogenic LDN motif 17;26, raising the question whether the kappa-5 
associated LDN receptor MGL (Figure 5F) plays a role in the induction of the granulomatous 
immune responses around S. mansoni eggs. Second, the observations that MR rather than DC-
SIGN is the most relevant CLR involved in the binding of the LeX-containing IPSE to iDCs 
might indicate an important function for MR during natural infection, as the secreted 
glycoproteins are generally believed to be the major immunoregulatory molecules of S. mansoni 
eggs 7;8;27-29. IPSE/α1 is postulated to have a Th2-regulating role during S. mansoni infection via 
the induction of IL-4 production by basophils 10;11, as well as an anti-inflammatory role by 
reducing cellular infiltration into granulomas 30. Both immunomodulatory properties are not 
related to its glycosylation, and thus CLR recognition will not be involved in this process. 
However, recently it was demonstrated that IPSE/α1 contains a functional C-terminal nuclear 
localisation signal via which it is transported to the nucleus in monocyte-derived human DCs 31. 
Interestingly, this was a Ca2+-dependent process, implicating that CLRs are involved in the initial 
uptake into the cell. Together with our results, it can be hypothesised that MR, which we found 
to be the primary CLR binding to IPSE/α1 via its antenna fucoses (Figure 4B), can mediate 
uptake of IPSE/α1 into cells, after which it is translocated to the nucleus to exert a currently 
unknown function. Interestingly, another major S. mansoni egg glycoprotein omega-1, which 
has RNase activity and Th2-inducing properties 8;32 expresses LeX-carrying glycans similar to 
IPSE/α1 16. In the mouse, a synthetic LeX conjugate has been shown to drive Th2 responses, 
involving the production of antigen-specific IgE and induction of IL-4 and IL-10 following 
intranasal immunization 32;33. However, the SEA glycoprotein associated LeX epitopes alone are 
not sufficient to confer the Th2-inducing properties initiated by S. mansoni eggs, as IPSE/α1 in 
contrast to omega-1 is not able to induce the strong DC-mediated type 2 responses 8. Since our 
current study shows that DCs recognise IPSE/α1 via MR by the same glycans as present on 
omega-1, it is conceivable that the latter glycoprotein is also bound by MR on DCs. 
Furthermore, experiments in mice as well as with bone marrow derived macrophages deficient 
for MR show the involvement of MR in the uptake of cercarial secretions and the 
downregulation of IFN-γ production in response to S. mansoni cercariae 34. These results 
demonstrate that soluble schistosome glycoconjugates indeed may depend on recognition by 
MR on APCs for modulation of the immune response. 
 In summary, while SEA is bound and internalised by iDCs via three CLRs, DC-SIGN, 
MGL, and MR, we found that single components in SEA are differentially bound. We 
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demonstrated that while in plate-or array based assays DC-SIGN but not MR binds relatively 
strongly to LeX conjugates including the LeX-containing glycoprotein IPSE/α1, MR is the major 
receptor for IPSE/α1 on iDCs. Furthermore, exo-glycosidase treatment of the two differentially 
glycosylated egg proteins, kappa-5 and IPSE/α1, revealed the preference of the three CLRs for 
specific elements in/of the glycan structures: antenna fucoses in LeX for DC-SIGN and MR, 
antenna fucoses in LDN-F for DC-SIGN, and the GalNAc-termini in LDN(-F) for MGL. This 
study provides a molecular and structural basis for future studies of the interaction between 
CLRs and other SEA glycoproteins, and their effects on the host immune response. 
 
Material and Methods 
Antigens and exo-glycosidase treatments 
SEA and IPSE/α1 were obtained as described previously 10. Kappa-5 was isolated by soybean 
agglutinin (SBA) affinity chromatography as described previously 17. Kappa-5-depleted SEA is 
defined as the non SBA-binding fraction in the kappa-5 isolation procedure. Kappa-5 and 
IPSE/α1 were fluorescently labeled with PF-647 using the Promofluor labeling kit according to 
the manufacturer’s recommendations (Promokine, Heidelberg, Germany). Either native or 
fluorescently labeled kappa-5 was treated with β-N-acetylhexosaminidase from Canavalia 
ensiformis (62.5 mU; Sigma, Zwijndrecht, the Netherlands) in 100 mM sodium phosphate buffer, 
pH 5.0, for 48 h at 37°C. α-Fucosidase treatment of (labeled) kappa-5 and IPSE/α1 was 
performed with α1-(3,4)-fucosidase from Xanthomonas manihotis (1 mU and 0.5 mU, 
respectively; Sigma) in 100 mM sodium phosphate buffer, pH 5.0, for 48 h at 37°C.  
 
Glycoconjugate array 
BSA-conjugates were prepared as described previously 35;36. Lacto-N-fucopentaose III (LNFPIII)-
HSA was obtained from Glycotech (Gaithersburg, MD, USA) and mannose-BSA from Sigma. 
The glycoconjugates were printed and immobilized on epoxide-modified glass slides (Slide E, 
Schott Nexterion, Jena, Germany) as described previously 37. Each glycoconjugate microarray 
was blocked for 60 min with TSM (20 mM Tris, 150 mM NaCl, 1 mM CaCl2, 2 mM MgCl2) 
containing 1% (w/v) BSA (Sigma) and 50 mM ethanolamine. After washing, arrays were 
incubated with either 2 μg mL-1 DC-SIGN-Fc (R&D Systems, Minneapolis, MN, USA), 5 μg mL-1  
MGL-Fc 5, or 5 μg mL-1  MR-Fc (a kind gift from L. Martinez-Pomares 38) in TSM/1% 
BSA/0.01% (v/v) Tween-20 for one hour. Slides were flushed and subsequently incubated with 
anti-human-IgG(Fc)-Cy3 (Sigma) for 30 min. After thorough washing and drying, the slides 
were scanned using the Agilent DNA Microarray Scanner. Data was analysed using GenePix Pro 
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6.1 (Molecular Devices). Mean fluorescence intensities (MFI) of triplicates were calculated on 
basis of median spot intensity using circular alignment and local background subtraction 39. 
 
DC-SIGN- and MGL-Fc ELISA 
96-well Maxi-Sorp plates (NUNC, Roskilde, Denmark) were coated overnight with antigens (1μg 
ml-1) in 0.1M NaHCO3 at 4°C in duplicate. Plates were washed three times with TSM, followed 
by incubation with TSM/1% BSA for 30 min. After three washes with TSM, various 
concentrations of DC-SIGN-Fc or MGL-Fc in TSM were added for 2 h, with or without a prior 
incubation for 15 min with EGTA (10 mM). The plates were washed five times with TSM/0.05% 
Tween and bound DC-SIGN-Fc or MGL-Fc was detected with alkaline phosphatase-labeled goat 
anti-human Fc (1:25 000; Sigma) in TSM/0.05% Tween. 
 
Cells 
DCs were generated from monocytes, isolated from venous blood of healthy volunteers by 
density centrifugation on Ficoll followed by a Percoll gradient as previously described 8;40. 
Monocytes were cultured in RPMI medium supplemented with 10% FCS, human rGM-CSF (80 
ng ml-1, Biosource-Invitrogen, Breda, The Netherlands) and human rIL-4 (250 units ml-1, R&D 
Systems). 
The K562 cell line stably expressing DC-SIGN and a mock transfected control (a kind 
gift from C. Figdor 41), were maintained in mixed medium consisting of 25% IMDM (Gibco) 
medium + 5% FCS and 75% RPMI (Gibco) medium + 10% FCS. The CHO cell line stably 
expressing MGL 41 and an untransfected control were maintained in RPMI (Gibco) containing 
10% FCS.  NIH3T3 cell lines expressing human MR (3T3.hMR) or the control pFB vector were a 
kind gift from Joanna Miller and Gordon Brown 38. 3T3 cell lines were cultured in DMEM 
(BioWitthaker) medium + 10% FCS. All media were supplemented with penicillin and 
streptomycin and transfected cell lines were continuously kept under selection of 0.5 mg ml-1 
geneticin (Gibco). 
 
Cellular adhesion assay 
Fluorescently labeled kappa-5 and IPSE/α1 were treated or not with various exo-glycosidases, as 
described in the section “Antigens and exo-glycosidase treatments”. Cells (50.000/well) were 
seeded in a V-bottom 96 well plate. Where indicated cells were pre-incubated with 10mM 
EGTA, 100 ug ml-1 mannan (Sigma-Aldrich), 20 μg ml-1 anti-DC-SIGN (clone AZN-D1, azide 
free, Beckman Coulter, Woerden, the Netherlands), 20 μg ml-1 anti-MR (clone 15.2, Biolegend, 
San Diego, CA, USA) or a combination of two anti-MGL antibodies (20 μg ml-1 clone 
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125A10.03, Dendritics, and 20 μg ml-1 1G6.6 42) for 45 min at 37 °C. Subsequently, cells were 
incubated with 2 μg ml-1 PF-647 labeled glycoprotein variants at 37 °C for 1 h and washed in ice 
cold PBS before analysis using flowcytometry (FACSCalibur, Becton Dickinson). 
 
Mass spectrometry 
Trypsin (Promega, Leiden, The Netherlands) was added to a sample of IPSE/α1 or kappa-5 
variants at a 1:100 trypsin/antigen ratio and incubated overnight at 37 °C. Resulting IPSE/α1 and 
kappa-5 (glyco)peptides were analysed as described previously using respectively MALDI-TOF-
MS 15 and nano-HPLC-ESI-ion trap-MS 16.  
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Supplementary figure 2. Exo-glycosidase treatment of IPSE/α1. IPSE/α1, either untreated (A) or treated 
with α-fucosidase (B), was digested with trypsin and the resulting glycopeptides were analyzed by MALDI. 
Analysis of glycans on glycosylation site N80 in peptide E69RPYWYLFDNVNYTGR84 is given. Signals are 
labeled with monoisotopic masses and single charged. Non-glycopeptide signals are marked with asterisks 
(*).Triangle, fucose; light square, N-acetylgalactosamine; dark square, N-acetylglucosamine; light circle, 
galactose; dark circle, mannose; pep, peptide; IPSE/α1fuc, IPSE/α1 treated with α-fucosidase.
Supplementary figure 1. Expression of DC-SIGN, MR, MGL and isotype control (IgG1) on monocyte-
derived immature DC. Open histograms represent the mAb staining, filled histrograms represent unstained 











Supplementary Figure 3. Exo-glycosidase treatment of kappa-5. Kappa-5, either untreated (A) or treated 
with β-N-acetylhexosaminidase (B) and α-fucosidase (C), was digested and the resulting glycopeptides were 
analyzed by nano-LC-MS. Analysis of glycans on glycosylation site N251 in peptide I246NENFNK252 is given. 
Signals are labeled with monoisotopic masses. Signals are triple charged (A and C) or double charged (B), 
unless indicated otherwise. Non-glycopeptide signals are marked with asterisks (*).Triangle, fucose; light 
square, N-acetylgalactosamine; dark square, N-acetylglucosamine; light circle, mannose; open star, xylose; pep, 
peptide; κ5, kappa-5; κ5hexnac, kappa-5 treated with β-N-acetylhexosaminidase; κ5fuc, kappa-5 treated with 
α-fucosidase. 
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Supplementary figure 4. Interactions of exo-glycosidase treated IPSE/α1 and kappa-5 with DC-SIGN-Fc 
and MGL-Fc. Binding of 1 μg ml-1 of DC-SIGN-Fc (A, C) and MGL-Fc (B, D) to exo-glycosidase-treated 
IPSE/α1 (A,B) and kappa-5 (C,D) was determined by ELISA in the absence (black bars) or presence (white 
bars) of EGTA. The given glycan structures represent the major glycans present on the (treated) glycoproteins, 
while the structures marked with an asterisk (*) are present on a small subset of kappa-5 glycoproteins. 
Binding of Fc-constructs to untreated kappa-5 or IPSE/α1 was set to 100%. The presented results represent 
two combined, independent experiments. Triangle, fucose; light square, N-acetylgalactosamine; dark square, 
N-acetylglucosamine; light circle, galactose; dark circle, mannose; open star, xylose; κ5, kappa-5; κ5hexnac, 
kappa-5 treated with β-N-acetylhexosaminidase; κ5fuc, kappa-5 treated with α-fucosidase; κ5fuc/hexnac, 
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Schistosome-derived omega-1 drives Th2 
polarization by suppressing protein synthesis 





Omega-1, a glycosylated ribonuclease secreted by Schistosoma mansoni eggs and abundantly 
present in soluble egg antigen (SEA), has recently been shown to condition dendritic cells (DCs) 
to prime Th2 responses. However, the molecular mechanisms underlying this effect remain 
unknown. We show here by site-directed mutagenesis of omega-1 that both the glycosylation 
and the RNase activity are essential to condition DCs for Th2 polarization. Mechanistically, we 
demonstrate that omega-1 is bound and internalized via its glycans by the mannose receptor 
(MR) and subsequently impairs protein synthesis by degrading ribosomal RNA. These studies 
reveal an unrecognized pathway, involving MR and interference with protein synthesis that 
conditions DCs for Th2 priming. 
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Dendritic cells (DCs) play a central role in the development and maintenance of immune 
responses during infection, as they govern both the activation and polarization of adaptive T 
helper (Th) cells. Classically, upon recognition of invading pathogens, resting DCs undergo a 
process of activation, so-called maturation, that involves stable presentation of peptides in the 
context of major histocompatibility complex (MHC)-II, up-regulation of co-stimulatory 
molecules, and production of polarizing cytokines, that collectively enable DCs to potently 
activate and direct CD4+ T cell responses 1.  
This paradigm is largely based on observations of responses towards pathogens, like 
bacteria, viruses and fungi. These pathogens harbour pathogen associated molecular patterns 
(PAMPs) that lead to classic DC activation by engaging several classes of innate pattern 
recognition receptors (PRRs), including the Toll-like receptors (TLRs). Binding of PAMPs to 
these receptors initiates signalling cascades that generally result in the conditioning of DCs for 
priming of Th1- or Th17-biased responses which are instrumental in combating prokaryotic and 
single cell eukaryotic pathogens 2. In contrast to this classical view of DC activation, components 
derived from parasitic helminths fail to induce all traditional signs of DC maturation. However, 
although overt maturation is not observed, unlike immature DCs, helminth antigen-treated DCs 
are altered such that they prime Th2-polarized immune responses 3.  
Despite this consistent picture, the pathways through which helminth antigens 
manipulate DC function and drive Th2 responses are still poorly understood 4. The majority of 
the studies have been conducted with a complex mixture of soluble egg antigens (SEA) from the 
trematode Schistosoma mansoni. SEA is regarded as one of the most potent helminth-derived 
antigenic extracts that instruct DCs to drive Th2 polarization 3;5. So far these studies have mainly 
suggested that carbohydrate structures play a role in DC modulation by SEA, given that 
chemical modification of glycans on proteins present in SEA is known to abolish their capacity 
to induce Th2 polarization 6. In this respect, another class of PRRs expressed by DCs, the 
carbohydrate-binding C-type lectin receptors (CLRs), have been suggested to play a role in 
modulation of DC function by SEA 7. For instance, SEA contains carbohydrate structures, such 
as Galβ1-4(Fucα1-3)GlcNAc (Lewis X, LeX), that can be recognized by DC-SIGN 8-10. 
Engagement of this receptor by components from pathogens such as Helicobacter pylori has 
been shown to suppress IL-12 production and modulate TLR-induced DC activation and T cell 
polarization 8;11. In addition, more recently it has been shown that SEA can modulate cytokine 
responses through another CLR, Dectin-2 12. Finally, a number of studies have raised the 
possibility that TLRs are involved in SEA-mediated Th2 induction 13;14. However, direct evidence 
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for involvement of specific receptors or downstream pathways in SEA-driven Th2 polarization 
has been missing. 
The recent identification of a defined glycoprotein with RNase activity, omega-1, as the 
major component in schistosome eggs that is responsible for conditioning DCs for Th2 
polarization 15;16, has allowed us to dissect the involved molecular pathways in a precise manner. 
Through site-directed mutagenesis we show that the RNase activity as well as the glycosylation 
of omega-1 are essential for programming of DCs for Th2 induction. Furthermore, we provide 
evidence that mannose receptor (MR) is critical for omega-1-driven Th2 responses and that 
internalization via this receptor is needed for biological activity of omega-1, as it allows omega-1 
to interfere with ribosomal function and thereby to condition these cells to prime Th2 responses. 
 
Results 
Omega-1 requires both its glycosylation and RNase activity to condition DCs for priming of Th2 
responses 
A role for the RNase activity of omega-1 has been proposed in the conditioning of DCs to prime 
Th2 responses 16. However, this was based on a chemical inactivation of the RNase activity by 
DEPC-treatment, which may also alter the function or structure of the whole protein. Therefore, 
we addressed the role of RNase activity in a more stringent and specific manner by creating a 
mutant of recombinant wildtype (WT) omega-1 lacking RNase activity by site-directed 
mutagenesis. Specifically, a histidine residue in its catalytic domain, known from other T2 
RNases to be essential for the enzymatic activity, was replaced by phenylalanine (omega-1 H58F) 
17 (Supplementary figure 1A). Apart from RNase activity, glycosylation of omega-1 may also be 
important for its Th2-priming capacity, since chemical modification of glycans on proteins 
present in SEA is known to abolish the ability of SEA to induce Th2 polarization 6. Moreover, 
potentially Th2-polarizing LeX glycan motifs have recently been described to be present in 
glycans on omega-1 18. To address the role of glycosylation in Th2 priming by omega-1, a 
glycosylation mutant was generated by a single amino-acid replacement at each of the two 
putative N-linked glycosylation sites (omega-1-N71/176Q) (Supplementary figure 1A) 19. An 
RNase assay showed that RNase mutant did not have any RNase activity, while that the RNase 
activity of the glycosylation mutant was unaffected (Supplementary figure 1B). In addition, using 
a silver-stained SDS PAGE as well as an anti-omega-1 Western blot, we confirmed the absence of 
glycosylation on the glycosylation mutant. On the other hand, the mass shift of the RNase 
mutant on a silver-stained SDS PAGE was identical to recombinant WT omega-1, suggesting the 
glycosylation on the RNase mutant was still intact (Supplementary figure 1C). With regard to 
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Figure 1. The glycosylation and RNase activity of omega-1 are essential for conditioning DCs to prime 
Th2 responses (A) Monocyte-derived DCs were pulsed for 48 h with the different variants of recombinant 
omega-1 (2 μg/ml) in combination with LPS (100 ng/ml) as a maturation factor and surface expression of 
CD86 was determined by FACS analysis. The expression levels, based on geometric mean fluorescence, are 
shown relative to the DCs stimulated with LPS alone, which is set to 100%. (B) Conditioned DCs were co-
cultured for 24 h with a CD40-L expressing cell line, to mimic the interaction with T cells. IL-12p70 
cytokine expression levels are shown relative to the DCs stimulated with LPS alone, which is set to 1. (C+D) 
Conditioned DCs were cultured with allogeneic naive CD4+ T cells for 12 days in the presence of 
staphylococcal enterotoxin B and IL-2. Intracellular cytokine production was assayed by FACS 6 h after the 
stimulation of primed T cells with phorbol 12-myristate 13-acetate (PMA) and ionomycin. The frequencies 
of each population are indicated as percentages in the plot. One representative result from 3 independent 
experiments is shown. Based on intracellular cytokine staining, the ratio of T cells single-positive for either 
IL-4 or IFN-γ was calculated relative to the control condition. (E) DCs were pulsed for 40 h with mock- or 
periodate-treated (PD) natural omega-1 (500 ng/ml) in combination with LPS (100 ng/ml). Conditioned 
DCs were cultured with allogeneic naive CD4+ T cells for 12 days in the presence of staphylococcal 
enterotoxin B and IL-2 and analyzed as described in (D). Data are representative of 3 independent 
experiments. Bars represent mean ± SD. *,# p < 0.05, ** p<0.01, *** p<0.001 for significant differences with 




Figure 2. Glycosylation and RNase 
activity are essential for omega-1 to 
prime Th2 responses in vivo 4get/KN2 
IL-4 dual reporter mice were injected 
s.c. with SEA (20 μg) or WT 
recombinant omega-1 and the two 
mutants (3 μg) into the footpad. After 7 
days the frequency of GFP+ and 
huCD2+ within the CD4+CD44high 
effector T cell population was 
determined by flow cytometry in the 
draining popliteal lymph nodes. 
Depicted are (A) concatenated FACS 
plots, (B) frequencies of huCD2+ within 
the CD4+CD44high population and (C) 
total huCD2+ T cell numbers in 
draining lymph nodes of combined data 
of 4 mice per group. (A) The 
frequencies of each population are 
indicated as percentages in the plots. 
One of 3 independent experiments is 
shown. Bars represent mean ± SD. *,# p 
< 0.05, ** p<0.01, *** p<0.001 for values 
significantly different from the PBS 
control (*) or between test conditions 
(#) based on two-sided t-test.  
the glycans present on recombinant WT omega-1 and the RNase mutant, mass spectrometric 
analysis of tryptic glycopeptides showed the presence of N-glycans on Asn176 with the 
monosaccharide composition Hex3HexNAc6Fuc2/3 (Supplementary figure 2). This is indicative of 
the presence of fucosylated LDN antennae (LDN-F), a glycan element previously found on a 
protein from HEK293 cells, the cell type in which recombinant omega-1 is expressed 20. LDN-F 
is thought to have similar immunological characteristics as the LeX motifs present on natural 
omega-1 9;10;18.  
To assess the role of glycosylation and RNase activity in omega-1-driven Th2 
polarization, a well established in vitro culture system of human monocyte-derived DCs and 
naïve CD4+ T cells was used, which mimics in vivo DC-mediated Th cell polarization 1. Similar 
to natural omega-1 15, recombinant WT omega-1 consistently and significantly suppressed the 
LPS-induced upregulation of the costimulatory molecule CD86 (Figure 1A), as well as the 
production of IL-12 (Figure 1B), which is an important characteristic of Th2-priming DCs 3. 
However, both the glycosylation as well as the RNase mutant failed to alter LPS-induced CD86 
expression or IL-12 production of DCs. Importantly, in contrast to DCs primed with 
recombinant WT omega-1, those conditioned with the glycosylation mutant or the RNase 
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mutant did not prime a Th2 response (Figure 1C). Similar results were obtained with cultures in 
which DCs were conditioned by the omega-1 variants in the absence of LPS (Figure 1D). The 
importance of omega-1 glycosylation for polarizing towards Th2 was further substantiated by 
experiments performed with natural omega-1 on which the glycans were disrupted by periodate 
treatment (Figure 1E). These data show that the RNase activity and the glycosylation of omega-1 
are both essential, but as single property not sufficient, for the induction of Th2 responses via 
DCs. 
  
Omega-1 requires both its glycosylation and RNase activity to prime Th2 responses in vivo 
To test whether the in vivo Th2-priming capacity of omega-1 is dependent on glycosylation and 
RNase activity, recombinant WT omega-1 or its mutants were administered to 4get/KN2 IL-4 
dual-reporter mice 21. In these mice IL-4-competent cells are GFP+ and IL-4-producing cells 
additionally express huCD2, allowing the direct visualization of Th2 differentiation and IL-4 
production. Following the s.c. injection of the antigens into the footpad, the draining popliteal 
lymph nodes (LNs) were harvested on day 7 and CD4+CD44high effector T cells were analyzed for 
the expression of GFP and huCD2 directly ex vivo. Injection of SEA resulted in a significant 
increase of GFP+ and huCD2+ cells, reflecting the induction of Th2 differentiation and acute IL-4 
production in vivo (Figure 2). Importantly, while recombinant WT omega-1 alone also induced 
a marked Th2 response and the production of IL-4, both mutants were significantly impaired to 
prime this response as evidenced by lower frequencies (Figures 2A and 2B) as well as total 
numbers of huCD2+ T cells (Figure 2C) in the draining LN. Taken together, these data show that 
the glycosylation and the RNase activity of omega-1 play a crucial role in Th2 polarization 
induced by omega-1 in vivo. 
 
Omega-1 is internalized by DCs via mannose receptor (MR) 
To get a better understanding of how glycosylation is involved in omega-1-driven Th2 
polarization, we tested whether recognition of omega-1 by DCs was dependent on glycans from 
omega-1. To this end an assay was used that quantifies binding and uptake of fluorescently-
labelled antigens by DCs (Supplementary figure 3). While DCs were capable of binding and 
internalizing recombinant WT omega-1 or the RNase mutant, DCs failed to bind and internalize 
the glycosylation mutant, demonstrating that glycans present on omega-1 are essential for 
recognition by DCs (Figure 3A). Given the importance of glycosylation of omega-1 for binding 
to DCs, we explored the involvement of carbohydrate-binding CLRs in the recognition of 
omega-1. When DCs were pre-incubated with calcium-chelator EGTA, which blocks CLR 
function, binding and internalization of natural omega-1 was totally prevented (Figure 3B), 
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suggesting that DCs recognize omega-1 via CLRs. SEA has been reported to be recognized and 
endocytosed by human DCs via the CLRs DC-SIGN and MR 7, that have the capacity to bind 
fucose-residues such as ones found in LeX 9;10;22, a glycan motif present on natural omega-1 18. To 
determine whether MR and DC-SIGN are involved in recognition and internalization of natural 
omega-1, DCs were pre-incubated with mannan (a natural ligand that competes for binding to 
DC-SIGN and MR), or DC-SIGN- and MR-specific blocking antibodies, followed by an 1h 
incubation with fluorescently-labelled SEA or natural omega-1. Uptake of SEA, as previously 
published 7, could be reduced by mannan and either DC-SIGN or MR blocking antibodies in an 
additive manner. With regard to omega-1, pre-treatment with mannan could almost completely 
block binding and uptake of the molecule. Interestingly, binding and uptake of natural omega-1 
were significantly reduced by MR but not by DC-SIGN blocking antibodies (Figure 3C). 
 
Figure 3. Mannose Receptor (MR) is the principal receptor through which omega-1 is recognized and 
internalized by DCs (A) Human monocyte-derived DCs were incubated for 1 h with PF-647-labeled 
recombinant WT omega-1, the glycosylation mutant or the RNase mutant and analyzed for uptake of antigens 
by FACS analysis. One representative experiment with duplicate samples out of 2 experiments is shown. (B) A 
binding and internalization assay on immature monocyte-derived DCs was performed as described in (A) 
following preincubation with EGTA. One representative experiment based on duplicate samples out of 5 is 
shown. Data are shown as mean ± S.D. (C) A binding and internalization assay on immature monocyte-
derived DCs was performed as described in (A) following preincubation with indicated reagents. Binding and 
internalization are shown relative to mock pre-treatment. Data are representative of 5 experiments. (D) 3T3 
cell-line expressing MR and (E) K-SIGN expressing DC-SIGN or parental control cell lines (3T3 and K-562) 
were incubated with PF-647-labeled omega-1 and SEA in the presence or absence of EGTA to determine 
specificity. One representative experiment based on duplicate samples out of 2 is shown. Bars represent mean 
± SD. * p < 0.05, ** p<0.01, *** p<0.001 for significant differences compared to the control (two-sided t-test). 
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Pre-incubation with the combination of both blocking antibodies did not have any additional 
effect on the uptake of omega-1 as compared to pre-incubation with anti-MR antibody alone. Of 
note, we found that recombinant omega-1 was recognized and internalized by DCs in similar 
MR-dependent fashion as natural omega-1 (data not shown). To further investigate the 
observations of selective recognition and uptake of omega-1 by MR, we made use of the K562 
and 3T3 cell lines selectively expressing human DC-SIGN and MR, respectively. Fluorescently-
labelled SEA was readily bound by both the DC-SIGN- and MR-expressing cells, which was not 
observed upon pre-incubation with EGTA or in parent control cell lines lacking CLR expression. 
In line with the DC-binding and uptake data, omega-1 binding could be observed in the cell line 
expressing MR (Figure 3D), but not in the cell line expressing DC-SIGN (Figure 3E). It should 
be noted, that not only in DC uptake experiments but also in the omega-1 binding experiments 
with the cell line selectively expressing MR, blocking with anti-MR antibody was not complete 
(Figure 3C and data not shown), suggesting that a relatively low affinity of the anti-MR antibody 
accounts for this finding rather than that other receptors are involved. Taken together, our data 
suggest that recognition and internalization of omega-1 by human DCs is dependent on its 
glycosylation and that MR is the primary CLR involved in this process.  
Figure 4. Omega-1 suppresses protein 
synthesis through interference with ribosomal 
function (A) Following 16 h incubation of DCs 
with a concentration range of indicated reagents 
in the presence of LPS (100 ng/ml), protein 
synthesis was assessed after a 2 h pulse with 
radioactive labelled methionine. Ricin, as potent 
inhibitor of protein synthesis, was taken along as 
positive control 23. (B) Protein synthesis by DCs 
following exposure to the recombinant omega-1 
variants (2 g/ml) was assessed as described in 
(A). (C) After rabbit reticulocyte lysate 
containing functional ribosomes was incubated 
for 1 h with omega-1 or IPSE/α1, as a negative 
control, isolated ribosomal RNA was analyzed 
for breakdown on a 2% agarose gel. The RNase 
α-sarcin was taken along as positive control as it 
should give a single rRNA cleavage product 
when incubated with functional ribosomes 
(white arrowhead) 35. (D) rRNA isolated from 
24h omega-1-stimulated DCs and was visualized 
by running a lab-on-a-chip picogel and (E) 
28S/18S rRNA ratio was determined from these 
samples as a measure for rRNA integrity. (A-E) 
One representative experiment from 3 
independent experiments is shown. Bars 




Omega-1 suppresses DC function by interfering with protein synthesis 
Next we examined the molecular mechanism through which the RNase activity of omega-1 
exerts its modulatory effects on DCs. We noted that omega-1-stimulated DCs in response to 
CD40 ligation were not only impaired in their capacity to produce IL-12 p70, as reported 
previously 15, but also fail to express a large panel of other cytokines (Supplementary figure 4). 
This indicates that the suppression may not be gene specific, but could be the result of inhibition 
of protein synthesis globally. Indeed, following exposure of DCs to omega-1 or SEA, a dose-
dependent reduction of protein synthesis could be observed, similar to what is found in DCs 
exposed to ricin, a well known protein synthesis inhibitor 23 (Figure 4A). The capacity to inhibit 
protein synthesis was dependent on its RNase activity and uptake via its glycans, since the RNase 
as well as the glycosylation mutant failed to interfere with protein synthesis (Figure 4B). As 
several fungal ribonucleolytic proteins, so-called ribotoxins, have been described to inhibit 
protein synthesis through cleavage of ribosomal RNA (rRNA) 24, we tested whether omega-1 
could cleave rRNA in the context of functional ribosomes in a cell free assay. Omega-1 was able 
to break down rRNA, while IPSE/α1, another S. mansoni egg-derived protein that lacks RNase 
activity but has identical glycans as omega-1 25, did not induce any rRNA digestion (Figure 4C), 
indicating that omega-1 is able to interfere with ribosomal function by cleavage of rRNA. Finally 
analysis of the integrity of rRNA isolated from omega-1-exposed DCs revealed a selective 
breakdown of 28S rRNA (Figure 4D), resulting in time dependent decrease in 28S/18S ratio 
(Figure 4E). Taken together, these data support the notion that the RNase activity enables 
omega-1 to modulate DC function by interfering with protein synthesis through cleavage of 
rRNA.  
 
MR mediates omega-1-induced protein synthesis inhibition, DC modulation and Th2 polarization 
To address the role of omega-1 binding by MR in mediating RNase-dependent DC modulation 
and Th2 priming by omega-1, we used blocking antibodies directed against MR or DC-SIGN. 
Blocking of MR during the stimulation of DCs with omega-1 significantly prevented the 
inhibition of protein synthesis (Figure 5A), while blocking of DC-SIGN had no effect, showing 
that the interference with protein synthesis by omega-1 is dependent on MR. In line with these 
observations, blocking of MR significantly reduced the capacity of omega-1 to suppress LPS-
induced CD86 expression (Figure 5B) and IL-12 production following CD40 ligation (Figure 
5C) or to condition DCs to induce a Th2 response (Figure 5D). As a last step, murine MR-/- 
splenic DCs were tested for their Th2-priming capacity in response to omega-1. While OVA 
peptide-pulsed WT splenic DCs, when conditioned with omega-1, primed a Th2-skewed OVA 
peptide-specific T cell response in vitro, MR-/- splenic DCs failed to do so (Figure 5E). 
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Figure 5. MR mediates omega-1-induced DC modulation and Th2 polarization in vitro. Following 1 h pre-
incubation with blocking antibodies against MR, DC-SIGN or an isotype control (20 μg/ml), monocyte-
derived DCs were pulsed for 16 h (A) or 48 h (B-D) with natural omega-1 (500 ng/ml) in combination with 
LPS (100 ng/ml). (A) Protein synthesis was assessed as described in Fig. 4 A. One representative experiment 
based on duplicate samples out of 3 experiments is shown. (B) The expression levels of CD86 on DCs were 
assessed by FACS and are shown, based on geometric mean fluorescence, relative to the DCs stimulated with 
LPS alone, which is set to 100% (dashed line). Data are based on 3 independent experiments (C) Conditioned 
DCs were co-cultured for 24 h with a CD40-L expressing cell line, to mimic the interaction with T cells. IL-
12p70 cytokine expression levels are shown relative to the DCs stimulated with LPS alone, which is set to 1 
(dashed line). Data are based on 3 independent experiments. (D) Conditioned DCs were cultured with 
allogeneic naive CD4+ T cells for 12 days in the presence of staphylococcal enterotoxin B and IL-2 and T cell 
polarization was analyzed as described in figure 1. Data are based on 6 independent experiments. (E) Splenic 
WT or MR-/- DCs were co-cultured with OVA-specific OT-II cells for 4 days in the presence of indicated 
antigens. At day 4 T cells were restimulated with PMA and ionomycin and analyzed for intracellular IL-
4/IFN-γ cytokine ratio as described in Fig. 1 D. 1 representative experiment out of 2 experiments is shown. 
Bars represent mean ± SD. *,# p < 0.05, **,## p<0.01, *** p<0.001 for significant differences with the LPS 
control (*) or between test conditions (#) based on paired analysis (two-sided paired t-test). ω-1, omega-1. 
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These data establish that MR is essential for the omega-1-driven Th2 polarization via DCs in 
vitro.  
 
Omega-1 requires MR to prime Th2 responses in vivo 
Finally, to investigate the role of MR in Th2-priming by omega-1 in vivo, natural omega-1 or 
PBS were injected subcutaneously into the footpad of WT and MR-/- mice. After 7 days the 
draining popliteal LNs were harvested and restimulated in vitro with PBS, omega-1 or a 
polyclonal stimulus PHA and analyzed for cytokine production. Antigen specific restimulation 
of omega-1-primed LNs from WT mice resulted in a Th2-polarized response as evidenced by 
elevated levels of Th2-associated cytokine IL-5 but not of Th1-associated cytokine IFN-γ, which 
was absent in LN cells derived from MR-/- (Figure 6A). Furthermore, intracellular staining for 
IFN-γ and IL-4 following antigen-specific restimulation of CD4+ T cells from omega-1-primed 
LNs, showed a significant increase in the ratio between IL-4- and IFN-γ-producing T cells from 
WT but not MR-/- mice (Figure 6B). The failure of MR-/- mice to prime a Th2-polarized 
response in response to omega-1 was not due to a general failure of MR-/- cells to produce these 
cytokines as the responses to PHA were comparable in WT and MR-/- mice (Figures 6A and 
6B). Taken together, these data show that MR is essential for priming of Th2 responses by 
omega-1 in vivo. 
 
Discussion 
Utilizing omega-1, a single molecule derived from Schistosoma mansoni, we studied the 
molecular mechanisms involved in conditioning DCs to induce Th2 responses. By generating 
mutant proteins we could show that both the glycosylation and RNase activity of omega-1 are 
essential for its potent Th2-inducing activity both in vitro and in vivo. The glycan structures on 
omega-1 suggested that CLRs might play a role in its interaction with DCs. Although both MR 
and DC-SIGN have been shown to mediate binding and uptake of fucosylated antigens by DCs 
and omega-1 harbours fucose-containing LeX moieties 18, we observed that omega-1 only 
significantly bound to a MR-, and not DC-SIGN-expressing cell-line and was internalized by 
DCs in a MR-, and not DC-SIGN-dependent manner. Lack of potent binding and uptake of 
omega-1 by DC-SIGN might be explained by the fact that in most DC-SIGN binding studies 
polyvalent LeX-containing beads or conjugates have been used, which may be bound by DC-
SIGN with a higher affinity than soluble glycoproteins, such as omega-1 that presents LeX at a 
low valency 27. In line with this observation, DC-SIGN blocking experiments suggest that 
interactions with DC-SIGN do not play a major role in omega-1-driven Th2 polarization via 
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DCs. On the other hand, the importance of MR in recognition and uptake of omega-1 was 
substantiated by the finding that inhibition of protein synthesis and conditioning of DCs for Th2 
polarization by omega-1 was significantly impaired by blocking of MR, but not DC-SIGN. We 
confirmed and extended the importance of MR in Th2 polarization by omega-1 by showing in 
vivo that an antigen-specific Th2 response induced in MR-deficient mice following footpad 
injection of omega-1 was strongly reduced compared to the response elicited in WT mice. In this 
respect it is important to note that human and murine MR have a similar carbohydrate binding 
specificity 28. Thus, this establishes that omega-1 relies on MR to drive Th2 polarization. This is 
consistent with earlier observations that crosslinking of MR with antibodies 29 or engagement by 
mannosylated antigens 30;31 can drive an anti-inflammatory cytokine program in DCs away from 
  
Figure 6. MR is essential for omega-1-driven Th2 polarization in vivo MR-/- and WT Bl/6 mice were 
injected s.c. with omega-1 (2 μg in 30 μl PBS) or PBS into the footpad. (A) After 7 days the cells from the 
draining lymph node (LNs) were restimulated in vitro for 4 days with PBS, omega-1 (2 μg/ml) or PHA (10 
μg/ml), as polyclonal stimulus, after which cytokine production was determined by ELISA. (B) Intracellular 
cytokine production of the CD3+/CD4+ T cells from these LNs was assayed by FACS after an additional 6 h 
restimulation with PMA and ionomycin. The percentage of T cells single-positive for either IL-4 or IFN-γ is 
shown. One experiment of 2 independent experiments is shown. Data are means ± s.e.m. of 4 mice per group 
based on pooled triplicate wells for each mouse. * p < 0.05, ** p<0.01 for significant differences based on 
paired analysis (two-sided paired t-test). ω-1, omega-1. 
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a Th1-promoting profile 29 and that allergen-driven Th2 polarization by DCs is in part 
dependent on MR 32;33. These studies point towards a direct role for MR in Th2 induction, 
potentially via signalling events. However, our data demonstrate that MR binding alone is not 
sufficient for Th2 polarization by omega-1, since glycans present on omega-1, in absence of 
RNase activity, are not sufficient to program DCs to induce Th2 responses. This is in line with 
the observation that IPSE/α1, another major glycoprotein secreted by S. mansoni eggs with 
identical glycosylation as omega-1 25, which can bind a cell line expressing MR (chapter 4 of this 
thesis) but lacking RNase activity, fails to prime Th2 responses 15. 
Furthermore, we specifically confirmed that apart from glycosylation, omega-1 
requires its RNase activity to induce a Th2 response via modulation of DCs by using an RNase 
mutant. It was observed that omega-1 could cleave rRNA in the context of ribosomes in a cell 
free assay, and could induce 28S rRNA breakdown in DCs. The finding that the integrity and 
yield of mRNA isolated from omega-1-stimulated DCs was not different from unpulsed control 
DCs (data not shown), suggests that interference with translation via selective cleavage of rRNA 
is the mode of action through which the RNase activity enables omega-1 to condition DCs for 
priming of Th2 responses. Some RNases have been linked to Th2 polarization before. For 
instance, the major birch pollen allergen, Bet v 1 34, was identified as an RNase. Furthermore, 
some fungal RNAses that selectively cleave rRNA, such as mitogillin and Aspf-1, are known to 
be allergens 35. Interestingly, for Aspf-1 it was found that its allergenicity was lost when its 
capacity to interfere with ribosomal function was abolished 36. In addition, a report has linked an 
endogenous RNase, the eosinophil-derived neurotoxin, to DC-mediated Th2 polarization 37. 
Although these studies have not specifically addressed the role of RNase activity in direct 
priming of Th2 responses, they do highlight the possibility that Th2 priming through 
interference with ribosomal function may not be a unique feature of S. mansoni-derived omega-
1, but may be shared by other RNases as well. However, such an RNase needs to be recognized 
by DCs and routed in a specific manner to reach the ribosomes and exert its enzymatic activity 
which in turn would result in suppression of protein synthesis, yet without shutting down DC 
function altogether or inducing cell death before T cell priming has occurred. One would predict 
that only certain RNases or ribosome-inactivating proteins will meet those requirements, and as 
such would be able to drive Th2 responses.  
It remains to be established how omega-1 would be able to reach the ribosomes present 
in the cytosol. Some ribosome-inactivating proteins have been shown to translocate from the ER 
into the cytosol after retrograde transport or by direct escape from endosomes into the cytosol 38. 
In this respect, since omega-1 is internalized via MR, it is interesting to note that cross-
presentation of OVA by DCs, a process that requires translocation of the antigen from 
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endosomes into the cytosol, has been shown to be dependent on MR 39;40. Mechanistically, it was 
demonstrated that binding of the MR to OVA leads to poly-ubiquitination of MR, resulting in 
the recruitment of the ATPase p97, a member of the ER-associated degradation machinery, 
towards the endosomal membrane. p97 in turn was found to provide the energy to pull out the 
MR ligand into the cytoplasm 41. This suggests that the MR itself can regulate the transport of its 
ligand, into the cytoplasm and provides a mechanism through which omega-1 could be 
translocated into the cytosol of DCs.   
Apart from inhibition of protein synthesis, we observed that omega-1 could promote 
apoptosis in DCs in a RNase dependent manner (unpublished data), reminiscent of ribotoxins 
that are known to induce cytotoxicity by interfering with ribosomal function 24. It is important to 
note that in line with the protective effects of maturation on DC death 42, omega-1-driven 
cytotoxicity was not observed in LPS-matured DCs, excluding the possibility that the results 
obtained from our DC-T cell cultures regarding T cell polarization were influenced by potential 
immunomodulatory effects of apoptotic cells. Furthermore, our observations that omega-1 relies 
on MR to be internalized by DCs may explain the documented hepatotoxic effects of S. mansoni 
egg-derived protein fractions containing omega-1 43;44, given that apart from DCs, sinusoidal 
endothelial cells and Kupfer cells express MR 45;46, which would render them sensitive to omega-
1-induced cytotoxicity. 
The suppression of protein synthesis in DCs by omega-1, would be in line with the 
documented inhibitory effects of omega-1 as well as SEA on DC activation and TLR-induced 
expression of co-stimulatory molecules and cytokines 15;16. In addition, this mode of action 
would also provide an explanation for the finding that omega-1 alters DC morphology as a result 
of cytoskeletal changes 16, since halting of translation and concomitant stress responses can affect 
actin rearrangements and thereby cell morphology 47. Importantly, during interactions with 
naïve T cells, omega-1-conditioned DCs will, in contrast to unconditioned DCs, be largely 
refractory to respond to CD40 ligation by T cells, as their protein synthesis machinery is 
impaired. As a consequence, T cells are primed in the absence of IL-12 and in the context of low 
antigen presentation and/or co-stimulation, a situation that is known to favour the induction of 
Th2 responses 48;49. This mechanism would be different from the initially proposed ‘default 
hypothesis’ for Th2 induction 50, as it represents a dominant and active suppression of signals 
during DC-T cell interactions. Such a model of active suppression of DC signals for Th2 
polarization would be in line with recent data showing that SEA-pulsed DCs, although still 
capable of processing antigen to present it on MHC-II, are impaired in their upregulation of 
surface expression of MHC-II and CD86 or IL-12 in response to CD40 ligation 15;51, as well as the 
observations that omega-1-primed DCs have a reduced capacity to form T cell-DC conjugates 16.   
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Taken together, based on our data we propose a model in which the glycans present on 
omega-1 do not play a dominant role in functional modulation of DC function for induction of 
Th2 responses, but instead are essential for efficient recognition and internalization by DCs via 
MR. Subsequently, following translocation into the cytosol omega-1 programs DCs to drive Th2 
polarization in an RNase dependent manner by interfering with ribosomal function and protein 
synthesis. These studies have uncovered a novel mechanism through which DCs can be 
programmed to drive Th2 responses. It will be of great interest to study whether targeting of MR 
and the protein synthesis machinery to condition DCs for priming Th2 responses is unique to 
schistosome-driven Th2 polarization, or a mechanism that is also involved in the initiation of 
other Th2-polarized immune responses, found during other helminth infections or allergies. In 
addition, the insight may help the design of Th2-polarizing molecules, that could be used in the 
development of immune-driven manipulation of metabolic disorders such as insulin resistance, 
vaccines against parasitic worm infections or approaches to counterbalance unwanted Th1 
responses 52;53. 
 
Materials and Methods 
Preparation and purification of S. mansoni egg-derived antigens  
SEA, omega-1 and IPSE/α1 were prepared and isolated as described previously 15;54. The purity of 
the preparations was controlled by SDS-PAGE and silverstaining. Protein concentrations were 
tested using the Bradford or BCA procedure.  
 
Periodate treatment of antigens 
Antigens were treated with sodium periodate as previously described 55;56. In short, sodium 
acetate buffer (pH 4.5) was added to the antigens to a final concentration of 0.1M prior to 
exposure to periodate. Antigens were incubated in 20 mM sodium periodate overnight in the 
dark at 4oC. The incubation was stopped by addition of an equal volume of 50 mM sodium 
borohydride for 30 minutes. To remove the sodium periodate, sample buffer was exchanged to 
phosphate buffered saline using protein desalting spin columns according to manufacturer’s 
recommendations (Pierce, Rockford, IL, USA). 
 
MALDI-TOF-MS of omega-1 glycopeptides 
Glycopeptides of recombinant omega-1 were generated by trypsin treatment of reduced and 
alkylated omega-1, either in solution or in excised gel bands 18. Mass spectra were recorded using 
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an Ultraflex II time-of-flight mass spectrometer (Bruker-Daltonics, Bremen, Germany) as 
described 25. 
 
Generation and production of WT, glycosylation mutant and RNase mutant forms of recombinant 
omega-1 
Site directed mutagenesis was used to generate a glycosylation and RNase mutant by mutating 
the two putative N-linked glycosylation sites (N71/176Q) or by targeting a conserved amino-
acid residue (H58F) that is known to be critical for enzymatic activity in other homologous 
RNases [20;85], respectively (see supplemental Figure 1). H58F and N71/176Q mutants were 
created by polymerase chain reaction (PCR) using mutagenic primers on a DH5α/pProExHtb- 
plasmid containing  the WT omega-1 sequence (Invitrogen). Introduction of the right mutations 
was confirmed by DNA sequencing. Subsequently, using restriction enzymes HindIII and ApaI 
the templates for WT and omega-1 mutant were subcloned into a pSecTag2-plasmid 
(Invitrogen) for stable transfection into HEK cells 15. Secreted recombinant omega-1 forms were 
sequentially purified from the HEK cell culture medium by immobilized metal affinity 
chromatography and size exclusion chromatography as described previously 15.  
 
Human DC culture, stimulation and analysis.  
Monocytes were isolated from venous blood of healthy volunteers using Institutional Review 
Board-approved protocols by density centrifugation on ficoll followed by a Percoll gradient as 
described 15 and were cultured in RPMI medium supplemented with 10% FCS, human rGM-CSF 
(500 units/ml, Invitrogen) and human rIL-4 (250 units/ml) (R&D Systems). On day 3, culture 
medium including the supplements was replaced and on day 6 immature DCs were stimulated 
with the indicated reagents in the presence of ultrapure LPS (100 ng/ml) (E. coli 0111 B4 strain, 
InvivoGen). For CLR blocking indicated cells were pre-incubated with 20μg/ml anti-DC-SIGN 
(clone AZN-D1, Beckman Coulter) or 20μg/ml anti-MR (clone 15.2, Biolegend) for 60 min at 
37 °C. As a Th1 control DCs were also pulsed with IFN- (1000 U/ml). After 48 h, DCs were 
harvested for co-culture with naïve T cells. In addition, 1x104 matured DCs were co-cultured 
with 1x104 CD40L-expressing J558 cells for 24 h to determine cytokine production by the DCs 
following activation by CD40L. IL-12p70 concentrations were determined by ELISA using 
mouse anti-human IL-12, clone 20C2 as capture antibody and biotinylated mouse-anti-human 
IL-12, clone C8.6 as detection antibody (both Becton Dickinson). Concentrations of IL-10, TNF-
α, MIP-1β and RANTES were determined by a multiplex LUMINEX assay according to the 
manufacturer’s instruction (InvivoGen). The expression of CD86-PE pulsed DCs was 
determined by FACS (FACSCanto) through staining with CD86-FITC (Becton Dickinson). 
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Murine DC and  T cell polarization assay 
Splenic CD11c+MHCII+ DCs and OT-II CD4+ T cells were isolated by sorting from naive 
splenocytes. 5 × 105 Tg CD4+ lymphocytes/ml were co-cultured with 2.5 × 105 syngeneic splenic 
DCs/ml and stimulated interchangeably with 100 μg/ml OVA. At d4, CD3+/CD4+ T cells were 
restimulated with 50 ng/ml phorbol 12-myristate 13-acetate plus 2 μg/ml ionomycin for 6 h. 10 
μg/ml brefeldin A was added during the last 2 h (all Sigma). The cells were stained with a 
combination of IL-4-PE and IFN--FITC antibodies (BD). and analyzed for intracellular IL-
4/IFN-γ cytokine ratio. 
 
Human T cell culture and determination of T cell polarization  
To determine T cell polarization, 5 x 103 48 h-pulsed DCs were co-cultured with 2 x 104 naïve T 
cells that were purified using a human CD4+/CD45RO- column kit (R&D, Minneapolis, MN) in 
the presence of staphylococcal enterotoxin B (10 pg/ml; Sigma) in 96-well flat-bottom plates 
(Corning). On day 5, rhuIL-2 (10 U/ml, Cetus Corp., Emeryville, CA) was added and the 
cultures were expanded for another 7 days. For intracellular cytokine production, the primed 
CD4+ T cells were restimulated with 50 ng/ml phorbol 12-myristate 13-acetate plus 2 μg/ml 
ionomycin for 6 h. 10 μg/ml brefeldin A was added during the last 2 h (all Sigma). The cells were 
stained with a combination of IL-4-PE and IFN--FITC antibodies (BD).  
 
TLR-transfected HEK cell activation 
HEK-293-CD14, HEK-293-CD14/TLR2 and HEK-293-CD14/TLR4 cells were maintained in 
DMEM culture medium, supplemented with 10% FCS, 10 g/ml ciprofloxacin and 5 g/ml 
puromycin. For stimulation experiments, cells were seeded at 3.5 x 104 cells/well in 96-well 
flatbottom plates and were stimulated the next day. For stimulation of HEK-293-CD14/TLR4 
cells, 12.5% supernatant of MD-2 transfected cells was added. IL-8 production was measured in 
supernatants after 22 hours using a commercial kit (Sanquin, Amsterdam, The Netherlands) 
following the manufacturer’s recommendations. 
 
DC-SIGN- and MR-expressing cell line 
K562 cell line stably expressing DC-SIGN (a kind gift from K. Figdor 57) or 3T3 cellline stably 
expressing human MR (a kind gift from G. Brown 58) and their respective parental control cell 
lines were seeded overnight in a 96 well plate at 10.000 cells/well. Where indicated, cells were 
pre-incubated with 10mM EGTA for 30 min at 37 °C. Subsequently, cells were incubated with 
2μg/ml PF-647 labeled SEA or 500ng/ml PF-647 labeled omega-1 at 37 °C for 1 h and washed in 
ice cold PBS before analysis using flowcytometry. 
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Protein synthesis inhibition 
Immature DC were seeded overnight in 96 well flatbottom plates before stimulation with 
indicated reagents in the presence of LPS. 16 h after stimulation protein synthesis was 
determined by a 2 h pulse at 37 °C with 3μCi /0,05 ml [35S]-methionine (EasyTag Express 
Protein labeling mix, Perkin Elmer) in serum- and and L-methionine free RPMI1640. After a 
double washing step in PBS, cells were lysed for 5 min in AV-lysis buffer (20mM Tris HCl, 
pH7.6, 150 mM NaCl, 0.5% DOC, 1.0% NP40, 0.1% SDS) in the presence of protease inhibitors 
Leupeptin and Aprotinin 200ug/ml. Lysates were transferred on a filter (Perkin Elmer) and 
dried. After radioactive labeled proteins were precipitated on the filter with trichloroacetic acid, 
filters were washed with 96% ethanol and dried. The radioactivity present on the filters was 
measured in a β-counter by a liquid scintillation cocktail for aqueous solution. 
 
RNase activity assay 
RNA was extracted from PBMC using the RNeasy kit (Qiagen). RNA was incubated for 1 h at 37 
˚C with indicated antigens 0.01M Tris 0.02% Cu. Subsequently, RNA breakdown was visualized 
by running the samples on a 2% agarose gel containing ethidium bromide. 
 
Ribosomal RNA breakdown  
Rabbit Reticulocyte Lysate (Promega) was incubated with antigens as described by others 35. 
Briefly, following 1 h incubation at 37 °C in Tris-HCl (15 mM NaCl, 50 mM KCl, 2,5 mM 
EDTA), the reaction was stopped with 10% SDS and RNA was extracted from the ribosomes 
with phenol/chlorophorm. Next, isolated ribosomal RNA was denatured at 95°C and visualized 
by running the samples on a 2% agarose gel containing ethidium bromide. 
 
Analysis of ribosomal RNA integrity in human DCs  
mRNA was isolated from DCs conditioned by omega-1 for indicated time points using  RNeasy 
mini Kit (Qiagen) according to the manufacturers recommendations. Integrity of rRNA was 
visualized and quantified using Agilent RNA 6000 Pico Kit in a 2100 Bioanalyzer (Agilent) 
according to the manufacturers recommendations.      
 
Antigen uptake by DCs 
SEA and omega-1 were fluorescently labeled with PF-647 using the Promofluor labeling kit 
(Promokine and according to the manufacturers recommendations). 10.000 immature DC/well 
were seeded in a 96 well plate. Where indicated cells were pre-incubated with 10mM EGTA, 
100ug/ml Mannan (Sigma Aldrich), 20μg/ml anti-DC-SIGN (clone AZN-D1, Beckman Coulter) 
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or 20μg/ml anti-MR (clone 15.2, Biolegend) for 60 min at 37 °C. Subsequently, cells were 
incubated with 2μg/ml PF-647 labeled SEA or 500ng/ml PF-647 labeled omega-1 at 37 °C for 1 h 
and washed in ice cold PBS before analysis using flowcytometry. 
 
In vivo experiments 
4get/KN2 59 mice were bred and housed in the animal facility of the Trudeau Institute and used 
at 8-12 weeks of age. MR-/- mice on a C57BL/6 background were provided by Dr. M. C. 
Nussenzweig (Rockefeller University, New York, NY) and were bred and housed in the animal 
facility of the Institutes of Molecular Medicine and Experimental Immunology at the University 
Hospital, Bonn. All experimental procedures were approved by the Institutional Animal Care 
and Use Committee. Mice were immunized s.c. into one hind footpad with SEA (20μg), omega-1 
(3μg), in a volume of 50 ul and the draining popliteal lymph nodes were analyzed one week later.  
 
In vitro restimulation of lymph node cells 
1.5 × 106 popliteal LN cells/ml from individual animals were restimulated with 10 μg/ml SEA or 
2 μg/ml omega-1. IL-5, IL-4 and IFN-γ were measured by ELISA in day 4 supernatants 
according to the manufacturer’s recommendations (R&D). Following removal of the 
supernatants, cells were restimulated with 50 ng/ml phorbol 12-myristate 13-acetate plus 2 
μg/ml ionomycin for 6 h. 10 μg/ml brefeldin A was added during the last 2 h (all Sigma). The 
cells were stained with a combination of IL-4-PE and IFN--FITC antibodies (BD). 
 
Statistical analysis 
Data were analyzed for statistical significance using a two-sided paired Student’s t-test or where 
indicated a two-sided unpaired Student’s t-test. All p-values < 0.05 were considered significant.  
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Supplementary figure 1. Generation and evaluation of glycosylation and RNase mutants of recombinant 
omega-1 (A) The amino acid sequence of omega-1 is shown in which the  mutation sites are depicted. The two 
conserved amino acid sequence (CAS)-domains essential for catalytical activity are marked in grey and the 
two N-linked glycosylation sites are depicted in white boxes. (B) RNA from PBMCs was incubated for 1 h with 
the different omega-1 variants and analyzed on a 2% agarosegel for breakdown. The RNase mutant, in contrast 
to the glycosylation mutant and WT recombinant omega-1, fails to degrade RNA  (C) The omega-1 variants 
were run under non-reducing conditions by SDS-PAGE and silver stained. A Western Blot by staining with a 
specific anti-omega-1 monoclonal antibody confirmed native conformation of the different omega-1 mutants 
as well as the absence of glycosylation only on the omega-1 glycosylation mutant, as evidenced by a single 









Supplementatry figure 2. Glycosylation of recombinant omega-1 MALDI-TOF mass spectrum of 
glycopeptides from a tryptic digest of recombinant omega-1, covering the glycosylation site N176. Recombinant 
omega-1 was subjected to SDS-PAGE under reducing conditions and stained with Colloidal blue. Stained bands 
were excised, subjected to reduction and alkylation and digested with trypsin. The MALDI-TOF-MS spectrum 
derived from the upper band in the SDS-PAGE pattern is depicted. Signals ([M+H+]) are labeled with 
monoisotopic masses. Composition of the glycan moieties are given in terms of hexose (H), N-acetylhexosamine 
(N) and fucose (F). Differences in fucose content are indicated by double-headed arrows. Signals that cannot be 
assigned to glycopeptides are marked with asteriks (*). Based on the presence of the common N-glycan core 
structure (H3N2), the monosaccharide composition of the glycan species H3N6F2 and H3N6F3 indicates that these 
contain fucosylated antennae.
 
Supplementary figure 3. Validation of an assay for binding and uptake of antigens by DCs  (A) DCs were 
incubated for 1 h with PF-647-labeled omega-1 at 37 °C and, where indicated, either preincubated with EGTA 
to prevent binding to CLRs or treated afterwards with EGTA to remove any potential antigen bound to CLRs 
on the cell surface. After 1h incubation at 37 °C, EGTA treatment afterwards did not remove any 
fluorescently-labeled omega-1 from the surface, given that the fluorescent intensity of the DCs was not 
affected, suggesting that all omega-1 is internalized by DCs, (B) As a control, the same assay was performed at 
4 °C, a temperature that precludes receptor-mediated uptake, to show that EGTA treatment afterwards, can 
abolish surface binding of omega-1. 
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Supplementary figure 4. Omega-1 dose dependently suppresses expression of multiple cytokines After DCs 
had been pulsed for 40 h with the different antigen preparations in combination with LPS (100 ng/ml), the 
cells were co-cultured for 24 h with the J558 cell-line, expressing CD40-L, to mimic the interaction with T 
cells. Concentrations of the stimuli are given in μg/ml. Bars represent mean ± SD of triplicate wells. * p < 0.05, 
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The main pathology of schistosomiasis is caused by a granulomatous response which develops 
around eggs that get trapped in host tissue. Previously, granuloma formation has been explored 
in pulmonary and hepatic mouse models using antigen-coated Sepharose beads as artificial eggs. 
Using the hepatic model, it has been shown that the glycan portion of soluble egg antigens (SEA) 
can induce granuloma formation similar to SEA. Moreover, from a group of synthetic 
schistosome-related glycoconjugates, only those terminating in GalNAc1-4GlcNAc (LDN) and 
Gal1-3/4GlcNAc (LN) were able to induce the same granulomatous responses. So far, the 
native S. mansoni egg glycoproteins expressing these granuloma-inducing glycans have 
remained elusive. Recently, we have identified kappa-5 as the major glycoprotein in SEA that 
expresses LDN-motifs. In this report, we show in a pulmonary mouse model for granuloma 
formation that kappa-5 coated to Sepharose beads is able to induce type 2-polarized 
granulomatous responses. Furthermore, we show that the capacity of kappa-5 to induce 
granulomas involves its LDN motifs, as selective removal of LDN significantly diminished 
granuloma formation. 
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Schistosomes are parasitic helminths that infect over 200 million people in (sub-) tropical areas 
around the world. The main pathology of S. mansoni infection is initiated by the large 
proportion of parasite eggs that instead of being excreted with the feces, get trapped in various 
organs such as the liver. Here, egg antigens induce a type 2 inflammatory response, leading to 
the formation of periovular granulomas composed of mainly CD4+ T cells, macrophages and 
eosinophils, and collagen fibers 1. The development of the egg granuloma is shown to be highly 
dependent on Th2-polarized CD4+ T cells 2 and alternatively activated macrophages 3. 
The nature of S. mansoni egg molecules involved in the induction and modulation of 
granulomas has been explored in established experimental mouse models by injection of 
antigen-coated Sepharose beads as artificial eggs into the liver 4-6 and lungs 7-9. In the liver model, 
beads coated with S. mansoni soluble egg antigens (SEA) give rise to granulomas comparable to 
those around schistosome eggs in terms of cellular composition and expression of adhesion 
molecules and extracellular matrix components 4;6. Destruction of the integrity of SEA glycans by 
meta-periodate abolished the inflammatory properties of the SEA beads, demonstrating a major 
role for glycosylation in the initiation of the granulomatous reaction 6. To explore the type of 
glycans involved, beads were injected coated with a selected set of synthetic model 
glycoconjugates containing glycan elements representative for schistosome eggs, such as 
GalNAcβ1-4GlcNAc (LacdiNAc, LDN), Galβ1-4(Fucα1-3)GlcNAc (Lewis X), Fucα1-2Fucα1-
3GlcNAc (DF-Gn) and Fucα1-3GalNAcβ1-4(Fucα1-3)GlcNAc (F-LDN-F) 10. Interestingly, from 
the tested set, only beads coated with a synthetic LDN-conjugate and beads coated with 
asialofetuin, a glycoprotein with terminal Gal1-3/4GlcNAc (LacNAc, LN) groups, were able to 
induce granulomas in this model. All other glycoconjugates tested elicited only a monolayer of 
macrophages, similar to uncoated and albumin-coated beads. 
Recently, we have described kappa-5 as one of the major antigens in S. mansoni SEA 
11;12. Glycosylation analysis demonstrated that kappa-5 contains four N-glycosylation sites which 
for a large part carry triantennary LDN motifs. Moreover, kappa-5 was found to be the major 
LDN-containing glycoprotein in SEA 11, in terms of abundance as well as reactivity with the 
GalNAc-specific lectin soybean agglutinin and an LDN-binding antibody. These characteristics 
prompted us to test the immunological properties of kappa-5 in the pulmonary mouse model. 
Although kappa-5 is presumably not present during the early stages of egg development, it is 
definitely presented to the immune system later on, as it gives rise to antibody responses in 
infected hosts 13. Therefore we set out to investigate whether kappa-5 might have a role in 
granuloma formation and/or modulation. Using the pulmonary model, we demonstrate that 
 
 150
kappa-5 coated beads are able to induce granulomas of a similar nature as egg- and SEA-induced 
granuloma. Furthermore, beads containing kappa-5 of which the LDN motifs were 
enzymatically removed induce significantly less and smaller sized granulomas opposed to 
untreated kappa-5 coated beads. Conclusively, here we describe the first native S. mansoni egg 
glycoprotein with glycan-dependent granuloma-inducing properties.  
 
 
Figure 1. Induction of pulmonary granuloma formation by kappa-5 in an experimental mouse model. 
Antigen-coated beads were injected into the lungs of mice and at 14 days post-injection, granuloma formation 
was assessed. (A-C) Representative examples of BSA- (A), SEA- (B) and kappa-5- (C) induced granuloma are 
shown for every experimental group. Lung slides are stained with H&E. (D) The relative granuloma area 
(granuloma area divided by bead area) was assessed for each experimental group. (E) The percentage of 
eosinophils was calculated for SEA- and kappa-5-induced granulomas Graphs show mean values with SEM 
(Mann-Whitney: * indicates p < 0.001).  
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The S. mansoni egg glycoprotein kappa-5 induces Th2-polarized granuloma formation 
Sepharose beads were coated with SEA or the SEA component kappa-5, and tested in an 
established mouse model for pulmonary granuloma formation 7. Fourteen days after bead 
injection, control beads coated with bovine serum albumin (BSA) showed no cellular reaction 
except for a monolayer of cells (Figure 1A), while granuloma formation was observed around 
beads coated with SEA (Figure 1B). Importantly, the majority of beads (93 %) coated with 
isolated, native kappa-5 were able to induce granulomatous responses (Figure 1C). As the size of 
the commercially obtained beads varied significantly, the granuloma area relative to the bead 
area was used as a measure for the granuloma size (relative granuloma area; Figure 1D). We 
found that there was no significant difference between the granuloma sizes induced by SEA- and 
kappa-5-coated beads. 
To investigate the nature of the granulomas induced by the antigen-coated beads, 
granulomas within H&E-stained lung slides were screened for the presence of eosinophils, which 
is a hallmark for type 2 granulomas 3;6. 16.6 ± 2.9 % of the cells within the SEA-induced 
granulomas were eosinophils (Figure 1E). For the kappa-5-induced granulomas, the majority of 
inspected granulomas also contained eosinophils (10.7 ± 1.4 %; Figure 1E).  
 
The granuloma-inducing properties of kappa-5 are partly mediated by its LDN motifs  
To investigate whether the LDN motifs on kappa-5 are involved in the granuloma-inducing 
properties of this glycoprotein, kappa-5-coated beads were treated with β-N-
acetylhexosaminidase to remove LDN motifs (kappa-5Δhexnac beads). Nano-LC-MS analysis 
verified the nearly complete removal of unsubstituted GalNAc and GlcNAc residues from 
kappa-5, as shown for site N251 in Supplementary Figure 1. When tested in the pulmonary 
mouse model, the overall relative granuloma area of kappa-5Δhexnac beads was significantly 
lower as compared to that of untreated kappa-5 beads (Figure 2A). To further explore this 
difference, the potency of coated beads to induce granulomas, as well as the distribution of the 
different sizes of the granulomas induced, was studied. Interestingly, 33 % of the kappa-
5Δhexnac beads was no longer able to induce granulomas but instead induced monolayer 
reactions similar to the BSA control, compared to only 7 % of kappa-5 coated beads (Figures 2B 
and 2C). Moreover, when evaluating granuloma formation around individual beads, it became 
evident that the kappa5Δhexnac bead population contained more small-sized and less large-
sized granulomas as compared to untreated beads (Figure 2D and Supplementary Figure 2). The 
reduction in granuloma size upon LDN removal was due to a decrease in cell numbers, as a 
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strong correlation was found between granuloma area and cell numbers (r=0.468, p<0.001). To 
summarize, removal of LDN from kappa-5-coated beads resulted in a higher percentage of beads 
unable to induce granulomas and a reduction in granuloma cell numbers around the remaining, 
granuloma-inducing beads. 
Notably, kappa-5Δhexnac beads initiated similar, Th2-type granulomas as untreated 
kappa-5 beads, as was demonstrated by a comparable percentage of eosinophils within kappa-
5Δhexnac- and kappa-5-induced granulomas (10.3 ± 0.9 % and 10.7 ± 1.4 %, respectively).  
 
 
Figure 2. Enzymatic removal of LDN from kappa-5 leads to less and smaller sized granulomas. -N-
hexosaminidase-treated and untreated kappa-5 beads were injected into the lungs of mice and at 14 days post-
injection, granuloma formation was assessed. (A) The relative granuloma area (granuloma area divided by 
bead area) was assessed for untreated and treated kappa-5 beads. Graphs show mean values with SEM (Mann-
Whitney: * indicates p < 0.05). (B) Representative example of kappa-5 beads treated with -N-
acetylhexosaminidase inducing either a monolayer of cells or a multilayer granuloma. Lung slides are stained 
with H&E. (C) Percentage of beads surrounded by a monolayer of cells (monolayer) and beads surrounded by 
a granulomatous response (granuloma) for treated and untreated kappa-5 beads was calculated. (D) Untreated 
and treated kappa-5 beads surrounded by a granulomatous response (positive beads) were grouped on the 
basis of their relative granuloma area; small (<2), medium (2-4) and large (>4).  
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S. mansoni egg glycoconjugates induce strong Th2 type inflammatory responses in the host, 
which include the formation of granulomas around tissue-lodged eggs. Previous reports using a 
hepatic mouse model have demonstrated that glycans from S. mansoni SEA play a major role in 
the initiation of this inflammatory response 6. Also, in the same mouse model, LDN in the 
context of a synthetic glycoconjugate coated to beads was demonstrated to have similar 
granuloma-inducing properties 10. However, the native S. mansoni glycoproteins that carry these 
immunogenic glycans have remained undetermined. In this report, we present for the first time 
a single, native S. mansoni egg glycoprotein, the SEA-component kappa-5, with granuloma-
inducing properties. Moreover, we have found that the glycan motif LDN significantly 
contributes to this immunogenic effect. 
The type 2 granulomatous response induced by S. mansoni eggs and SEA-coated beads 
is characterized by an influx of Th2-polarized CD4+ cells, alternatively activated macrophages as 
well as eosinophils 3;6. As confirmed by the presence of eosinophils, we here show that 
granulomas induced by beads coated with kappa-5 and kappa-5Δhexnac share this type 2-
polarized nature. This indicates that the granulomatous properties of LDN and other, yet 
unknown components of kappa-5, could be of relevance during natural S. mansoni infection. 
Notably, the percentage of eosinophils in our SEA-induced granulomas is comparable with 
granulomas elicited by SEA beads in a similar model of pulmonary granuloma induction 9. 
Granulomas surrounding kappa-5 (Figure 1E) and kappa-5Δhexnac (data not shown) beads 
appear to contain lower percentages of eosinophils, although experiments need to be repeated to 
achieve statistical relevance. This might indicate that SEA contains other (glycosylated) proteins 
that have a positive effect on eosinophil infiltration.  
The mechanisms through which kappa-5 exerts the immunomodulatory effects 
described in this report, still need to be elucidated. However, the involvement of the glycan motif 
LDN indicates that recognition by pattern recognition receptors (PRRs) on antigen-presenting 
cells (APCs) might play an important role. PRRs which were previously shown to recognize 
LDN and/or GalNAc are galectin-3, MGL and Dectin-2. MGL is a C-type lectin with a narrow 
specificity for unsubstituted, terminal α- and β-linked N-acetylgalactosamine 14. Recognition of 
SEA by MGL has been demonstrated to be at least partially conferred by the GalNAc-containing 
LDN motifs 14. Moreover, in vitro recognition of kappa-5 by dendritic cells (DCs) is in part 
dependent on MGL binding (Chapter 4 of this thesis). However, MGL does not seem to 
recognize LN 14, a motif structurally related to LDN which has been shown to exhibit comparable 
granuloma-inducing properties, suggesting that other receptors recognizing both LDN as well as 
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LN are more likely to mediate their immunomodulatory effects. Galectin-3 recognizes both LDN 
and LN motifs and has previously been proposed to be a key molecule in S. mansoni granuloma 
formation, as it is upregulated in egg granulomas of S. mansoni-infected hamsters and mice and 
colocalizes with LDN-glycans on eggshells 10;15. However, galectin-3 -/- mice infected with S. 
mansoni only showed minor phenotypic changes compared to normal mice in terms of perioval 
granuloma formation 16-18. Therefore, this receptor does not seem to play an important role in 
the initiation or modulation of granulomas during natural infection. Recently, Dectin-2 has been 
shown to bind terminal galactose and GalNAc residues 19, and thus could be a potential receptor 
for both LN and LDN motifs. SEA has been demonstrated to be recognized by and signal via 
Dectin-2, and mice deficient for ASC and Nlrp2, signal molecules involved in SEA-induced 
Dectin-2 signaling, developed smaller granulomas around S. mansoni eggs 20. Hence, Dectin-2 
signaling might pose a potential mechanism for kappa-5 to modulate perioval granuloma 
formation.  
While we show that the LDN motifs on kappa-5 are involved in the granuloma-
inducing properties of kappa-5, the glycoprotein must contain other granulomagenic features, as 
β-N-acetylhexosaminidase-treated kappa-5 still contains some activity (Figure 2). Upon LDN 
removal, the major fraction of kappa-5 glycans consist of an N-glycan core containing two core 
fucose and a xylose, while a small fraction of glycans additionally carry an α3-fucosylated 
GlcNAc (Supplementary Figure 1). The latter structural element was however previously shown 
to lack granuloma-inducing properties in the hepatic mouse model 10. Also all other fucosylated 
structures tested were inactive in this model 10, suggesting that the di-fucosylated core is also not 
involved. A possible role for the core xylose residues on kappa-5 glycans in granuloma 
formation has so far not been investigated. In addition, involvement of the protein part of 
kappa-5 can also not be excluded, although the amino acid sequence of kappa-5 shares no 
similarities with any known functional motifs 11.  
Granuloma formation is initiated when eggs lodge into the organs of the host. The egg-
derived molecules involved in activation and maintenance of the granulomatous response may 
include soluble excretory/secretory (ES) glycoproteins as well as molecules associated with the 
egg shell. As kappa-5 is not considered to be secreted by eggs at the time point when granuloma 
formation sets in 11, it is unlikely that kappa-5 plays a dominant role in this stage of 
granulomagenesis. However, kappa-5 is effectively presented to the immune system as evident 
by the high antibody titers against kappa-5 that have been detected in S. mansoni-infected 
individuals 13. Moreover, it is believed that kappa-5 is a constituent of hatching fluid 11, to which 
the host presumably is exposed when eggs die in the tissues. While kappa-5 is capable of 
inducing granulomas in our model, in the biological context it might therefore be involved in the 
6 
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maintenance or modulation of granulomas. Well-studied immunomodulatory molecules that 
are probably presented to the immune system at the earlier stages of granuloma development are 
the major ES glycoproteins IPSE/α1 and omega-1. The LeX-dominated glycosylation of these 
two ES glycoproteins is unlikely to be directly involved in the initiation of granuloma formation, 
as LeX motifs on a synthetic glycoconjugate did not show any granuloma-inducing properties in 
a hepatic mouse model 10;21. IPSE/α1 has instead been reported to play a role in the down 
modulation of granuloma formation, as S. mansoni-infected mice that were treated with 
antibodies to block IPSE/α1 activity, developed significantly larger perioval granulomas 
compared to untreated infected mice 22. Besides a possible role for other secreted egg 
glycoproteins, also the egg shell may have glycan-dependent granuloma-inducing properties. It 
has been recently demonstrated that the shell of S. mansoni eggs is glycosylated 23, but clear 
structural information is lacking so far. 
To conclude, our data suggest that kappa-5 plays a role in the induction and 
modulation of periovular granulomas during schistosome infection, and that this property is 
partly dependent on the terminal LDN structures on the kappa-5 glycans. These data provide 
new insights in the glycan-dependent immunomodulatory properties of S. mansoni egg 
molecules. 
 
Material and Methods 
Animals 
Six week old female BALB/c mice were purchased from Harlan. Mice were housed under SPF 
conditions and all animal experiments were approved by the animal experimental committee of 
the University of Leiden, The Netherlands. 
 
Preparation of antigens and antigen-coated beads 
S. mansoni soluble egg antigens (SEA) was prepared and isolated as described previously 24. 
Kappa-5 was isolated by SBA affinity chromatography as described previously 12. For bead 
coating, 1 mg of glycoprotein was coupled to 1 ml Cyanogen bromide-activated Sepharose 4B 
heads (Sigma, St. Louis, MO), ranging in diameter from 45 to 165 μm, as previously described 7. 
50.000 kappa-5 coated beads were treated with 62.5 mU β-N-acetylhexosaminidase from 
Canavalia ensiformis (Sigma) in 100 mM sodium phosphate buffer, pH 5.0 for 24 h at 37°C, after 





Induction of pulmonary granulomas in mice 
BALB/c mice received 5000 antigen-coated beads suspended in sterile PBS i.v. in the lateral tail 
vein. Four mice were used for every set of beads. The animals were sacrificed 14 days after 
injection and lungs were removed. 
 
Light microscopy and immunohistochemistry  
To evaluate the granulomatous response, 4 μm-thick formalin-fixed paraffin-embedded lung 
sections as well as acetone-fixed cryostat sections were stained with H&E. Granuloma as well as 
bead areas were quantified using Bersoft Image Measurement Software v4.03 (Bersoft Inc., 
Puerto Plata, Dominican Republic) and the relative granuloma area was calculated, representing 
the average of the granuloma area divided by the average of the bead area. Only granulomas with 
visible central beads and bead area above 1600 μm2 were included. Also, granuloma sizes were 
grouped in small, medium and large-sized granulomas, based on relative granuloma areas of 
under 2 (small), between 2 to 4 (medium) and over 4 (large). For each experimental group, at 
least 50 granulomas were assessed and the variables were compared and statistically analyzed 
with a Mann-Whitney test. P values of less than 0.05 were considered significant. In addition, at 
least 20 granulomas per experimental group were visually inspected for the total number of cells 
and number of eosinophils.  
 
Mass spectrometry 
Trypsin (Promega, Leiden, The Netherlands) was added to a sample of the β-N-
acetylhexosaminidase and untreated kappa-5 beads at a 1:100 trypsin/antigen ratio and 
incubated overnight at 37 °C. Resulting (glyco)peptides were analyzed using nano-HPLC-ESI-
ion trap-MS as described previously 21.  
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Supplementary igure 1. -N-acetylhexosaminidase treatment of kappa-5 beads. Beads coated with kappa-
5 were either left untreated (A) or  treated with β- N-acetylhexosaminidase (B) and a sa mple of b eads was 
digested with trypsin. Resulting kappa-5 glycopeptides were analyzed by nano-LC-MS. The accumulative mass 
spectrum representing all glycoforms of the tryptic glycopeptide cont aining glycosylation site N251 is shown. 
Signals are labeled with monoisotopic masses. Differences in fucose, N-acetylglucosamine and N-
acetylgalactosamine content of the glycan moiety are indicated. Triangle, fucose; light square, N-


















Supplementary igure 2. Representative examples of small 
(A), medium (B) and large (C) sized granulomas. 
Granulomas were grouped on the ba sis of their  relative 


















Soluble egg glycoproteins of Schistosoma mansoni exhibit potent immunomodulatory properties 
including those that lead to T-helper 2 (Th2) polarization and granuloma formation 1. The 
glycans carried by these proteins are thought to be responsible for a large part of these properties 
by directing interactions with host lectins. Until now, most experiments supporting this line of 
thought have been performed with soluble egg antigen (SEA) preparations and/or synthetic, 
schistosome-related glycoconjugates 2-6. However, SEA comprises a very complex mixture of 
soluble glycoproteins 7 and therefore it is difficult to determine which individual glycoproteins 
or specific structural characteristics of SEA are involved. Moreover, when using synthetic 
glycoconjugates as a basis for immunological studies, certain aspects of native glycoproteins are 
not addressed, such as the spatial presentation of glycans and the influence of the underlying 
protein structure. Comprehensive analysis of single, native S. mansoni glycoproteins in terms of 
glycan and protein structure, lectin binding behavior as well as functional capacities is essential 
to achieve a more profound understanding of immunological properties of schistosome eggs. In 
this thesis, the structural features of the glycans expressed on three major egg glycoproteins and 
the role that these glycans play in various aspects of host-parasite interplay have been studied. 
 
One of these egg glycoproteins is the major ES component omega-1 8. Recently, omega-1 has 
been shown to harbor potent Th2 polarizing activities via modulation of dendritic cells (DCs), in 
vitro using human blood-derived cells and in vivo in mouse models 9;10. We show in chapter 2 
that omega-1 carries core-difucosylated diantennary N-glycans with one or more Galβ1-
4(Fucα1-3)GlcNAc (Lewis X, LeX) motifs in the antennae. These structural observations are 
particularly interesting because a) the same glycans are present on IPSE/α1, a second major ES 
glycoprotein with immunomodulatory properties 11;12; b) LeX as part of model glycoconjugates 
can modulate DC activation via DC-SIGN signaling, resulting in a immunological phenotype 
that is thought to be capable of inducing Th2 polarization 3;4;13-15. It is reasonable to speculate that 
omega-1 uses this mechanism to condition DCs for Th2 priming. However, in chapter 5 we 
show that DC-SIGN is dispensable for omega-1-induced Th2 polarization. Moreover, IPSE/α1, 
despite having similar glycans and C-type lectin receptor (CLR)-binding characteristics as 
omega-1 (12 and chapter 4), does not exhibit the same Th2-polarizing properties observed for 
omega-1 10. Interestingly, the reported immunomodulatory effects of IPSE/α1, i.e. induction of 
IL-4 release in human and murine basophils 16;17 and reduction of cellular infiltration into 
granulomas 18, do not require intact glycosylation 16-18. While literature suggests that respectively 
IgE binding- and chemotactic activities of IPSE/α1 are responsible for the immunological 
properties of this glycoprotein 11;16-18, we show in chapter 5 that the mechanism through which 
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native omega-1 induces DC-mediated Th2 polarization is based on internalization of omega-1 
via LeX-MR interactions, allowing its RNase activity to functionally modulate DCs. 
In accordance with a major role for MR in the immunomodulatory effects of omega-1, 
we demonstrate that MR is the dominant receptor on monocyte-derived immature DCs (iDCs) 
that recognizes the LeX-dominated glycosylation on soluble IPSE/α1 and omega-1, while DC-
SIGN interactions seem to be of only minor importance (chapter 4 and 5). In contrast to a 
dominant role for MR over DC-SIGN for these soluble LeX-expressing glycoproteins, MR binds 
only marginally to plate-coated LeX glycoconjugates (chapter 4 and 19), while DC-SIGN displays 
a strong affinity for these coated glycoconjugates as well as plate- and particle-coated SEA 
(chapter 4 and 5;20;21). These findings imply that the specificity of these CLR is at least partially 
dependent on the molecular presentation of the ligand. 
Several studies describing the CLR-dependent molecular mechanisms of 
immunomodulatory molecules from other pathogens in addition imply that the multivalency 
characteristics of a ligand can influence the mechanism of action. Ligation of MR on DC by 
specific mannosylated molecules, including the mannose-capped lipoarabinomannans 
(ManLAM) from Mycobacterium species, has been demonstrated to promote anti-inflammatory 
responses via the induction of anti-inflammatory cytokines and interference with pro-
inflammatory TLR signalling 15;22;23. Other mannosylated ligands for MR, including mannan and 
thyroglobulin, are not able to induce these signalling pathways 22. Cross-linking of MR by anti-
MR antibodies leads to similar effects as ManLAM, indicating that the polyvalent nature of 
ManLAM is involved in its MR-mediated effects 22;23. For DC-SIGN, it has been shown that 
pathogens expressing mannosylated (e.g. Mycobacterium tuberculosis and human 
immunodeficiency virus type 1; HIV-1) as well as fucosylated (Helicobacter pylori) glycan 
structures on a pathogenic surface can interfere with TLR-induced signaling via modulation of a 
signaling complex associated with DC-SIGN 15;24. The type of glycan moiety recognized by DC-
SIGN is critically important for the recruitment or dissociation of signaling molecules to the 
signaling complex. More importantly, the glycan moiety thereby affects the consequential 
modulation of cytokine responses. Mannose-mediated DC-SIGN signaling leads to upregulation 
of IL-10, IL-12 and IL-6 transcript while fucose-mediated signaling induces a more anti-
inflammatory profile with enhanced IL-10 levels and decreased IL-12 and IL-6 levels 15.  
These findings, combined with ours, indicate the presence of at least two separate 
mechanisms via which interplay of pathogen-associated or -derived glycoconjugates with CLRs 
can condition DCs for immune modulation of T cells: a) CLR-mediated internalization of 
bioactive molecules; and b) CLR-induced interference with TLR signalling. Which mechanism is 






spatial presentation, and co-stimulatory factors provided by the targeted molecule itself and/or 
surrounding pathogenic molecules. Interestingly, the fucosylated and mannosylated pathogeni-
derived molecules that are thought to induce functional DC signaling, are expressed on the 
surface of pathogens. Such a multivalent presentation of glycan ligands might be a prerequisite 
for functional signalling in DCs leading to Th polarization, and could explain why omega-1 and 
IPSE/α1, being secreted glycoproteins, are unable to use this specific type of mechanism 
(chapter 5).  
For kappa-5, the third major egg glycoprotein studied, no immunomodulatory function has 
been described in literature. We show in chapter 3 that kappa-5 mainly carries core-
difucosylated and -xylosylated triantennary N-glycans that are substituted with GalNAcβ1-
4GlcNAc (LacdiNAc, LDN) antennae, a minority of which carry an additional α3-linked fucose 
on the GlcNAc residue (LDN-F). These glycans mediate interaction of kappa-5 with DC-SIGN, 
MGL and MR (chapter 4), and at the same time are a target for IgE-binding (chapter 3), 
suggesting multiple roles for these glycans in the host-pathogen interaction. In chapter 6, we 
demonstrate in a pulmonary mouse model that native kappa-5 coated to Sepharose beads can 
induce type 2-polarized granulomatous responses, and that the LDN motifs on kappa-5 are 
involved in this process. These results indicate a dual role for kappa-5 as a granulomagenic as 
well as a Th2-modulating agent.  
The mechanism by which LDN induces granulomatous responses remains to be 
elucidated, but its recognition by CLRs on DCs suggests that CLR-expressing antigen-presenting 
cells (APCs) are likely to be involved. Also, preliminary data indicate a role for the chemokines 
CCL17 and CCL22, as mRNA expression of these glycoproteins could be induced in DCs upon 
kappa-5 stimulation (data not shown). CCL17 and CCL22 have been previously shown to be 
upregulated in presensitized mice upon tail vein injections of S. mansoni eggs 25, Moreover, these 
chemokines can functionally act via CCR4 which has been shown to be expressed on a wide 
array of immune cells including Th2 cells, eosinophils and macrophages, cells that are major 
constituents of the S. mansoni egg-induced granuloma 26-29. Neutralization of either of these 
chemokines in mice resulted in reduced egg granuloma size and eosinophil numbers as well as 
increased cytokine levels 26. Given these and our findings, we hypothesize that recognition of 
LDN motifs by CLRs on APCs leads to the release of CCL17 and CCL22 and therefore the 
attraction of CCR4-expressing immune cells. This may provide one mechanism of action via 
which eggs can induce and/or modulate type 2 granuloma formation.  
 
Unpublished findings indicate that kappa-5 is not the only granulomagenic component in SEA 
or ES, as depletion of kappa-5 does not completely abrogate the capacity of these mixtures to 
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induce granuloma formation in a pulmonary mouse model (data not shown). Likewise, SEA 
depleted of omega-1 is still able to induce Th2 polarization in a mouse model 10, indicating that 
other soluble egg (glyco)proteins are in addition involved in these immunomodulatory 
processes. Considerable data is now available on the proteome and glycome of S. mansoni eggs 
7;30;31. However, apart from the glycoproteins described in this thesis, it is generally unknown 
which proteins express which glycans, complicating the search for new immunogenic molecules. 
Still, the structural information of SEA and ES glycans provides interesting clues. Omega-1 and 
IPSE/α1 have been shown to be the main carriers of LeX motifs within the ES glycome 31, while 
kappa-5 is the major LDN-expressing glycoprotein within SEA (chapter 3). Therefore, we 
suggest that the remaining immunoactive soluble egg glycoproteins can modulate immune 
responses via other, yet undetermined, glycans and/or protein motifs. Major glycan motifs on 
these glycoproteins include α3-fucose and β2-xylose core modifications, fucosylated LDN 
motifs, and Fucα1-2Fucα1-3-HexNAc elements 30;31.  
For the fucosylated LDN motifs present on S. mansoni egg glycoproteins (see Table 2 
in chapter 1), we and others have shown that DC-SIGN recognizes the majority of these 
structures (chapter 4 and 20,21). Interestingly, LDN-based structures are expressed by many other 
helminth parasites that induce Th2-polarized responses, including Haemonchus contortus 32, 
Fasciola hepatica 33 and Trichinella spiralis 34;35. This is in contrast to LN/LeX motifs, that have 
only been found on schistosomes and the nematode Dictyocaulus viviparus 31;33. Thus, the 
fucosylated LDN motifs form common helminth ligands for DC-SIGN, although the 
significance of these motifs remains unknown.  
Fucα1-2Fucα1-3 (DF) elements are frequently occurring on LDN structures of egg O-
glycans, while only a minority of N-glycans seem to display this element 31;36. DF has so far not 
been reported in any species other than schistosomes, and therefore could potentially be very 
interesting in terms of immune recognition. Indeed, DF elements elicit high antibody responses 
during S. mansoni infection in humans and chimpanzees 37-39. Moreover, LDN-DF 
glycoconjugates induce a pronounced production of pro- and anti-inflammatory cytokines in 
peripheral-blood mononuclear cells (PBMCs) from non-exposed humans, to a level far higher 
than the production induced by other glycoconjugates including those terminating in LeX and 
LDN-F 40. The latter observation may indicate that DF elements may be involved in innate 
recognition of eggs by APCs. Our glycoconjugate array data show that DC-SIGN, MGL and MR 
do not or only slightly bind the DF-element on a single GlcNAc residue (chapter 4), and it was 
previously demonstrated that DC-SIGN is unable to bind LDN-DF 20, indicating that DC-SIGN, 
MGL and MR do not play a role in the recognition of DF elements by the immune system. To 






In addition to the described properties of soluble egg glycoproteins, insoluble 
components of the S. mansoni egg shell as well as glycolipids may also contain (glycosylated) 
molecules with immunomodulatory properties. Egg glycolipids have been shown to express 
LDN, LDN-F and LeX, as well as the DF-element in the form of repetitive Fucα1-2Fucα1-3-
HexNAc stretches 36,41, and have been linked to innate immunity 40. Recently, it has been shown 
that the egg shell also appears to be glycosylated 42. Moreover, we found that egg shell N-glycans 
are dominated by Galβ1-4GlcNAc (LacNAc, LN) motifs (unpublished finding), which as a part 
of asialofetuin on Sepharose beads have been shown to harbor granulomagenic properties 43.  
 
Concluding remarks 
Pathogens are recognized by the innate immune system via a multitude of conserved molecules 
that are bound by pattern recognition receptors (PRR) such as CLRs, leading to activation of the 
adaptive immune system. However, pathogens have evolved to modulate immune responses via 
the same group of molecules to ensure survival within the host. Schistosomes are particularly 
persistent, as clearance of these parasites usually does not occur without treatment. 
Immunogenic glycan motifs of egg molecules are suggested to play a major role in the 
immunomodulation leading to long term survival. 
While affecting CLR-induced signaling in DCs seems to be a common mechanism for 
pathogens to polarize Th-cell responses, we have shown that the S. mansoni egg glycoprotein 
omega-1 uses LeX-CLR interplay for its internalization into DCs, which is an essential step for 
the Th2 priming effect of this glycoprotein (chapter 2 and 5). In the case of IPSE/α1, intact 
glycosylation is dispensable for its anti-inflammatory and Th2 regulatory effects, although its 
glycans are efficiently recognized by CLRs (chapter 4). For kappa-5, we have shown that LDN 
glycosylation is involved in its granulomagenic properties (chapter 3 and 6). The exact 
mechanisms via which the immune system mediates this effect remain unclear, although CLR 
recognition of kappa-5 glycans might play a role (chapter 4). The approach used in this thesis, in 
which studies on primary structural features, binding properties, as well as functional effects of a 
single glycoprotein are combined, has helped to gain insight in the mechanisms of action of 
three S. mansoni egg glycoproteins and could also be useful for the identification of other 
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Schistosomes are parasitic helminths that cause chronical infections in over 200 million people 
in tropical and sub-tropical areas around the world. In the case of Schistosoma mansoni, one of 
the three major schistosome species infectious to humans, infection starts when cercariae 
penetrate the skin, after which the developing S. mansoni larvae travel to the mesenteric venules 
near the liver where they further mature. Adult male and female worms form pairs and start to 
produce eggs, which either leave the body to continue the life cycle, or get trapped in the liver 
and other organs. The host reacts to eggs and egg products by inducing Th2-mediated 
granulomatous immune responses which can lead to pathological tissue remodeling, fibrosis, 
severe organ damage and potentially death. 
The majority of molecular and immunological S. mansoni egg-related studies have 
been performed using SEA (soluble egg antigens), an experimental preparation consisting of the 
soluble egg proteins and glycoproteins. Part of the immunological activity associated with S. 
mansoni eggs is mediated by protein glycosylation. An extensive overview of the immunological 
capacities of SEA, as well as the current knowledge on immunogenic SEA glycans and 
glycoproteins, is given in chapter 1. This chapter in addition introduces common mass 
spectrometry-based methods and their application to identify glycan structures on egg 
glycoproteins. 
Three major, immunogenic SEA glycoproteins have been identified: omega-1, IPSE/α1 
and kappa-5. The studies described in this thesis focus on the structural and molecular details of 
these three glycoproteins and their interactions with the human and murine immune systems. In 
chapter 2 and 3, the glycosylation of omega-1 and kappa-5 were studied by a mass spectrometry 
(MS)-based approach. Glycoproteins were digested with trypsine and analysed by nanoscale LC-
MS and MALDI-TOF-MS to generate site-specific glycosylation information. Structural details 
were obtained by tandem mass analysis, exo-glycosidase treatments and anti-glycan antibodies 
We found that omega-1 contains two occupied glycosylation sites which for primarily carry 
diantennary N-glycans of the complex-type (chapter 2). The antennae are predominantly 
composed of Lewis X and N-acetyllactosamine structures, with a minority composed of 
(fucosylated) LDN structures. The innermost core N-acetylglucosamine is typically decorated 
with α3/α6 difucosylation. Interestingly, the glycosylation of IPSE/α1, which has previously been 
analyzed using a similar MS-based approach,  is highly identical to that of omega-1. Kappa-5 on 
the other hand was found to express a completely different set of glycans (chapter 3). It mainly 
carries triantennary N-glycans that are substituted with LDN antennae, a minority of which 
carry an additional α3-fucose on the GlcNAc (LDN-F). Like omega-1 and IPSE/α1, most kappa-
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5 glycans are α3/α6 core fucosylated, however kappa-5 glycans are in addition modified with a 
xylose attached to the β4-linked mannose. Notably, we found that kappa-5 is the major LDN-
expressing glycoprotein within SEA. 
 SEA glycan motifs are primarily recognized by C type lectin receptors (CLRs) that are 
expressed by antigen-presenting cells, a type of innate immune cells that include the dendritic 
cells (DCs). SEA glycoproteins induce responses in DCs that lead to a characteristic Th2 skewing 
of the host immune system.The recognition and uptake of SEA glycoproteins by DCs is largely 
mediated through three CLRs; DC-specific ICAM-3-grabbing nonintegrin (DC-SIGN), 
mannose receptor (MR) and macrophage galactose-type lectin (MGL). Chapter 4 investigates 
the binding of these receptors to native IPSE/α1 and kappa-5, in a plate-based assay as well as in 
a cellular context. To define the structural elements involved in binding to the three receptors, 
glycoprotein variants were created using exo-glycosidase digestions. In Chapter 5, a similar 
strategy was used to investigate binding of omega-1 to DC-SIGN and MR. We found that 
IPSE/α1 and omega-1 are primarily recognized by DCs via the interaction of LeX on the egg 
glycoproteins and MR on DCs. DC-SIGN and MGL are in addition involved in binding of DCs 
to IPSE/α1, albeit to a much lesser extent. Kappa-5 is recognized by DC-SIGN, MR and MGL 
without one of these being the dominant receptor, as well as via other, Ca2+-independent 
receptor(s). Kappa-5 interacts with DC-SIGN via its LDN-F antennae, whereas binding of MR 
may involve either LDN-F antennae or the fucosylated and xylosylated chitobiose core. MGL 
binding of kappa-5 was mediated via LDN as well as LDN-F antennae. The binding studies in 
chapter 4 and 5 provide a molecular basis for the CLR-mediated interaction of DCs with 
individual, native glycoproteins of schistosome eggs. 
 It has long been established that the SEA mixture has Th2 polarizing properties;, but 
the SEA molecules responsible for this effect have remained unknown. Recently, omega-1 was 
reported to be a major Th2-inducing component of SEA through functional modulation of DCs. 
In Chapter 5, we show using site-directed mutagenesis that two features of omega-1, its 
glycosylation and RNase activity, are involved in this process. Omega-1 glycosylation is 
necessary for the internalization of omega-1 by DCs. We show that this process is mediated via 
the interaction between LeX on omega-1 and MR on DCs. Within the cell, the RNase activity of 
omega-1 can then block protein production via cleavage of ribosomal RNA, leading to the 
conditioning of DCs for Th2 polarization. The immunological data as described in chapter 5 
provide new insights in the molecular processes that direct Th2 induction. 
To study S. mansoni perioval granuloma formation, mouse models involving the 
injection of Sepharose beads into liver or lungs are commonly used tools. The beads can be 






enabling the identification of native granuloma-inducing and/or modulating molecules. Using 
such a model, SEA-induced granuloma formation has previously been demonstrated to be 
dependent on glycosylation. Interestingly, beads coated with LDN and N-acetyllactosamine-
terminating glycoconjugates were able to induce granulomatous responses similar to SEA. As we 
found in chapter 4 that kappa-5 is the major LDN-expressing glycoprotein in SEA, we 
hypothesized that kappa-5 might be an important granuloma-modulating molecule within eggs. 
Indeed, we showed in chapter 6 that kappa-5 coated beads are able to induce granulomatous 
reactions in a pulmonary mouse model. Kappa-5-induced granulomas contain eosinophils, 
indicating a Th2-polarized nature that is also observed in egg- and SEA-induced granulomas. 
LDN is partly responsible for this effect, as enzymatic removal of LDN from kappa-5 coated 
beads results in significantly less and smaller granulomas as opposed to untreated kappa-5. 
Chapter 6 describes kappa-5 as the first, native S. mansoni egg molecule with glycan-dependent, 
granuloma-inducing properties.  
Various mechanisms exist via which interplay of pathogen-derived glycoconjugates 
with CLR on innate immune cells can mediate immunomodulation. In Chapter 7, we discuss 
the CLR-dependent mechanisms exploited by omega-1, IPSE/α1 and kappa-5, as well as related 
pathogenic molecules, in the light of the results presented in this thesis and previously published 
data. We conclude that pathogens make use of at least two separate CLR-dependent mechanisms 
to condition DCs for immune modulation of T cells: CLR-mediated internalization of bioactive 
molecules; and CLR-induced interference with TLR signalling. In chapter 7 we additionally 
review the knowledge on other egg glycoconjugates and glycan motifs that might also be 











Nederlandse samenvatting  
 
Schistosomen zijn parasitaire wormen die in veel tropische en sub-tropische landen voor grote 
medische en sociaal-economische problemen zorgen. In het geval van Schistosoma mansoni, een 
van de drie belangrijkste schistosoom soorten die mensen infecteren, start de infectie als 
cercariën de huid binnendringen. Eenmaal in het lichaam verplaatsen ze zich naar de lever, 
terwijl ze zich ontwikkelen tot volwassen wormen. Een volwassen vrouwelijke en mannelijke 
worm vormen een paartje en beginnen eieren te produceren. Een substantieel deel van deze 
eieren verlaat het menselijk lichaam om de levenscyclus te vervolgen, maar een ander deel loopt 
vast in de lever en andere organen. De menselijke gastheer reageert op deze eieren door middel 
van een Th2-gemedieerde granulomateuze immuunrespons, die kan leiden tot pathologische 
weefselveranderingen, fibrose, ernstige orgaanschade en in sommige gevallen zelfs tot de dood. 
De meerderheid van de moleculaire en immunologische S. mansoni ei-gerelateerde 
studies is uitgevoerd met behulp van SEA (oplosbare -Soluble- Ei Antigenen). SEA is een 
experimenteel mengsel van oplosbare ei proteïnen en glycoproteïnen. Een deel van de 
immunologische activiteit geassocieerd met S. mansoni eieren wordt gemedieerd door de 
glycosylering op de SEA glycoproteïnen. Hoofdstuk 1 geeft een uitgebreid overzicht van de 
immunologische capaciteiten van SEA en van de huidige kennis over immunogene SEA 
glycanen en glycoproteïnen. Dit hoofdstuk beschrijft daarnaast de meest gangbare massa 
spectrometrie (MS) methoden die gebruikt worden om glycaan structuren op ei glycoproteïnen 
te identificeren.  
Er zijn drie belangrijke, immunogene glycoproteïnen in SEA geïdentificeerd; omega-1, 
IPSE/α1 and kappa-5. De studies die in dit proefschrift worden beschreven richten zich op de 
structurele en moleculaire details van deze drie glycoproteïnen en hun interacties met de 
immuunsystemen van de mens en de muis. In hoofdstuk 2 en 3 hebben we met behulp van MS 
de glycosylering van omega-1 en kappa-5 bestudeerd. Om site-specifieke glycosylerings 
informatie te verkrijgen, zijn de glycoproteïnen behandeld met trypsine en geanalyseerd met 
nano-LC-MS en MALDI-TOF-MS. Daarnaast is gebruik gemaakt van tandem mass analyse, exo-
glycosidase behandelingen en anti-glycaan antilichamen om de structurele details te ontrafelen. 
Het blijkt dat omega-1 twee glycosylerings sites bevat die voor het grootste deel bezet zijn met 
diantennaire N-glycanen van het complexe type (hoofdstuk 2). De antennes bestaan 
voornamelijk uit Lewis X en N-acetyllactosamine structuren, en voor een kleiner gedeelte uit 
(gefucosyleerde) LDN structuren. De core van de meeste omega-1 glycanen is bezet een α3- en 
een α6-gebonden fucose. Interessant is dat de glycosylering van IPSE/α1, die al eerder is 
geanalyseerd met behulp van een vergelijkbare methode, erg lijkt op die van omega-1. Kappa-5 
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bevat daarentegen een compleet verschillende set glycanen (hoofdstuk 3). Dit glycoproteïne 
draagt voornamelijk triantennaire N-glycanen met LDN antennes, waarvan een klein gedeelte 
nog een extra α3-fucose op de GlcNAc heeft (LDN-F). Net als omega-1 en IPSE/α1 hebben de 
meeste kappa-5 glycanen twee α3/α6-gebonden fucoses op de core, maar kappa-5 glycanen 
dragen nog een extra xylose op de β4-gebonden mannose. We laten in hoofdstuk 3 ook zien dat 
kappa-5 het belangrijkste, LDN-bevattende glycoproteïne in SEA is. 
SEA glycaan motieven worden voornamelijk herkend door C-type lectine receptoren 
(CLRs), die zich bevinden op het oppervlak van antigeen-presenterende cellen (APCs). APCs 
zijn een type immuuncellen waaronder onder meer de dendritische cellen (DCs) vallen. SEA 
glycoproteïnen induceren responsen in DCs die leiden tot een karakteristieke Th2 polarisatie 
van het immuunsysteem van de gastheer. De herkenning en opname van SEA glycoproteïnen 
door DCs wordt voor een groot deel bepaald door drie CLRs; DC-specific ICAM-3-grabbing 
nonintegrin (DC-SIGN), mannose receptor (MR) and macrophage galactose-type lectin (MGL). 
In hoofdstuk 4 hebben we de binding van deze drie receptoren aan natuurlijk IPSE/α1 and 
kappa-5 onderzocht. Om de structurele elementen te definiëren die betrokken zijn bij de binding 
aan de drie receptoren, zijn varianten van IPSE/α1 en kappa-5 gemaakt met behulp van exo-
glycosidase digesties. In hoofdstuk 5 hebben we een soortgelijke strategie gebruikt om de 
binding van omega-1 aan DC-SIGN en MR te onderzoeken.  Het blijkt dat IPSE/α1 en omega-1 
voornamelijk door DCs worden herkend via de interactie van LeX op deze ei glycoproteïnen met 
de MR op DCs. Bij de binding van DCs aan IPSE/α1 zijn daarnaast DC-SIGN en MGL 
betrokken, alhoewel in veel mindere mate. Kappa-5 wordt in vergelijkbare mate herkend door 
zowel DC-SIGN, MR en MGL op DCs. Daarnaast zijn nog andere, Ca2+-onafhankelijke, 
receptoren betrokken bij de herkenning van kappa-5 door DCs. De binding tussen kappa-5 en 
DC-SIGN wordt gemedieerd door LDN-F, terwijl bij de kappa-5-MR binding mogelijk de LDN-
F danwel de fucoses en/of xylose op de chitobiose core betrokken zijn. De binding van MGL aan 
kappa-5 gaat via de LDN en LDN-F motieven. De binding studies van hoofdstuk 4 en 5 geven 
een moleculaire basis voor de CLR-gemedieerde interactie tussen DCs en individuele 
schistosoom ei glycoproteïnen. 
Het is al eerder vastgesteld dat het SEA mengsel een Th2-polariserend effect heeft. 
Echter, de SEA moleculen die verantwoordelijk zijn voor dit effect waren nog onbekend. Recent 
is gebleken dat omega-1 een belangrijke component in SEA is die Th2 responsen kan induceren 
via functionele modulatie van DCs. In hoofdstuk 5 beschrijven we twee eigenschappen van 
omega-1 die betrokken zijn bij dit proces: glycosylering en RNase activiteit. De glycosylering van 
omega-1, en meer specifiek de  interactie tussen LeX op omega-1 en MR op DCs, is nodig voor 






omega-1 de proteïne productie via de afbraak van ribosomaal RNA. Dit leidt uiteindelijk tot de 
conditionering van DCs voor Th2 polarisatie. De immunologische data die in hoofdstuk 5 
worden beschreven bevatten nieuwe inzichten in de moleculaire processen die leiden tot de 
inductie van Th2 responsen. 
Bij de bestudering van granuloomvorming rondom S. mansoni eieren wordt vaak 
gebruik gemaakt van muis modellen waarbij Sepharose partikels in the lever of longen worden 
gespoten. Aan de partikels kunnen verscheidene schistosoom ei moleculen worden gekoppeld, 
waardoor identificatie van natuurlijke granuloma-inducerende en -modulerende moleculen 
mogelijk wordt. Met behulp van een dergelijk model is eerder aangetoond dat SEA granulomen 
kan induceren, en dat dit afhankelijk is van glycosylering. Daarnaast is ook gebleken dat 
glycoconjugaten met LDN en N-acetyllactosamine een granulomateuze respons kunnen 
induceren die lijkt op de respons geïnduceerd door SEA. Omdat we in hoofdstuk 4 lieten zien 
dat kappa-5 het belangrijkste LDN-bevattende glycoproteïne in SEA is, vermoedden wij dat 
kappa-5 wellicht een belangrijk granulomogeen molecuul in eieren is. We laten in hoofdstuk 6 
zien dat kappa-5 gekoppeld aan partikels inderdaad granulomen kan induceren in een long 
model in muizen. We laten verder zien dat deze granulomen eosinofielen bevatten, wat aangeeft 
dat ze, net als de granulomen rondom eieren en SEA, Th2 gepolariseerd zijn. LDN is deels 
verantwoordelijk voor het granulomogene effect, aangezien kappa-5 partikels waarvan LDN op 
enzymatische wijze verwijderd is, minder en kleinere granulomen induceren in vergelijking met 
onbehandelde kappa-5 partikels. Hoofdstuk 6 beschrijft kappa-5 als het eerste, natuurlijke S. 
mansoni ei molecuul met glycaan-afhankelijke granulomogene eigenschappen. 
Er bestaan verscheidene mechanismen waarop de interacties tussen glycoconjugaten 
van pathogenen en CLR op immuuncellen kunnen leiden tot immuunmodulatie, zoals de 
inductie van signaleringsroutes of de internalisatie van bioactieve moleculen. In hoofdstuk 7 
bespreken we, in het licht van de resultaten uit dit proefschrift, de CLR-afhankelijke 
mechanismen betrokken bij de immunologische effecten van omega-1, IPSE/α1, kappa-5 en 
gerelateerde pathogene moleculen. We beschrijven ook andere ei glycoconjugaten en glycaan 
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